# ===========================================================================
#
#                            PUBLIC DOMAIN NOTICE
#               National Center for Biotechnology Information
#
#  This software/database is a "United States Government Work" under the
#  terms of the United States Copyright Act.  It was written as part of
#  the author's official duties as a United States Government employee and
#  thus cannot be copyrighted.  This software/database is freely available
#  to the public for use. The National Library of Medicine and the U.S.
#  Government have not placed any restriction on its use or reproduction.
#
#  Although all reasonable efforts have been taken to ensure the accuracy
#  and reliability of the software and data, the NLM and the U.S.
#  Government do not and cannot warrant the performance or results that
#  may be obtained by using this software or data. The NLM and the U.S.
#  Government disclaim all warranties, express or implied, including
#  warranties of performance, merchantability or fitness for any particular
#  purpose.
#
#  For daily update, we screen the search results of this PubMed query:
#  "coronavirus"[All Fields] OR "ncov"[All Fields] OR "cov"[All Fields] OR
#  "2019-nCoV"[All Fields] OR "COVID-19"[All Fields] OR "SARS-CoV-2"[All Fields].
#  Relevant articles are identified and curated with assistance from an automated
#  machine-learning and text-classification algorithm.
#
#  Please cite the authors in any work or product based on this material :
#
#  Chen Q, Allot A, & Lu Z. (2020) Keep up with the latest coronavirus research, Nature 579:193
#
#  Chen Q, Allot A, Lu Z. LitCovid: an open database of COVID-19 literature. Nucleic Acids Research. 2020.
#
# ==========================================================================
pmid	title_e	journal
36250091	Molecular characterization of a new SARS-CoV-2 recombinant cluster XAG identified in Brazil.	Front Med (Lausanne)
36248817	SARS-CoV-2 variants Alpha, Beta, Delta and Omicron show a slower host cell interferon response compared to an early pandemic variant.	Front Immunol
36248791	Immunological study of COVID-19 vaccine candidate based on recombinant spike trimer protein from different SARS-CoV-2 variants of concern.	Front Immunol
36248312	A Genetically Engineered Biofilm Material for SARS-CoV-2 Capturing and Isolation.	Adv Mater Interfaces
36247553	A recombinant subunit vaccine candidate produced in plants elicits neutralizing antibodies against SARS-CoV-2 variants in macaques.	Front Plant Sci
36246069	Recombinant expression of SARS-CoV-2 receptor binding domain (RBD) in Escherichia coli and its immunogenicity in mice.	Iran J Basic Med Sci
36243381	Novel coronavirus mutations: Vaccine development and challenges.	Microb Pathog
36228897	Recombinant protein polymer-antibody conjugates for applications in nanotechnology and biomedicine.	Adv Drug Deliv Rev
36225252	Spike S1 domain interactome in non-pulmonary systems: A role beyond the receptor recognition.	Front Mol Biosci
36224764	Expression and Immunogenicity of SARSCoV- 2 Virus-Like Particles based on Recombinant Truncated HEV-3 ORF2 Capsid Protein.	J Microbiol Biotechnol
36223774	Reduced B cell antigenicity of Omicron lowers host serologic response.	Cell Rep
36223228	Artificial Cell Membrane Polymersome-Based Intranasal Beta Spike Formulation as a Second Generation Covid-19 Vaccine.	ACS Nano
36222988	SARS-CoV-2 Vaccines: Types, Working Principle, and Its Impact on Thrombosis and Gastrointestinal Disorders.	Appl Biochem Biotechnol
36220879	Galectin-3 binding protein stimulated IL-6 expression is impeded by antibody intervention in SARS-CoV-2 susceptible cell lines.	Sci Rep
36220274	Biophysical and structural characterizations of the effects of mutations on the structure-activity relationships of SARS-CoV-2 spike protein.	Methods Enzymol
36217145	As the virus evolves, so too must we: a drug developer's perspective : We need a new paradigm in searching for next-generation countermeasures.	Virol J
36211961	Engineering recombinantly expressed lectin-based antiviral agents.	Front Cell Infect Microbiol
36210931	Inspiration to mRNA-based COVID-19 vaccination: Serious adverse case reports with hepatitis B vaccine in real-world.	Front Pediatr
36210481	Safety and Efficacy of the NVX-CoV2373 COVID-19 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial.	Clin Infect Dis
36207334	The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotype.	Nat Commun
36205380	Rapid and sensitive SARS-CoV-2 detection using a homogeneous fluorescent immunosensor Quenchbody with crowding agents.	Analyst
36204257	A Hitchhiker's Guide to Worldwide COVID-19 Vaccinations: A Detailed Review of Monovalent and Bivalent Vaccine Schedules, COVID-19 Vaccine Side Effects, and Effectiveness Against Omicron and Delta Variants.	Cureus
36204065	Production and secretion of functional SARS-CoV-2 spike protein in Chlamydomonas reinhardtii.	Front Plant Sci
36203571	Saliva is suitable for SARS-CoV-2 antibodies detection after vaccination: A rapid systematic review.	Front Immunol
36202985	A novel vaccine based on SARS-CoV-2 CD4(+) and CD8(+) T cell conserved epitopes from variants Alpha to Omicron.	Sci Rep
36202799	DNA-delivered antibody cocktail exhibits improved pharmacokinetics and confers prophylactic protection against SARS-CoV-2.	Nat Commun
36202252	Novel bridge multi-species ELISA for detection of SARS-CoV-2 antibodies.	J Immunol Methods
36199292	Therapeutic Approaches in COVID-19 Patients: The Role of the Renin-Angiotensin System.	Can Respir J
36198531	[COVID-19 vaccination for allogeneic hematopoietic stem cell recipients].	Rinsho Ketsueki
36198358	An efficient approach for SARS-CoV-2 monoclonal antibody production via modified mRNA-LNP immunization.	Int J Pharm
36197765	Cohort-Specific Serological Recognition of SARS-CoV-2 Variant RBD Antigens.	Ann Clin Lab Sci
36194133	SARS-CoV-2 3CL(pro) mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376.	Sci Transl Med
36192065	Systematic analysis and comparison of O-glycosylation of five recombinant spike proteins in beta-coronaviruses.	Anal Chim Acta
36191145	Recombinant Protein Micelles to Block Transduction by SARS-CoV-2 Pseudovirus.	ACS Nano
36189653	Optimized rapid production of recombinant secreted proteins in CHO cells grown in suspension: the case of RBD.	Biotechnol Appl Biochem
36189209	SARS-CoV-2 neutralizing camelid heavy-chain-only antibodies as powerful tools for diagnostic and therapeutic applications.	Front Immunol
36188733	Mucosal COVID-19 vaccines: Risks, benefits and control of the pandemic.	World J Virol
36188435	Immunogenicity, durability, and safety of an mRNA and three platform-based COVID-19 vaccines as a third dose following two doses of CoronaVac in China: A randomised, double-blinded, placebo-controlled, phase 2 trial.	EClinicalMedicine
36183680	Immunoglobulin yolk targeting spike 1, receptor binding domain of spike glycoprotein and nucleocapsid of SARS-CoV-2 blocking RBD-ACE2 binding interaction.	Int Immunopharmacol
36177742	Development of functional anti-Gn nanobodies specific for SFTSV based on next generation sequencing and proteomics.	Protein Sci
36177466	Receptor-binding domain-anchored peptides block binding of severe acute respiratory syndrome coronavirus 2 spike proteins with cell surface angiotensin-converting enzyme 2.	Front Microbiol
36176309	Acquired hemophilia following COVID-19 vaccination: Case report and review of literature.	Res Pract Thromb Haemost
36164386	Short Term Effect of Corona Virus Diseases Vaccine on the Menstrual Cycles.	Int J Womens Health
36163863	CLL-050 Induction of Neutralizing Antibodies in Chronic Lymphocytic Leukemia Patients After SARS-CoV-2 mRNA Vaccination: A Monocentric Experience.	Clin Lymphoma Myeloma Leuk
36163133	Mamestra brassicae NIAS-Mb-32 cell strain 2g2 enables high-yield recombinant protein production in baculovirus-free and baculovirus-based insect cell expression.	J Biosci Bioeng
36162760	An albumin-angiotensin converting enzyme 2-based SARS-CoV-2 decoy with FcRn-driven half-life extension.	Acta Biomater
36161446	The DEAD box RNA helicase DDX42 is an intrinsic inhibitor of positive-strand RNA viruses.	EMBO Rep
36159845	Recombinant COVID-19 vaccine based on recombinant RBD/Nucleoprotein and saponin adjuvant induces long-lasting neutralizing antibodies and cellular immunity.	Front Immunol
36156215	A fast, ultrasensitive SERS immunoassay to detect SARS-CoV-2 in saliva.	Anal Chim Acta
36154880	Will Peptides Help to Stop COVID-19?	Biochemistry (Mosc)
36152463	A six-month study of anti-SARS-CoV-2 BNT162b2 mRNA vaccination: A comparative analysis of essential trace elements and anti-RBD IgG sera levels.	J Trace Elem Med Biol
36152043	Humoral immunoresponse elicited against an adenoviral-based SARS-CoV-2 coronavirus vaccine in elderly patients.	Aging (Albany NY)
36151805	[Preparation and immungenicity of recombinant protein containing intramolecular adjuvant in SARS-CoV-2 RBD domain].	Sheng Wu Gong Cheng Xue Bao
36151100	Inactivated rabies-vectored SARS-CoV-2 vaccine provides long-term immune response unaffected by vector immunity.	NPJ Vaccines
36148457	Epitope mapping of severe acute respiratory syndrome coronavirus 2 neutralizing receptor binding domain-specific monoclonal antibodies.	Front Med (Lausanne)
36146847	Cross-Reactivity of SARS-CoV-2 Nucleocapsid-Binding Antibodies and Its Implication for COVID-19 Serology Tests.	Viruses
36146826	Enhancing the Immunogenicity of RBD Protein Variants through Amino Acid E484 Mutation in SARS-CoV-2.	Viruses
36146823	Molecular Analyses of Clinical Isolates and Recombinant SARS-CoV-2 Carrying B.1 and B.1.617.2 Spike Mutations Suggest a Potential Role of Non-Spike Mutations in Infection Kinetics.	Viruses
36146713	Heterogenous CD8+ T Cell Maturation and 'Polarization' in Acute and Convalescent COVID-19 Patients.	Viruses
36146661	A Novel Single-Stranded RNA-Based Adjuvant Improves the Immunogenicity of the SARS-CoV-2 Recombinant Protein Vaccine.	Viruses
36146579	Human Fc-Conjugated Receptor Binding Domain-Based Recombinant Subunit Vaccines with Short Linker Induce Potent Neutralizing Antibodies against Multiple SARS-CoV-2 Variants.	Vaccines (Basel)
36146526	Analysis of Adverse Effects of COVID-19 Vaccines Experienced by Healthcare Workers at Guizhou Provincial Staff Hospital, China.	Vaccines (Basel)
36145416	Strain Variation Based on Spike Glycoprotein Gene of SARS-CoV-2 in Kuwait from 2020 to 2021.	Pathogens
36145267	Potential Coronaviral Inhibitors of the Nucleocapsid Protein Identified In Silico and In Vitro from a Large Natural Product Library.	Pharmaceuticals (Basel)
36143354	SARS-CoV-2 and HIV: Impact on Pulmonary Epithelial Cells.	Life (Basel)
36142345	SARS-CoV-2 Spike Proteins and Cell-Cell Communication Inhibits TFPI and Induces Thrombogenic Factors in Human Lung Microvascular Endothelial Cells and Neutrophils: Implications for COVID-19 Coagulopathy Pathogenesis.	Int J Mol Sci
36140622	Molecular Characterization of Whole-Genome SARS-CoV-2 from the First Suspected Cases of the XE Variant in the Lazio Region, Italy.	Diagnostics (Basel)
36140339	A Protein Microarray-Based Respiratory Viral Antigen Testing Platform for COVID-19 Surveillance.	Biomedicines
36140256	The Effects of H2S and Recombinant Human Hsp70 on Inflammation Induced by SARS and Other Agents In Vitro and In Vivo.	Biomedicines
36139010	Impact of SARS-CoV-2 RBD Mutations on the Production of a Recombinant RBD Fusion Protein in Mammalian Cells.	Biomolecules
36136995	An ACE2-dependent Sarbecovirus in Russian bats is resistant to SARS-CoV-2 vaccines.	PLoS Pathog
36129018	Structural communication fingerprinting and dynamic investigation of RBD-hACE2 complex from BA.1 x AY.4 recombinant variant (Deltacron) of SARS-CoV-2 to decipher the structural basis for enhanced transmission.	J Biomol Struct Dyn
36123381	Identification and characterization of a novel cell binding and cross-reactive region on spike protein of SARS-CoV-2.	Sci Rep
36121829	SARS-CoV-2-specific immunoglobulin Y antibodies are protective in infected mice.	PLoS Pathog
36120494	Simple neutralization test report: Do probiotics contribute to COVID-19 therapy?	Biochem Biophys Rep
36120231	COVID-19 Vaccine Clinical Trials: A Bird's Eye Perspective.	Cureus
36115850	A randomized controlled trial of heterologous ChAdOx1 nCoV-19 and recombinant subunit vaccine MVC-COV1901 against COVID-19.	Nat Commun
36115213	Glucocorticoid use as a cause of non-cellular immune response to SARS-Cov2 Spike in patients with immune system diseases.	J Autoimmun
36113829	Modular nanoarray vaccine for SARS-CoV-2.	Nanomedicine
36110455	Attenuation of Human Growth Hormone-Induced Rash With Graded Dose Challenge.	Cureus
36106692	Type I interferon receptor signalling deficiency results in dysregulated innate immune responses to SARS-CoV-2 in mice.	Eur J Immunol
36096430	Evaluating the efficacy and safety of SpikoGen(R), an Advax-CpG55.2-adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine: a phase 3 randomized placebo-controlled trial.	Clin Microbiol Infect
36095143	Obesity Is Associated with Attenuated Tissue Immunity in COVID-19.	Am J Respir Crit Care Med
36093444	Case series of nebulizing r-tPA for COVID-19 induced acute respiratory distress syndrome.	Clin Case Rep
36091032	A century of BCG vaccination: Immune mechanisms, animal models, non-traditional routes and implications for COVID-19.	Front Immunol
36088193	Permissive omicron breakthrough infections in individuals with binding or neutralizing antibodies to ancestral SARS-CoV-2.	Vaccine
36077564	Antiviral Activity of N1,N3-Disubstituted Uracil Derivatives against SARS-CoV-2 Variants of Concern.	Int J Mol Sci
36075374	SARS-CoV-2 dual infection with Delta and Omicron variants in an immunocompetent host: a case report.	Int J Infect Dis
36075211	Spike protein-independent attenuation of SARS-CoV-2 Omicron variant in laboratory mice.	Cell Rep
36073022	Efficacy of hydrogen peroxide wipes for decontamination of AZD1222 adenovirus COVID-19 vaccine strain on pharmaceutical industry materials.	Lett Appl Microbiol
36071962	Simultaneous measurement of the antibody responses against SARS-CoV-2 and its multiple variants by a phage display mediated immuno-multiplex quantitative PCR-based assay.	Front Microbiol
36070806	A 21L/BA.2-21K/BA.1 "MixOmicron" SARS-CoV-2 hybrid undetected by qPCR that screen for variant in routine diagnosis.	Infect Genet Evol
36069551	A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection.	J Virol
36069348	A replication-competent smallpox vaccine LC16m8Delta-based COVID-19 vaccine.	Emerg Microbes Infect
36069130	Antiviral activity of Cenostigma pluviosum var. peltophoroides extract and fractions against SARS-CoV-2.	J Biomol Struct Dyn
36065800	Semen characteristics of individuals before and after CovishieldTM vaccination.	Reprod Fertil
36065751	Myocarditis following COVID-19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases.	Eur J Heart Fail
36064951	Utility of in silico-identified-peptides in spike-S1 domain and nucleocapsid of SARS-CoV-2 for antibody detection in COVID-19 patients and antibody production.	Sci Rep
36064667	Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology.	Vaccine
36064410	Steric accessibility of the N-terminus improves the titer and quality of recombinant proteins secreted from Komagataella phaffii.	Microb Cell Fact
36064262	mRNA-based therapies: Preclinical and clinical applications.	Int Rev Cell Mol Biol
36063568	Flexible, disposable photocatalytic plastic films for the destruction of viruses.	J Photochem Photobiol B
36062974	SARS-CoV-2 spike trimer vaccine expressed in Nicotiana benthamiana adjuvanted with Alum elicits protective immune responses in mice.	Plant Biotechnol J
36061868	Development of a panel of three multiplex allele-specific qRT-PCR assays for quick differentiation of recombinant variants and Omicron subvariants of SARS-CoV-2.	Front Cell Infect Microbiol
36060923	Review on Approved and Inprogress COVID-19 Vaccines.	Iran J Pharm Res
36055873	Intranasal immunization with recombinant Vaccinia virus encoding trimeric SARS-CoV-2 spike receptor-binding domain induces neutralizing antibody.	Vaccine
36053553	SARS-CoV-2 ORF8 is a viral cytokine regulating immune responses.	Int Immunol
36053300	[Fecal microbiota transplantation: indications, risks and opportunities].	Inn Med (Heidelb)
36048877	Cytochromes P450 2C8 and 3A Catalyze the Metabolic Activation of the Tyrosine Kinase Inhibitor Masitinib.	Chem Res Toxicol
36048716	Electrochemical Immunosensors Based on Zinc Oxide Nanorods for Detection of Antibodies Against SARS-CoV-2 Spike Protein in Convalescent and Vaccinated Individuals.	ACS Biomater Sci Eng
36043125	SARS-CoV-2 recombinant spike protein induces cell apoptosis in rat taste buds.	J Dent Sci
36037810	Effectiveness of Booster and Influenza Vaccines against COVID-19 among Healthcare Workers, Taiwan.	Emerg Infect Dis
36034096	A Changing World in Gene Therapy Research: Exciting Opportunities for Medical Advancement and Biosafety Challenges.	Appl Biosaf
36032096	Display of receptor-binding domain of SARS-CoV-2 Spike protein variants on the Saccharomyces cerevisiae cell surface.	Front Immunol
36031045	Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation.	Nanomedicine
36030585	Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?	Biomed Pharmacother
36029105	Safety and immunogenicity of a recombinant receptor-binding domain-based protein subunit vaccine (Noora vaccine) against COVID-19 in adults: A randomized, double-blind, placebo-controlled, Phase 1 trial.	J Med Virol
36027618	An integrated metabolomic and proteomic approach for the identification of covalent inhibitors of the main protease (M(pro)) of SARS-COV-2 from crude natural extracts.	Talanta
36026606	S100A8/A9 drives the formation of procoagulant platelets through GPIbalpha.	Blood
36018753	A personal COVID-19 dendritic cell vaccine made at point-of-care: Feasibility, safety, and antigen-specific cellular immune responses.	Hum Vaccin Immunother
36016321	Role of Genetic Polymorphism Present in Macrophage Activation Syndrome Pathway in Post Mortem Biopsies of Patients with COVID-19.	Viruses
36016181	SARS-CoV-2 Subunit Virus-like Vaccine Demonstrates High Safety Profile and Protective Efficacy: Preclinical Study.	Vaccines (Basel)
36015150	Recombinant Decoy Exhibits Broad Protection against Omicron and Resistance Potential to Future Variants.	Pharmaceuticals (Basel)
36014368	Investigation of the N-Glycosylation of the SARS-CoV-2 S Protein Contained in VLPs Produced in Nicotiana benthamiana.	Molecules
36007475	Selective reversed-phase high-performance liquid chromatography method for the determination of intact SARS-CoV-2 spike protein.	J Chromatogr A
36006993	High activity of an affinity-matured ACE2 decoy against Omicron SARS-CoV-2 and pre-emergent coronaviruses.	PLoS One
36004989	Determination of rSpike Protein by Specific Antibodies with Screen-Printed Carbon Electrode Modified by Electrodeposited Gold Nanostructures.	Biosensors (Basel)
36004516	Methods to evaluate the impact of SARS-CoV-2 nucleocapsid mutations on antigen detection by rapid diagnostic tests.	Biotechniques
36003367	T cell perturbations persist for at least 6 months following hospitalization for COVID-19.	Front Immunol
35997943	Amubarvimab/Romlusevimab: First Approval.	Drugs
35995361	The current status of COVID-19 vaccines. A scoping review.	Drug Discov Today
35995266	Biochemical Characterization of Emerging SARS-CoV-2 Nsp15 Endoribonuclease Variants.	J Mol Biol
35994646	SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern.	Proc Natl Acad Sci U S A
35993765	Qualification of a Biolayer Interferometry Assay to Support AZD7442 Resistance Monitoring.	Microbiol Spectr
35993012	DEVELOPMENT AND VALIDATION OF AN ENZYME-LINKED IMMUNOASSAY KIT FOR DIAGNOSIS AND SURVEILLANCE OF COVID-19.	J Clin Virol Plus
35991037	SARS-CoV-2 and Plasmodium falciparum Co-Infection in a Returning Traveler.	Front Public Health
35989498	Celastrol: A lead compound that inhibits SARS-CoV-2 replication, the activity of viral and human cysteine proteases, and virus-induced IL-6 secretion.	Drug Dev Res
35985887	Functional profiling of Covid 19 vaccine candidate by flow virometry.	Vaccine
35982925	Construction and Immunogenicity of a Recombinant Pseudorabies Virus Expressing SARS-CoV-2-S and SARS-CoV-2-N.	Front Vet Sci
35980204	Monitoring SARS-CoV-2 Infection Using a Double Reporter-Expressing Virus.	Microbiol Spectr
35980012	Sialic Acid and Fucose Residues on the SARS-CoV-2 Receptor-Binding Domain Modulate IgG Antibody Reactivity.	ACS Infect Dis
35979616	Multisystem Inflammatory Syndrome in Adults (MIS-A) After COVID-19 Infection and Recent Vaccination with Recombinant Adenoviral Vector Encoding the Spike Protein Antigen of SARS-CoV-2 (ChAdOx1 nCoV-19, Vaxzevria).	J Intensive Care Med
35979461	The acceptance to heterologous booster vaccination of COVID-19 vaccine among HCWs and targeted population: A cross-sectional study in central China.	Front Public Health
35978541	Genomics and pathogenesis of the avian coronavirus infectious bronchitis virus.	Aust Vet J
35978143	The spike of SARS-CoV-2 promotes metabolic rewiring in hepatocytes.	Commun Biol
35967905	Adenovirus-vectored SARS-CoV-2 vaccine expressing S1-N fusion protein.	Antib Ther
35967447	BSL2-compliant lethal mouse model of SARS-CoV-2 and variants of concern to evaluate therapeutics targeting the Spike protein.	Front Immunol
35967350	Reduced binding activity of vaccine serum to omicron receptor-binding domain.	Front Immunol
35967323	Human surfactant protein D facilitates SARS-CoV-2 pseudotype binding and entry in DC-SIGN expressing cells, and downregulates spike protein induced inflammation.	Front Immunol
35963274	Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trial.	Lancet Infect Dis
35962463	Expedient Synthesis of Ubiquitin-like Protein ISG15 Tools through Chemo-Enzymatic Ligation Catalyzed by a Viral Protease Lb(pro).	Angew Chem Int Ed Engl
35959109	Development and validation of an enzyme-linked immunoassay kit for diagnosis and surveillance of COVID-19.	J Clin Virol Plus
35953030	An engineered SARS-CoV-2 receptor-binding domain produced in Pichia pastoris as a candidate vaccine antigen.	N Biotechnol
35952714	Pandemic-scale phylogenomics reveals the SARS-CoV-2 recombination landscape.	Nature
35949340	Immune thrombocytopenic purpura induced by the COVID-19 vaccine after the second dose in a 78-year-old patient: A case report.	Exp Ther Med
35943810	NVX-CoV2373 vaccination induces functional SARS-CoV-2-specific CD4+ and CD8+ T cell responses.	J Clin Invest
35941922	Towards Control and Oversight of SARS-CoV-2 Diagnosis and Monitoring through Multiplexed Quantitative Electroanalytical Immune Response Biosensors.	Angew Chem Weinheim Bergstr Ger
35935962	Immunogenicity of a vaccinia virus-based severe acute respiratory syndrome coronavirus 2 vaccine candidate.	Front Immunol
35935759	Case report: Successful outcome of COVID-19 in the context of autologous hematopoietic stem cell transplantation: The impact of the anti-SARS-CoV-2 vaccine and early remdesivir.	Front Med (Lausanne)
35933571	Expression of Codon-Optimized Gene Encoding Murine Moloney Leukemia Virus Reverse Transcriptase in Escherichia coli.	Protein J
35930194	Jacareubin inhibits TLR4-induced lung inflammatory response caused by the RBD domain of SARS-CoV-2 Spike protein.	Pharmacol Rep
35928505	Adjunctive Recombinant Human Plasma Gelsolin for Severe Coronavirus Disease 2019 Pneumonia.	Open Forum Infect Dis
35925807	Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged >/=18 years - United States, July 2022.	MMWR Morb Mortal Wkly Rep
35922243	[Advances in clinical research of virus vector-based COVID-19 vaccines].	Zhonghua Yu Fang Yi Xue Za Zhi
35917969	Rational design of AAVrh10-vectored ACE2 functional domain to broadly block the cell entry of SARS-CoV-2 variants.	Antiviral Res
35916825	The SARS-CoV-2 rS1-E-PLGA nanovaccine and evaluation of its immune effect in BALB/c mice.	Eur Rev Med Pharmacol Sci
35915784	Omicron SARS-CoV-2 epidemic in England during February 2022: A series of cross-sectional community surveys.	Lancet Reg Health Eur
35915635	Temperature-Responsive Liposome-Linked Immunosorbent Assay for the Rapid Detection of SARS-CoV-2 Using Immunoliposomes.	ACS Omega
35915123	Sputnik-V reactogenicity and immunogenicity in the blood and mucosa: a prospective cohort study.	Sci Rep
35914959	COVID-19 management landscape: A need for an affordable platform to manufacture safe and efficacious biotherapeutics and prophylactics for the developing countries.	Vaccine
35910658	A Comprehensive Review of the Protein Subunit Vaccines Against COVID-19.	Front Microbiol
35910603	Mapping Genetic Events of SARS-CoV-2 Variants.	Front Microbiol
35906244	Mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-2.	NPJ Vaccines
35905562	Current evidence on the use of anakinra in COVID-19.	Int Immunopharmacol
35902282	Engineering ACE2 decoy receptors to combat viral escapability.	Trends Pharmacol Sci
35896714	Characterization of binding interactions of SARS-CoV-2 spike protein and DNA-peptide nanostructures.	Sci Rep
35895717	A highly efficacious live attenuated mumps virus-based SARS-CoV-2 vaccine candidate expressing a six-proline stabilized prefusion spike.	Proc Natl Acad Sci U S A
35895480	Composition of naturally occurring compounds decreases activity of Omicron and SARS-CoV-2 RdRp complex.	Eur J Microbiol Immunol (Bp)
35893672	Fixed-Dose Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Pulmonary Embolism Associated with COVID-19.	Viruses
35891490	Hyperimmunized Chickens Produce Neutralizing Antibodies against SARS-CoV-2.	Viruses
35891385	Inhibitors of Deubiquitinating Enzymes Interfere with the SARS-CoV-2 Papain-like Protease and Block Virus Replication In Vitro.	Viruses
35891306	Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector.	Vaccines (Basel)
35891234	The COVID-19 Vaccination Still Matters: Omicron Variant Is a Final Wake-Up Call for the Rich to Help the Poor.	Vaccines (Basel)
35891232	Immunity after COVID-19 Recovery and Vaccination: Similarities and Differences.	Vaccines (Basel)
35891178	Safety and Immunogenicity of Inactivated Bacillus subtilis Spores as a Heterologous Antibody Booster for COVID-19 Vaccines.	Vaccines (Basel)
35890352	Using Dual Toll-like Receptor Agonism to Drive Th1-Biased Response in a Squalene- and alpha-Tocopherol-Containing Emulsion for a More Effective SARS-CoV-2 Vaccine.	Pharmaceutics
35890179	The N-Methyl-D-Aspartate Receptor Blocker REL-1017 (Esmethadone) Reduces Calcium Influx Induced by Glutamate, Quinolinic Acid, and Gentamicin.	Pharmaceuticals (Basel)
35890050	GMP Manufacturing and IND-Enabling Studies of a Recombinant Hyperimmune Globulin Targeting SARS-CoV-2.	Pathogens
35888077	Emerging SARS-CoV-2 Mutational Variants of Concern Should Not Vary in Susceptibility to Microbicidal Actives.	Life (Basel)
35886882	Engineered Sleeping Beauty Transposon as Efficient System to Optimize Chimp Adenoviral Production.	Int J Mol Sci
35885534	An RBD-Based Diagnostic Method Useful for the Surveillance of Protective Immunity against SARS-CoV-2 in the Population.	Diagnostics (Basel)
35884237	Silent Antibodies Start Talking: Enhanced Lateral Flow Serodiagnosis with Two-Stage Incorporation of Labels into Immune Complexes.	Biosensors (Basel)
35880589	Comment on Recombinant Adjuvanted Zoster Vaccine and Reduced Risk of Coronavirus Disease 2019 Diagnosis and Hospitalization in Older Adults.	J Infect Dis
35879941	Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trial.	EClinicalMedicine
35878004	Protease-Responsive Peptide-Conjugated Mitochondrial-Targeting AIEgens for Selective Imaging and Inhibition of SARS-CoV-2-Infected Cells.	ACS Nano
35876794	A Single-Component Luminescent Biosensor for the SARS-CoV-2 Spike Protein.	J Am Chem Soc
35874709	Vascular Endothelial Growth Factor Receptor, fms-Like Tyrosine Kinase-1 (Flt-1), as a Novel Binding Partner for SARS-CoV-2 Spike Receptor-Binding Domain.	Front Immunol
35874089	From a recombinant key antigen to an accurate, affordable serological test: Lessons learnt from COVID-19 for future pandemics.	Biochem Eng J
35867642	ACE2-like enzyme B38-CAP suppresses abdominal sepsis and severe acute lung injury.	PLoS One
35864694	Post ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant) (Covishield) Pulmonary Thromboembolism with Multiple Intracranial Ischemic Infarcts.	Neurol India
35862952	RG203KR Mutations in SARS-CoV-2 Nucleocapsid: Assessing the Impact Using a Virus-Like Particle Model System.	Microbiol Spectr
35862442	Structure-selected RBM immunogens prime polyclonal memory responses that neutralize SARS-CoV-2 variants of concern.	PLoS Pathog
35860236	In Vitro Exposure of Primary Human T Cells and Monocytes to Polyclonal Stimuli Reveals a Basal Susceptibility to Display an Impaired Cellular Immune Response and Develop Severe COVID-19.	Front Immunol
35860023	Virofree, an Herbal Medicine-Based Formula, Interrupts the Viral Infection of Delta and Omicron Variants of SARS-CoV-2.	Front Pharmacol
35859447	Incidence of COVID-19 among individuals vaccinated with ChAdOx1 nCoV-19 vaccine (recombinant) against SARS-CoV-2 at a tertiary health care centre in Telangana.	Indian J Med Res
35859438	Reporting adverse events of ChAdOx1 nCoV-19 coronavirus vaccine (Recombinant) among the vaccinated healthcare professionals: A cross-sectional survey.	Indian J Med Res
35859071	A Bayesian approach to infer recombination patterns in coronaviruses.	Nat Commun
35856283	Recombinant protein subunit COVID-19 vaccine-induced Guillain-Barre Syndrome in an adolescent: A case report.	Br J Clin Pharmacol
35853454	Emergence and widespread circulation of a recombinant SARS-CoV-2 lineage in North America.	Cell Host Microbe
35852257	Is there an interplay between the SARS-CoV-2 spike protein and Platelet-Activating factor?	Biofactors
35847120	Clinical Characteristics of Omicron SARS-CoV-2 Variant Infection After Non-mRNA-Based Vaccination in China.	Front Microbiol
35841263	Evidence of antibodies against SARS-CoV-2 in wild mustelids from Brittany (France).	Transbound Emerg Dis
35839756	Multi-species outbreak of SARS-CoV-2 Delta variant in a zoological institution, with the detection in two new families of carnivores.	Transbound Emerg Dis
35838231	Utilization of SUMO Tag and Freeze-thawing Method for a High-level Expression and Solubilization of Recombinant Human Angiotensinconverting Enzyme 2 (rhACE2) Protein in E. coli.	Protein Pept Lett
35837255	Plant-produced recombinant SARS-CoV-2 receptor-binding domain; an economical, scalable biomaterial source for COVID-19 diagnosis.	Biomater Transl
35837077	The Impact on COVID-19 by Intravenous Bevacizumab Used for Hereditary Hemorrhagic Telangiectasia: A Case Report.	J Med Cases
35834710	Challenging treatment for refractory acquired haemophilia A complicated with severe severe acute respiratory coronavirus 2 infection.	Blood Coagul Fibrinolysis
35822799	In-Line Monitoring of Downstream Purification Processes for VSV Based SARS-CoV-2 Vaccine Using a Novel Technique.	BioTech (Basel)
35822796	Highly Efficient Purification of Recombinant VSV-G-Spike Vaccine against SARS-CoV-2 by Flow-Through Chromatography.	BioTech (Basel)
35821476	Bioluminescent and Fluorescent Reporter-Expressing Recombinant SARS-CoV-2.	Methods Mol Biol
35821156	Transjugular intrahepatic portosystemic shunt, local thrombaspiration, and lysis for management of fulminant portomesenteric thrombosis and atraumatic splenic rupture due to vector-vaccine-induced thrombotic thrombocytopenia: a case report.	J Med Case Rep
35820941	Intranasal administration of a live-attenuated recombinant newcastle disease virus expressing the SARS-CoV-2 Spike protein induces high neutralizing antibody levels and protects from experimental challenge infection in hamsters.	Vaccine
35817736	Long-term efficacy, safety, and medication compliance of roxadustat on peritoneal dialysis patients with renal anemia affected by the COVID-19 pandemic: a retrospective study.	Ann Palliat Med
35816998	Lectin Pathway Enzyme MASP-2 and Downstream Complement Activation in COVID-19.	J Innate Immun
35816490	Development of an aerosol intervention for COVID-19 disease: Tolerability of soluble ACE2 (APN01) administered via nebulizer.	PLoS One
35814334	Conserved recombination patterns across coronavirus subgenera.	Virus Evol
35813261	Novaferon Effectively Inhibits Ancestral SARS-CoV-2 and Omicron Variant in Vitro, 2022.	China CDC Wkly
35812633	Acute Extensive Deep Vein Thrombosis After Heterogeneous Administration of Moderna mRNA Booster Vaccine: A Case Report.	Cureus
35812392	Monocytic-Myeloid Derived Suppressor Cells Suppress T-Cell Responses in Recovered SARS CoV2-Infected Individuals.	Front Immunol
35809371	Safety and immunogenicity of intramuscular, single-dose V590 (rVSV-SARS-CoV-2 Vaccine) in healthy adults: Results from a phase 1 randomised, double-blind, placebo-controlled, dose-ranging trial.	EBioMedicine
35808102	Self-Assembled Nanoscale Materials for Neuronal Regeneration: A Focus on BDNF Protein and Nucleic Acid Biotherapeutic Delivery.	Nanomaterials (Basel)
35807537	From Repurposing to Redesign: Optimization of Boceprevir to Highly Potent Inhibitors of the SARS-CoV-2 Main Protease.	Molecules
35802999	Preclinical study of formulated recombinant nucleocapsid protein, the receptor binding domain of the spike protein, and truncated spike (S1) protein as vaccine candidates against COVID-19 in animal models.	Mol Immunol
35801956	A novel SARS-CoV-2 subunit vaccine engineered on an immune-activating platform technology.	Hum Vaccin Immunother
35800833	Acute Myocardial Infarction After COVID-19 Vaccination: A Case Report.	Cureus
35798332	Use of REGEN-COV in children after heart transplantation for treatment and post-exposure prophylaxis of COVID-19.	Cardiol Young
35798154	CaZnO-based nanoghosts for the detection of ssDNA, pCRISPR and recombinant SARS-CoV-2 spike antigen and targeted delivery of doxorubicin.	Chemosphere
35795227	Design and assembly of plant-based COVID-19 candidate vaccines: resmall es, Cyrillicent development and future prospects.	Vavilovskii Zhurnal Genet Selektsii
35792966	Application of Baculovirus Expression Vector system (BEV) for COVID-19 diagnostics and therapeutics: a review.	J Genet Eng Biotechnol
35792906	Optimized expression of large fragment DNA polymerase I from Geobacillus stearothermophilus in Escherichia coli expression system.	Prep Biochem Biotechnol
35791687	Rapid improvement in severe long COVID following perispinal etanercept.	Curr Med Res Opin
35790245	The COVID-19 Oral Drug Molnupiravir Is a CES2 Substrate: Potential Drug-Drug Interactions and Impact of CES2 Genetic Polymorphism In Vitro.	Drug Metab Dispos
35789966	Milk of Cow and Goat, Immunized by Recombinant Protein Vaccine ZF-UZ-VAC2001(Zifivax), Contains Neutralizing Antibodies Against SARS-CoV-2 and Remains Active After Standard Milk Pasteurization.	Front Nutr
35788687	Exosomes decorated with a recombinant SARS-CoV-2 receptor-binding domain as an inhalable COVID-19 vaccine.	Nat Biomed Eng
35788676	Development of an in-house quantitative ELISA for the evaluation of different Covid-19 vaccines in humans.	Sci Rep
35786476	[Expression of a SARS-CoV-2 neutralizing nanobody in Trichoderma reesei].	Sheng Wu Gong Cheng Xue Bao
35786475	[Discovery of SARS-CoV-2 main protease inhibitors using an optimized FRET-based high-throughput screening assay].	Sheng Wu Gong Cheng Xue Bao
35781796	Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants.	EMBO Mol Med
35777803	Abstracts of Presentations at the Association of Clinical Scientists 143(rd) Meeting Louisville, KY May 11-14,2022.	Ann Clin Lab Sci
35760812	Safety and immunogenicity of a hybrid-type vaccine booster in BBIBP-CorV recipients in a randomized phase 2 trial.	Nat Commun
35760254	Discovery of 2-thiobenzimidazoles as noncovalent inhibitors of SARS-CoV-2 main protease.	Bioorg Med Chem Lett
35758850	Immunogenicity and safety of SpikoGen(R), an adjuvanted recombinant SARS-CoV-2 spike protein vaccine as a homologous and heterologous booster vaccination: A randomized placebo-controlled trial.	Immunology
35757700	Remodeling of T Cell Dynamics During Long COVID Is Dependent on Severity of SARS-CoV-2 Infection.	Front Immunol
35757314	Deltacron is a recombinant variant of SARS-CoV-2 but not a laboratory mistake.	Ann Med Surg (Lond)
35754530	Development of an Indirect ELISA for the Detection of SARS-CoV-2 Antibodies in Cats.	Front Vet Sci
35752633	Detection of SARS-CoV-2 intra-host recombination during superinfection with Alpha and Epsilon variants in New York City.	Nat Commun
35750222	Validation of laboratory developed serology assays for detection of IgG antibody to severe acute respiratory syndrome coronavirus 2 in the South African population.	J Virol Methods
35748575	Adjuvant-Protein Conjugate Vaccine with Built-In TLR7 Agonist on S1 Induces Potent Immunity against SARS-CoV-2 and Variants of Concern.	ACS Infect Dis
35746737	Sequential Appearance and Isolation of a SARS-CoV-2 Recombinant between Two Major SARS-CoV-2 Variants in a Chronically Infected Immunocompromised Patient.	Viruses
35746710	Recombination in Coronaviruses, with a Focus on SARS-CoV-2.	Viruses
35746653	Vaccination with BNT162b2 and ChAdOx1 nCoV-19 Induces Cross-Reactive Anti-RBD IgG against SARS-CoV-2 Variants including Omicron.	Viruses
35746599	Characterization of Immune Response Diversity in Rodents Vaccinated with a Vesicular Stomatitis Virus Vectored COVID-19 Vaccine.	Viruses
35746505	Chimeric Antigen by the Fusion of SARS-CoV-2 Receptor Binding Domain with the Extracellular Domain of Human CD154: A Promising Improved Vaccine Candidate.	Vaccines (Basel)
35745526	Utilization of Recombinant Baculovirus Expression System to Produce the RBD Domain of SARS-CoV-2 Spike Protein.	Pathogens
35743208	Electrochemical Determination of Interaction between SARS-CoV-2 Spike Protein and Specific Antibodies.	Int J Mol Sci
35738968	Immunogenicity and safety of booster dose of S-268019-b or BNT162b2 in Japanese participants: An interim report of phase 2/3, randomized, observer-blinded, noninferiority study.	Vaccine
35736981	Non-Invasive Detection of SARS-CoV-2 Antigen in Saliva versus Nasopharyngeal Swabs Using Nanobodies Conjugated Gold Nanoparticles.	Trop Med Infect Dis
35731343	Simulation of COVID-19 symptoms in a genetically engineered mouse model: implications for the long haulers.	Mol Cell Biochem
35729949	Balanced cytokine upregulation by diluted ethanolic extract of Bryonia alba in Delta SARS-CoV-2 Spike protein RBD-induced pathogenesis in Gallus gallus embryo.	Bull Natl Res Cent
35729204	S100A4 exerts robust mucosal adjuvant activity for co-administered antigens in mice.	Mucosal Immunol
35725862	Intranasal vaccination of hamsters with a Newcastle disease virus vector expressing the S1 subunit protects animals against SARS-CoV-2 disease.	Sci Rep
35724739	Probing effects of the SARS-CoV-2 E protein on membrane curvature and intracellular calcium.	Biochim Biophys Acta Biomembr
35723031	Production of a functionally active recombinant SARS-CoV-2 (COVID-19) 3C-like protease and a soluble inactive 3C-like protease-RBD chimeric in a prokaryotic expression system.	Epidemiol Infect
35721551	SARS-CoV-2 Nucleocapsid Protein is Associated With Lower Testosterone Levels: An Experimental Study.	Front Physiol
35720155	Covishield vaccine induces robust immune responses in Bangladeshi adults.	IJID Reg
35719329	Validation of Serological Methods for COVID-19 and Retrospective Screening of Health Employees and Visitors to the Sao Paulo University Hospital, Brazil.	Front Cell Infect Microbiol
35717706	Principles of SARS-CoV-2 glycosylation.	Curr Opin Struct Biol
35715738	SARS-CoV-2: phenotype, genotype, and characterization of different variants.	Cell Mol Biol Lett
35713340	Peptide Binder with High-Affinity for the SARS-CoV-2 Spike Receptor-Binding Domain.	ACS Appl Mater Interfaces
35709328	Preferential uptake of SARS-CoV-2 by pericytes potentiates vascular damage and permeability in an organoid model of the microvasculature.	Cardiovasc Res
35709296	RANBP2 and USP9x regulate nuclear import of adenovirus minor coat protein IIIa.	PLoS Pathog
35708323	In Vitro Selection of Remdesivir-Resistant SARS-CoV-2 Demonstrates High Barrier to Resistance.	Antimicrob Agents Chemother
35705439	Molecular aspects of Omicron, vaccine development, and recombinant strain XE: A review.	J Med Virol
35702275	Antibodies against spike protein of SARS-CoV-2 variants in bovine whey IgG enriched fraction.	Int Dairy J
35695536	Production of High-Titer Recombinant Newcastle Disease Virus from Allantoic Fluid.	J Vis Exp
35693788	Safety and Efficacy of Combined Intramuscular/Intranasal RAZI-COV PARS Vaccine Candidate Against SARS-CoV-2: A Preclinical Study in Several Animal Models.	Front Immunol
35693215	The SARS-CoV-2 spike L452R-E484Q variant in the Indian B.1.617 strain showed significant reduction in the neutralization activity of immune sera.	Precis Clin Med
35691872	Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeys.	Vaccine
35691871	Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trials.	Vaccine
35691295	Safety and immunogenicity of the FINLAY-FR-1A vaccine in COVID-19 convalescent participants: an open-label phase 2a and double-blind, randomised, placebo-controlled, phase 2b, seamless, clinical trial.	Lancet Respir Med
35690161	Production and characterization of chimeric SARS-CoV-2 antigens based on the capsid protein of cowpea chlorotic mottle virus.	Int J Biol Macromol
35689434	Immunogenicity and efficacy of Ad26.COV2.S: An adenoviral vector-based COVID-19 vaccine.	Immunol Rev
35686904	Correlation of Angiotensin-converting Enzyme 2 Gene (rs1514283) Polymorphism with the Incidence of COVID-19.	J Popul Ther Clin Pharmacol
35686572	Efficacy of heterologous boosting against SARS-CoV-2 using a recombinant interferon-armed fusion protein vaccine (V-01): a randomized, double-blind and placebo-controlled phase III trial.	Emerg Microbes Infect
35682988	Smaller, Stronger, More Stable: Peptide Variants of a SARS-CoV-2 Neutralizing Miniprotein.	Int J Mol Sci
35681221	Recombinant ACE2 protein protects against acute lung injury induced by SARS-CoV-2 spike RBD protein.	Crit Care
35679343	Intranasal inoculation of an MVA-based vaccine induces IgA and protects the respiratory tract of hACE2 mice from SARS-CoV-2 infection.	Proc Natl Acad Sci U S A
35679246	Immunological investigation of a multiepitope peptide vaccine candidate based on main proteins of SARS-CoV-2 pathogen.	PLoS One
35678205	The baculovirus expression vector system: a modern technology for the future of influenza vaccine manufacturing.	Expert Rev Vaccines
35676539	Structure and activity of human TMPRSS2 protease implicated in SARS-CoV-2 activation.	Nat Chem Biol
35666264	Antigen-adjuvant interactions, stability, and immunogenicity profiles of a SARS-CoV-2 receptor-binding domain (RBD) antigen formulated with aluminum salt and CpG adjuvants.	Hum Vaccin Immunother
35665745	Immunogenicity and safety of NVSI-06-07 as a heterologous booster after priming with BBIBP-CorV: a phase 2 trial.	Signal Transduct Target Ther
35664651	Development of amperometric biosensor based on cloned hemagglutinin gene of H1N1 (swine flu) virus.	3 Biotech
35664008	Preclinical Assessment of IgY Antibodies Against Recombinant SARS-CoV-2 RBD Protein for Prophylaxis and Post-Infection Treatment of COVID-19.	Front Immunol
35663971	Bomidin: An Optimized Antimicrobial Peptide With Broad Antiviral Activity Against Enveloped Viruses.	Front Immunol
35663946	Comparison of Immune Responses Elicited by SARS-CoV-2 mRNA and Recombinant Protein Vaccine Candidates.	Front Immunol
35662254	A DNA vaccine candidate delivered by an electroacupuncture machine provides protective immunity against SARS-CoV-2 infection.	NPJ Vaccines
35659605	Recombinant chimpanzee adenovirus vector vaccine expressing the spike protein provides effective and lasting protection against SARS-CoV-2 infection in mice.	Virol Sin
35657058	Acute Unilateral Central Serous Chorioretinopathy after Immunization with Pfizer-BioNTech COVID-19 Vaccine: A Case Report and Literature Review.	Semin Ophthalmol
35655852	Immune-Mediated Thrombotic Thrombocytopenic Purpura Following mRNA-Based COVID-19 Vaccine BNT162b2: Case Report and Mini-Review of the Literature.	Front Med (Lausanne)
35655391	Antibody response three months after SARS-CoV-2 infection.	J Med Virol
35654621	Broad neutralization against SARS-CoV-2 variants induced by ancestral and B.1.351 AS03-Adjuvanted recombinant Plant-Derived Virus-Like particle vaccines.	Vaccine
35653804	Template-Assisted De Novo Sequencing of SARS-CoV-2 and Influenza Monoclonal Antibodies by Mass Spectrometry.	J Proteome Res
35652636	A Qualitative Comparison of the Abbott SARS-CoV-2 IgG II Quant Assay against Commonly Used Canadian SARS-CoV-2 Enzyme Immunoassays in Blood Donor Retention Specimens, April 2020 to March 2021.	Microbiol Spectr
35643023	Viral vector vaccines.	Curr Opin Immunol
35634958	Persistence of immune responses to the Sinopharm/BBIBP-CorV vaccine.	Immun Inflamm Dis
35634276	Safety and Immunogenicity of Inactivated and Recombinant Protein SARS-CoV-2 Vaccines in Patients With Thyroid Cancer.	Front Immunol
35632741	SARS-CoV-2 Envelope (E) Protein Binds and Activates TLR2 Pathway: A Novel Molecular Target for COVID-19 Interventions.	Viruses
35632717	Development and Scalable Production of Newcastle Disease Virus-Vectored Vaccines for Human and Veterinary Use.	Viruses
35632656	SARS-CoV-2 Virus-like Particles Produced by a Single Recombinant Baculovirus Generate Anti-S Antibody and Protect against Variant Challenge.	Viruses
35632644	Targeting of Silver Cations, Silver-Cystine Complexes, Ag Nanoclusters, and Nanoparticles towards SARS-CoV-2 RNA and Recombinant Virion Proteins.	Viruses
35632475	BCG-Based Vaccines Elicit Antigen-Specific Adaptive and Trained Immunity against SARS-CoV-2 and Andes orthohantavirus.	Vaccines (Basel)
35632432	A COVID-19 Vaccine for Dogs Prevents Reverse Zoonosis.	Vaccines (Basel)
35632412	Clinical and Immunologic Efficacy of the Recombinant Adenovirus Type-5-Vectored (CanSino Bio) Vaccine in University Professors during the COVID-19 Delta Wave.	Vaccines (Basel)
35628365	A Novel Human Neutralizing mAb Recognizes Delta, Gamma and Omicron Variants of SARS-CoV-2 and Can Be Used in Combination with Sotrovimab.	Int J Mol Sci
35620035	SARS-CoV-2 recombinant XN, Italy.	J Clin Virol Plus
35618994	Long-term evaluation of the COVID-19 pandemic impact on acute stroke management: an analysis of the 21-month data from a medical facility in Tokyo.	Acta Neurol Belg
35617687	Injection of Recombinant Tissue Plasminogen Activator into Extracorporeal Membrane Oxygenators Postpones Oxygenator Exchange in COVID-19.	ASAIO J
35617368	Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): A randomized, observer-blinded, placebo-controlled trial.	PLoS Med
35614524	A bivalent vaccine containing D614G and BA.1 spike trimer proteins or a BA.1 spike trimer protein booster shows broad neutralizing immunity.	J Med Virol
35609032	Immunization with SARS-CoV-2 Nucleocapsid protein triggers a pulmonary immune response in rats.	PLoS One
35607743	A Case Report of Herpes Zoster Ophthalmicus and Meningitis After COVID-19 Vaccination.	J Korean Med Sci
35606235	Phase 1/2 clinical trial of COVID-19 vaccine in Japanese participants: A report of interim findings.	Vaccine
35604776	The chimera of S1 and N proteins of SARS-CoV-2: can it be a potential vaccine candidate for COVID-19?	Expert Rev Vaccines
35604675	Investigation of the value of precipitins in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients with a positive marker for Aspergillus species.	Med Mycol
35603198	Design of a Recombinant Multivalent Epitope Vaccine Based on SARS-CoV-2 and Its Variants in Immunoinformatics Approaches.	Front Immunol
35602004	Safety and immunogenicity of Nanocovax, a SARS-CoV-2 recombinant spike protein vaccine: Interim results of a double-blind, randomised controlled phase 1 and 2 trial.	Lancet Reg Health West Pac
35597770	Recombinant human interferon-alpha1b inhibits SARS-CoV-2 better than interferon-alpha2b in vitro.	Virol Sin
35594709	In vitro characterization of the furin inhibitor MI-1851: Albumin binding, interaction with cytochrome P450 enzymes and cytotoxicity.	Biomed Pharmacother
35594398	MERS-CoV endoribonuclease and accessory proteins jointly evade host innate immunity during infection of lung and nasal epithelial cells.	Proc Natl Acad Sci U S A
35594121	Characterization of a dynamic self-replicating mammalian expression vector based on the circular ssDNA genome of beak and feather disease virus.	J Gen Virol
35592756	Homologous or heterogenous vaccination boosters enhance neutralizing activities against SARS-CoV-2 Omicron BA.1 variant.	MedComm (2020)
35587156	Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19.	Virulence
35585976	Seroreactivity of the Severe Acute Respiratory Syndrome Coronavirus 2 Recombinant S Protein, Receptor-Binding Domain, and Its Receptor-Binding Motif in COVID-19 Patients and Their Cross-Reactivity With Pre-COVID-19 Samples From Malaria-Endemic Areas.	Front Immunol
35585971	Furin and TMPRSS2 Resistant Spike Induces Robust Humoral and Cellular Immunity Against SARS-CoV-2 Lethal Infection.	Front Immunol
35584653	mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2.	Med (N Y)
35582002	SenSARS: A Low-Cost Portable Electrochemical System for Ultra-Sensitive, Near Real-Time, Diagnostics of SARS-CoV-2 Infections.	IEEE Trans Instrum Meas
35581200	Intranasal administration of a recombinant RBD vaccine induces long-term immunity against Omicron-included SARS-CoV-2 variants.	Signal Transduct Target Ther
35579135	Post COVID-19 Vaccination acute Disseminated Encephalomyelitis: A case report.	Curr Med Imaging
35577986	rVSV-DeltaG-SARS-CoV-2-S vaccine: repeated intramuscular (IM) toxicity, local tolerance, immunogenicity and biodistribution study in NZW rabbits.	Arch Toxicol
35577629	National safety surveillance of quadrivalent recombinant influenza vaccine in Taiwan during NH 20/21.	Vaccine
35576972	Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2.	Nature
35575357	Plasmonic Detection of SARS-CoV-2 Spike Protein with Polymer-Stabilized Glycosylated Gold Nanorods.	ACS Macro Lett
35572594	Analysis of the Protective Efficacy of Approved COVID-19 Vaccines Against Various Mutants.	Front Immunol
35569759	Recombinant SARS-CoV-2 variants XD, XE, and XF: The emergence of recombinant variants requires an urgent call for research - Correspondence.	Int J Surg
35568591	Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern.	Vaccine
35563292	Low-Dose SARS-CoV-2 S-Trimer with an Emulsion Adjuvant Induced Th1-Biased Protective Immunity.	Int J Mol Sci
35559681	Detecting anti-SARS-CoV-2 antibodies in urine samples: A noninvasive and sensitive way to assay COVID-19 immune conversion.	Sci Adv
35558112	A Bacterially Expressed SARS-CoV-2 Receptor Binding Domain Fused With Cross-Reacting Material 197 A-Domain Elicits High Level of Neutralizing Antibodies in Mice.	Front Microbiol
35554897	Evolution and Epidemiology of SARS-CoV-2 Virus.	Methods Mol Biol
35551714	SARS-CoV-2 Delta-Omicron Recombinant Viruses, United States.	Emerg Infect Dis
35548920	Potent neutralization by monoclonal human IgM against SARS-CoV-2 is impaired by class switch.	EMBO Rep
35548336	Histamine Potentiates SARS-CoV-2 Spike Protein Entry Into Endothelial Cells.	Front Pharmacol
35546150	Off-the-shelf CAR natural killer cells secreting IL-15 target spike in treating COVID-19.	Nat Commun
35535770	Evidence of transmission and circulation of Deltacron XD recombinant SARS-CoV-2 in Northwest France.	Clin Infect Dis
35533747	Non-glycosylated SARS-CoV-2 RBD elicited a robust neutralizing antibody response in mice.	J Immunol Methods
35532338	Containing the spread of COVID-19 virus facing to its high mutation rate: approach to intervention using a nonspecific way of blocking its entry into the cells.	Nucleosides Nucleotides Nucleic Acids
35532238	Remdesivir and GS-441524 Retain Antiviral Activity against Delta, Omicron, and Other Emergent SARS-CoV-2 Variants.	Antimicrob Agents Chemother
35529866	Intranasal Lentiviral Vector-Mediated Antibody Delivery Confers Reduction of SARS-CoV-2 Infection in Elderly and Immunocompromised Mice.	Front Immunol
35528048	Development and performance of a point-of-care rapid antigen test for detection of SARS-COV-2 variants.	J Clin Virol Plus
35527696	Nucleocapsid protein of SARS-CoV-2 is a potential target for developing new generation of vaccine.	J Clin Lab Anal
35527370	Hybrid Proteins with Short Conformational Epitopes of the Receptor-Binding Domain of SARS-CoV-2 Spike Protein Promote Production of Virus-Neutralizing Antibodies When Used for Immunization.	Biochemistry (Mosc)
35526244	Transient production of receptor-binding domain of SARS-CoV-2 in Nicotiana benthamiana plants induces specific antibodies in immunized mice.	Mol Biol Rep
35525527	Effects of spike protein and toxin-like peptides found in COVID-19 patients on human 3D neuronal/glial model undergoing differentiation: Possible implications for SARS-CoV-2 impact on brain development.	Reprod Toxicol
35515386	ACE2 as a potential therapeutic target for pandemic COVID-19.	RSC Adv
35513416	Development of functionally relevant potency assays for monovalent and multivalent vaccines delivered by evolving technologies.	NPJ Vaccines
35512052	3CL enzymatic activity	SARS-CoV-2 Assays
35507641	Antibody-Dependent Complement Responses toward SARS-CoV-2 Receptor-Binding Domain Immobilized on "Pseudovirus-like" Nanoparticles.	ACS Nano
35507573	Towards Control and Oversight of SARS-CoV-2 Diagnosis and Monitoring through Multiplexed Quantitative Electroanalytical Immune Response Biosensors.	Angew Chem Int Ed Engl
35507508	Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine.	N Engl J Med
35502206	Alterations in SARS-CoV-2 Omicron and Delta peptides presentation by HLA molecules.	PeerJ
35502082	A case of acute endothelial corneal transplant rejection following immunization with ChAdOx1 nCoV-19 coronavirus vaccine.	Indian J Ophthalmol
35501178	Safety and immunogenicity of NVX-CoV2373 (TAK-019) vaccine in healthy Japanese adults: Interim report of a phase I/II randomized controlled trial.	Vaccine
35500734	Recent Advances and Future Prospects of Treatment of Pulmonary Hypertension.	Curr Probl Cardiol
35489376	Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trial.	Lancet HIV
35489099	Preclinical study of a DNA vaccine targeting SARS-CoV-2.	Curr Res Transl Med
35488829	Immune treatment in COVID-19.	Rev Esp Quimioter
35487958	Phosphate-regulated expression of the SARS-CoV-2 receptor-binding domain in the diatom Phaeodactylum tricornutum for pandemic diagnostics.	Sci Rep
35484173	Airway epithelial interferon response to SARS-CoV-2 is inferior to rhinovirus and heterologous rhinovirus infection suppresses SARS-CoV-2 replication.	Sci Rep
35483554	Development of a smartphone-based quantum dot lateral flow immunoassay strip for ultrasensitive detection of anti-SARS-CoV-2 IgG and neutralizing antibodies.	Int J Infect Dis
35481636	Insect cell expression and purification of recombinant SARS-COV-2 spike proteins that demonstrate ACE2 binding.	Protein Sci
35477152	Rotational diffusometric sensor with isothermal amplification for ultra-sensitive and rapid detection of SARS-CoV-2 nsp2 cDNA.	Biosens Bioelectron
35476216	Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants.	BioDrugs
35474754	Apparent lack of association of COVID-19 vaccination with Herpes Zoster.	Am J Ophthalmol Case Rep
35474215	Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events.	Signal Transduct Target Ther
35472001	JAK inhibitor blocks COVID-19 cytokine-induced JAK/STAT/APOL1 signaling in glomerular cells and podocytopathy in human kidney organoids.	JCI Insight
35467028	Culture and identification of a "Deltamicron" SARS-CoV-2 in a three cases cluster in southern France.	J Med Virol
35465982	Covax-19/Spikogen(R) vaccine based on recombinant spike protein extracellular domain with Advax-CpG55.2 adjuvant provides single dose protection against SARS-CoV-2 infection in hamsters.	Vaccine
35464985	Oral SARS-CoV-2 Spike Protein Recombinant Yeast Candidate Prompts Specific Antibody and Gut Microbiota Reconstruction in Mice.	Front Microbiol
35464466	Regulation of Proinflammatory Molecules and Tissue Factor by SARS-CoV-2 Spike Protein in Human Placental Cells: Implications for SARS-CoV-2 Pathogenesis in Pregnant Women.	Front Immunol
35460453	Oral Immunization of Mice with Cell Extracts from Recombinant Lactococcus lactis Expressing SARS-CoV-2 Spike Protein.	Curr Microbiol
35458385	A Modified Fibronectin Type III Domain-Conjugated, Long-Acting Pan-Coronavirus Fusion Inhibitor with Extended Half-Life.	Viruses
35455942	SMYD2 Inhibition Downregulates TMPRSS2 and Decreases SARS-CoV-2 Infection in Human Intestinal and Airway Epithelial Cells.	Cells
35455357	COVID-19 Vaccines: Current and Future Perspectives.	Vaccines (Basel)
35455265	Preclinical Establishment of a Divalent Vaccine against SARS-CoV-2.	Vaccines (Basel)
35453504	First Recombinant High-Density Lipoprotein Particles Administration in a Severe ICU COVID-19 Patient, a Multi-Omics Exploratory Investigation.	Biomedicines
35452699	Expression, purification, and biophysical characterization of recombinant MERS-CoV main (M(pro)) protease.	Int J Biol Macromol
35451361	Genomic and epidemiological report of the recombinant XJ lineage SARS-CoV-2 variant, detected in northern Finland, January 2022.	Euro Surveill
35449619	An Interesting Case of Fatal Myasthenic Crisis Probably Induced by the COVID-19 Vaccine.	Cureus
35448821	Transient Expression of Glycosylated SARS-CoV-2 Antigens in Nicotiana benthamiana.	Plants (Basel)
35447085	Impact of previous exposure to SARS-CoV-2 and of S-Trimer (SCB-2019) COVID-19 vaccination on the risk of reinfection: a randomised, double-blinded, placebo-controlled, phase 2 and 3 trial.	Lancet Infect Dis
35445166	Rapid resolution of severe pericardial effusion using anakinra in a patient with COVID-19 vaccine-related acute pericarditis relapse: a case report.	Eur Heart J Case Rep
35444005	The Evolution and Biology of SARS-CoV-2 Variants.	Cold Spring Harb Perspect Med
35442417	Life-threatening viral disease in a novel form of autosomal recessive IFNAR2 deficiency in the Arctic.	J Exp Med
35437514	A rapid bead-based assay for screening of SARS-CoV-2 neutralizing antibodies.	Antib Ther
35436611	Safety and immunogenicity of SpikoGen(R), an Advax-CpG55.2-adjuvanted SARS-CoV-2 spike protein vaccine: a phase 2 randomized placebo-controlled trial in both seropositive and seronegative populations.	Clin Microbiol Infect
35434578	Safety, tolerability, and immunogenicity of a SARS-CoV-2 recombinant spike RBD protein vaccine: A randomised, double-blind, placebo-controlled, phase 1-2 clinical trial (ABDALA Study).	EClinicalMedicine
35433090	The "Wolf" Is Indeed Coming: Recombinant "Deltacron" SARS-CoV-2 Detected.	China CDC Wkly
35432364	Combined Subcutaneous-Intranasal Immunization With Epitope-Based Antigens Elicits Binding and Neutralizing Antibody Responses in Serum and Mucosae Against PRRSV-2 and SARS-CoV-2.	Front Immunol
35431536	Could anakinra outmatch dexamethasone/tocilizumab in COVID-19?	Bull Natl Res Cent
35431235	Assessment of specific human antibodies against SARS-CoV-2 receptor binding domain by rapid in-house ELISA.	Hum Antibodies
35426547	mRNA vaccines: the most recent clinical applications of synthetic mRNA.	Arch Pharm Res
35419806	The recombinant variants of SARS-CoV-2: Concerns continues amid COVID-19 pandemic.	J Med Virol
35412347	Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease.	J Virol
35411021	Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit.	Commun Biol
35405523	Cardiovascular signatures of COVID-19 predict mortality and identify barrier stabilizing therapies.	EBioMedicine
35405384	Sequence determinants of human-cell entry identified in ACE2-independent bat sarbecoviruses: A combined laboratory and computational network science approach.	EBioMedicine
35404741	Herpes Simplex Virus 1 Anterior Uveitis following Coronavirus Disease 2019 (COVID-19) Vaccination in an Asian Indian Female.	Ocul Immunol Inflamm
35401523	Persistent Overactive Cytotoxic Immune Response in a Spanish Cohort of Individuals With Long-COVID: Identification of Diagnostic Biomarkers.	Front Immunol
35394420	Recombinant BA.1/BA.2 SARS-CoV-2 Virus in Arriving Travelers, Hong Kong, February 2022.	Emerg Infect Dis
35393148	Potency, toxicity and protection evaluation of PastoCoAd candidate vaccines: Novel preclinical mix and match rAd5 S, rAd5 RBD-N and SOBERANA dimeric-RBD protein.	Vaccine
35389264	SARS-CoV-2 nsp5 Exhibits Stronger Catalytic Activity and Interferon Antagonism than Its SARS-CoV Ortholog.	J Virol
35388947	Elucidating Design Principles for Engineering Cell-Derived Vesicles to Inhibit SARS-CoV-2 Infection.	Small
35388686	Analysis of Viral Spike Protein N-Glycosylation Using Ultraviolet Photodissociation Mass Spectrometry.	Anal Chem
35385923	The deglycosylated form of 1E12 inhibits platelet activation and prothrombotic effects induced by VITT antibodies.	Haematologica
35385545	D-dimer and CoV-2 spike-immune complexes contribute to the production of PGE2 and proinflammatory cytokines in monocytes.	PLoS Pathog
35385518	Teaching during COVID-19 pandemic in practical laboratory classes of applied biochemistry and pharmacology: A validated fast and simple protocol for detection of SARS-CoV-2 Spike sequences.	PLoS One
35381724	Herpes zoster following vaccination with ChAdOx1 nCoV-19 Coronavirus vaccine (recombinant).	Indian J Public Health
35380919	David versus goliath: ACE2-Fc receptor traps as potential SARS-CoV-2 inhibitors.	MAbs
35380435	Online Hydrophilic Interaction Chromatography (HILIC) Enhanced Top-Down Mass Spectrometry Characterization of the SARS-CoV-2 Spike Receptor-Binding Domain.	Anal Chem
35380004	Development of a colorimetric assay for the detection of SARS-CoV-2 3CLpro activity.	Biochem J
35372556	A Spike Protein-Based Subunit SARS-CoV-2 Vaccine for Pets: Safety, Immunogenicity, and Protective Efficacy in Juvenile Cats.	Front Vet Sci
35371412	SARS-CoV-2 recombinant proteins-induced degeneration of taste buds in rat circumvallate papillae.	J Dent Sci
35371042	Evaluation of Spike Protein Epitopes by Assessing the Dynamics of Humoral Immune Responses in Moderate COVID-19.	Front Immunol
35369108	Rekombinante Antikorper als Alternativen in Forschung und Diagnostik.	Biospektrum (Heidelb)
35364223	Repeat-dose and local tolerance toxicity of SARS-CoV-2 FINLAY-FR-02 vaccine candidate in Sprague Dawley rats.	Toxicology
35362873	Correction to: Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients.	Ann Intensive Care
35360883	A COVID-19 vaccine candidate composed of the SARS-CoV-2 RBD dimer and Neisseria meningitidis outer membrane vesicles.	RSC Chem Biol
35357709	Vaccine based on folded receptor binding domain-PreS fusion protein with potential to induce sterilizing immunity to SARS-CoV-2 variants.	Allergy
35356392	Tocilizumab-Associated Small Bowel Perforation in a Young Patient With Rheumatoid Arthritis: A Lesson to Remember During COVID-19 Pandemic.	J Med Cases
35356002	Novel Synthetic Lipopeptides as Potential Mucosal Adjuvants Enhanced SARS-CoV-2 rRBD-Induced Immune Response.	Front Immunol
35349744	Recombinant subunits of SARS-CoV-2 spike protein as vaccine candidates to elicit neutralizing antibodies.	J Clin Lab Anal
35348281	Development of severe pemphigus vulgaris following ChAdOx1 nCoV-19 vaccination and review of literature.	J Cosmet Dermatol
35345325	A Yeast-Based Screening System for Differential Identification of Poisons and Suppressors of Human Topoisomerase I.	Front Biosci (Landmark Ed)
35343762	Inactivated SARS-CoV-2 Vaccine Shows Cross-Protection against Bat SARS-Related Coronaviruses in Human ACE2 Transgenic Mice.	J Virol
35343473	[A rare case of myocarditis and pulmonary embolism after BNT162b2 mRNA vaccine].	G Ital Cardiol (Rome)
35341894	Towards maximum acceleration of monoclonal antibody development: Leveraging transposase-mediated cell line generation to enable GMP manufacturing within 3 months using a stable pool.	J Biotechnol
35338855	Harnessing coronavirus spike proteins' binding affinity to ACE2 receptor through a novel baculovirus surface display system.	Biochem Biophys Res Commun
35337106	In Silico and In Vitro Identification of Pan-Coronaviral Main Protease Inhibitors from a Large Natural Product Library.	Pharmaceuticals (Basel)
35337003	A Five-Helix-Based SARS-CoV-2 Fusion Inhibitor Targeting Heptad Repeat 2 Domain against SARS-CoV-2 and Its Variants of Concern.	Viruses
35336950	OraSure InteliSwab() Rapid Antigen Test Performance with the SARS-CoV-2 Variants of Concern-Alpha, Beta, Gamma, Delta, and Omicron.	Viruses
35332581	Rational Development of a Polysaccharide-Protein-Conjugated Nanoparticle Vaccine Against SARS-CoV-2 Variants and Streptococcus pneumoniae.	Adv Mater
35331986	Covid-19: What do we know about the delta omicron recombinant variant?	BMJ
35328711	SARS-CoV-2 Spike Protein and Mouse Coronavirus Inhibit Biofilm Formation by Streptococcus pneumoniae and Staphylococcus aureus.	Int J Mol Sci
35313504	Biodistribution and environmental safety of a live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate.	Mol Ther Methods Clin Dev
35310850	Development of an Adeno-Associated Virus-Vectored SARS-CoV-2 Vaccine and Its Immunogenicity in Mice.	Front Cell Infect Microbiol
35305688	Sensitive and specific serological ELISA for the detection of SARS-CoV-2 infections.	Virol J
35304741	ChAdOx1-S adenoviral vector vaccine applied intranasally elicits superior mucosal immunity compared to the intramuscular route of vaccination.	Eur J Immunol
35301104	Novel T cell interferon gamma release assay (IGRA) using spike recombinant protein for COVID19 vaccine response and Nucleocapsid for SARS-Cov2 response.	Clin Immunol
35296091	A Novel Bacterial Protease Inhibitor Adjuvant in RBD-Based COVID-19 Vaccine Formulations Containing Alum Increases Neutralizing Antibodies, Specific Germinal Center B Cells and Confers Protection Against SARS-CoV-2 Infection in Mice.	Front Immunol
35295932	Using Clustered Regularly Interspaced Short Palindromic Repeats for Recombinant Biosynthesis of Antimicrobial Peptides as Anti-COVID-19 Agents.	ACS Pharmacol Transl Sci
35295298	Vaccine Candidate Against COVID-19 Based on Structurally Modified Plant Virus as an Adjuvant.	Front Microbiol
35290756	Correlation of COVID-19 Severity and Immunoglobulin Presence Against Spike and Nucleocapsid Proteins in SARS-CoV-2.	Viral Immunol
35286623	Sotrovimab: First Approval.	Drugs
35286211	A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease.	Proc Natl Acad Sci U S A
35284808	Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial.	EClinicalMedicine
35284045	Development of rapid antigen test prototype for detection of SARS-CoV-2 in saliva samples.	Ups J Med Sci
35282925	Boosting of SARS-CoV-2 immunity in nonhuman primates using an oral rhabdoviral vaccine.	Vaccine
35278580	Label-free duplex SAMDI-MS screen reveals novel SARS-CoV-2 3CLpro inhibitors.	Antiviral Res
35278248	Human adenovirus type 26 basic biology and its usage as vaccine vector.	Rev Med Virol
35276485	Kappa-RBD produced by glycoengineered Pichia pastoris elicited high neutralizing antibody titers against pseudoviruses of SARS-CoV-2 variants.	Virology
35275039	A nasal omicron vaccine booster elicits potent neutralizing antibody response against emerging SARS-CoV-2 variants.	Emerg Microbes Infect
35273945	Emergence of Within-Host SARS-CoV-2 Recombinant Genome After Coinfection by Gamma and Delta Variants: A Case Report.	Front Public Health
35273834	Incidence, Pattern and Severity of Adverse Events Following Immunization (AEFIs) Associated With Chadox1 nCOV-19 Corona Virus Vaccine (Recombinant) Among the Healthcare Workers of a Tertiary Care Institute of Eastern Uttar Pradesh, India.	Cureus
35272714	AstraZeneca ChAdOx1-S COVID-19 vaccine can be safely administered in patients with EDTA allergy.	Allergy Asthma Clin Immunol
35271769	Rapid, Point-of-Care scFv-SERS Assay for Femtogram Level Detection of SARS-CoV-2.	ACS Sens
35269938	Identification of Kukoamine A, Zeaxanthin, and Clexane as New Furin Inhibitors.	Int J Mol Sci
35264381	Case of acquired haemophilia a in Southeast Asia following COVID-19 vaccine.	BMJ Case Rep
35263081	A Recombinant Subunit Vaccine Induces a Potent, Broadly Neutralizing, and Durable Antibody Response in Macaques against the SARS-CoV-2 P.1 (Gamma) Variant.	ACS Infect Dis
35262004	Assessment of automated high-throughput serological assays for prediction of high-titer SARS-CoV-2 neutralizing antibody.	J Clin Virol Plus
35251909	Mechanistic insights from the review and evaluation of ayurvedic herbal medicines for the prevention and management of COVID-19 patients.	J Herb Med
35251049	Increased Interleukin 18-Dependent Immune Responses Are Associated With Myopericarditis After COVID-19 mRNA Vaccination.	Front Immunol
35250575	Tocilizumab and COVID-19: Timing of Administration and Efficacy.	Front Pharmacol
35250426	In-silico analysis of recombinant protein vaccines based on the spike protein of Indonesian SARS-CoV-2 through a reverse vaccinology approach.	J Taibah Univ Med Sci
35247654	Diffuse cutaneous systemic sclerosis following SARS-Co V-2 vaccination.	J Autoimmun
35246776	Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients.	Ann Intensive Care
35242627	Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients: the SOLID study.	Transl Lung Cancer Res
35241645	Immunogenicity and protective efficacy of a recombinant protein subunit vaccine and an inactivated vaccine against SARS-CoV-2 variants in non-human primates.	Signal Transduct Target Ther
35239997	A simple reverse genetics method to generate recombinant coronaviruses.	EMBO Rep
35238626	Cost-effectiveness of casirivimab/imdevimab in patients with COVID-19 in the ambulatory setting.	J Manag Care Spec Pharm
35234627	An integrated rapid nucleic acid detection assay based on recombinant polymerase amplification for SARS-CoV-2.	Virol Sin
35234625	Immunogenicity of a recombinant VSV-Vectored SARS-CoV vaccine induced robust immunity in rhesus monkeys after single-dose immunization.	Virol Sin
35233264	[Peripheral facial palsy following COVID-19 vaccination: a case report].	Pan Afr Med J
35231586	Addition of arginine hydrochloride and proline to the culture medium enhances recombinant protein expression in Brevibacillus choshinensis: The case of RBD of SARS-CoV-2 spike protein and its antibody.	Protein Expr Purif
35230230	Heterologous boosting with third dose of coronavirus disease recombinant subunit vaccine increases neutralizing antibodies and T cell immunity against different severe acute respiratory syndrome coronavirus 2 variants.	Emerg Microbes Infect
35228506	Editorial: First Approval of the Protein-Based Adjuvanted Nuvaxovid (NVX-CoV2373) Novavax Vaccine for SARS-CoV-2 Could Increase Vaccine Uptake and Provide Immune Protection from Viral Variants.	Med Sci Monit
35228502	Genome Recombination between the Delta and Alpha Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).	Jpn J Infect Dis
35228445	[Production of antiviral vaccines using a silkworm-baculovirus expression system].	Nihon Yakurigaku Zasshi
35224470	Coagulation factor V is a T-cell inhibitor expressed by leukocytes in COVID-19.	iScience
35218991	Diagnostic performance of two serological assays for the detection of SARS-CoV-2 specific antibodies: surveillance after vaccination.	Diagn Microbiol Infect Dis
35216789	Newly diagnosed neuromyelitis optica spectrum disorders following vaccination: Case report and systematic review.	Mult Scler Relat Disord
35216301	Self-Assembled Particles Combining SARS-CoV-2 RBD Protein and RBD DNA Vaccine Induce Synergistic Enhancement of the Humoral Response in Mice.	Int J Mol Sci
35216036	Collection of Monoclonal Antibodies Targeting SARS-CoV-2 Proteins.	Viruses
35216034	Naive Human Macrophages Are Refractory to SARS-CoV-2 Infection and Exhibit a Modest Inflammatory Response Early in Infection.	Viruses
35215976	Phage-Displayed Mimotopes of SARS-CoV-2 Spike Protein Targeted to Authentic and Alternative Cellular Receptors.	Viruses
35215927	Steep Decline in Binding Capability of SARS-CoV-2 Omicron Variant (B.1.1.529) RBD to the Antibodies in Early COVID-19 Convalescent Sera and Inactivated Vaccine Sera.	Viruses
35215848	Rapid Biosensor of SARS-CoV-2 Using Specific Monoclonal Antibodies Recognizing Conserved Nucleocapsid Protein Epitopes.	Viruses
35215786	Herpes zoster: A Review of Clinical Manifestations and Management.	Viruses
35215765	Versatile SARS-CoV-2 Reverse-Genetics Systems for the Study of Antiviral Resistance and Replication.	Viruses
35214708	Optimization, Production, Purification and Characterization of HIV-1 GAG-Based Virus-like Particles Functionalized with SARS-CoV-2.	Vaccines (Basel)
35213787	Sequentially immune-induced antibodies could cross-neutralize SARS-CoV-2 variants.	Animal Model Exp Med
35212337	Rapid colloidal gold immunochromatographic assay for the detection of SARS-CoV-2 total antibodies after vaccination.	J Mater Chem B
35206580	Classical and Next-Generation Vaccine Platforms to SARS-CoV-2: Biotechnological Strategies and Genomic Variants.	Int J Environ Res Public Health
35204774	Robust Recombinant Expression of Human Placental Ribonuclease Inhibitor in Insect Cells.	Biomolecules
35204473	Development, Analytical, and Clinical Evaluation of Rapid Immunochromatographic Antigen Test for SARS-CoV-2 Variants Detection.	Diagnostics (Basel)
35200162	COVID-19: vaccines, efficacy and effects on variants.	Curr Opin Pulm Med
35197485	An adjuvanted subunit SARS-CoV-2 spike protein vaccine provides protection against Covid-19 infection and transmission.	NPJ Vaccines
35196819	Estimating SARS-CoV-2 Seroprevalence in Canadian Blood Donors, April 2020 to March 2021: Improving Accuracy with Multiple Assays.	Microbiol Spectr
35194132	A synthetic protein as efficient multitarget regulator against complement over-activation.	Commun Biol
35192547	CMV-associated T cell and NK cell terminal differentiation does not affect immunogenicity of ChAdOx1 vaccination.	JCI Insight
35191746	Efficacy and Safety of SARS-CoV-2 Neutralizing Antibody JS016 in Hospitalized Chinese Patients with COVID-19: a Phase 2/3, Multicenter, Randomized, Open-Label, Controlled Trial.	Antimicrob Agents Chemother
35189393	Glyco-nanotechnology: A biomedical perspective.	Nanomedicine
35186513	Organizing Pneumonia Following Recombinant Zoster Vaccination: A Rare Adverse Reaction.	Cureus
35185912	Angiogenic Role of Mesothelium-Derived Chemokine CXCL1 During Unfavorable Peritoneal Tissue Remodeling in Patients Receiving Peritoneal Dialysis as Renal Replacement Therapy.	Front Immunol
35182622	Bioactive hybrid metal-organic framework (MOF)-based nanosensors for optical detection of recombinant SARS-CoV-2 spike antigen.	Sci Total Environ
35178379	In Planta Production of the Receptor-Binding Domain From SARS-CoV-2 With Human Blood Group A Glycan Structures.	Front Chem
35172194	Expression, purification and characterization of SARS-CoV-2 spike RBD in ExpiCHO cells.	Protein Expr Purif
35171046	High-Titer Neutralizing Antibodies against the SARS-CoV-2 Delta Variant Induced by Alhydroxyquim-II-Adjuvanted Trimeric Spike Antigens.	Microbiol Spectr
35164986	A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: Safety, reactogenicity and immunogenicity.	Vaccine
35157644	Guillain-Barre Syndrome After Ad26.COV2.S Vaccination.	Am J Case Rep
35157633	Vaccines and Public Trust: Containing COVID-19 in Cuba.	MEDICC Rev
35157221	COVID-19 vaccine development based on recombinant viral and bacterial vector systems: combinatorial effect of adaptive and trained immunity.	J Microbiol
35156068	Safety and immunogenicity of two recombinant DNA COVID-19 vaccines containing the coding regions of the spike or spike and nucleocapsid proteins: an interim analysis of two open-label, non-randomised, phase 1 trials in healthy adults.	Lancet Microbe
35154086	A Single Dose of an MVA Vaccine Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Protein Neutralizes Variants of Concern and Protects Mice From a Lethal SARS-CoV-2 Infection.	Front Immunol
35149878	Bacterial ligands as flexible and sensitive detectors in rapid tests for antibodies to SARS-CoV-2.	Anal Bioanal Chem
35143592	A protease-activatable luminescent biosensor and reporter cell line for authentic SARS-CoV-2 infection.	PLoS Pathog
35137080	Exploring the Natural Origins of SARS-CoV-2 in the Light of Recombination.	Genome Biol Evol
35130610	Foe and friend in the COVID-19-associated acute kidney injury: an insight on intrarenal renin-angiotensin system.	Acta Biochim Biophys Sin (Shanghai)
35127087	Quantitative measurement of IgG to SARS-CoV-2 antigens using monoclonal antibody-based enzyme-linked immunosorbent assays.	Clin Transl Immunology
35123472	Escherichia coli recombinant expression of SARS-CoV-2 protein fragments.	Microb Cell Fact
35122211	Early assessment of the safety and immunogenicity of a third dose (booster) of COVID-19 immunization in Chinese adults.	Front Med
35116045	Research Progress and Applications of Multivalent, Multispecific and Modified Nanobodies for Disease Treatment.	Front Immunol
35115773	Nanobubble Ozone Stored in Hyaluronic Acid Decorated Liposomes: Antibacterial, Anti-SARS-CoV-2 Effect and Biocompatibility Tests.	Int J Nanomedicine
35115195	Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452.	Vaccine
35111042	GM-CSF: Orchestrating the Pulmonary Response to Infection.	Front Pharmacol
35108595	Development of magnetic particle-based chemiluminescence immunoassay for measurement of SARS-CoV-2 nucleocapsid protein.	J Virol Methods
35107016	Fully Automated Chemiluminescence Microarray Analysis Platform for Rapid and Multiplexed SARS-CoV-2 Serodiagnostics.	Anal Chem
35104670	Recombinant VLPs empower RBM peptides showing no immunogenicity in native SARS-COV-2 protein to elicit a robust neutralizing antibody response.	Nanomedicine
35101265	Pan-SARS neutralizing responses after third boost vaccination in non-human primate immunogenicity model.	Vaccine
35096642	ACE2 Shedding and the Role in COVID-19.	Front Cell Infect Microbiol
35096528	Multisystem Inflammatory Syndrome after Ad26.COV2.S vaccination.	IDCases
35095820	Pseudotyped Vesicular Stomatitis Virus-Severe Acute Respiratory Syndrome-Coronavirus-2 Spike for the Study of Variants, Vaccines, and Therapeutics Against Coronavirus Disease 2019.	Front Microbiol
35090638	Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study.	Lancet Infect Dis
35089583	Nanoparticle and virus-like particle vaccine approaches against SARS-CoV-2.	J Microbiol
35088958	[Antibody Response After Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthcare Workers with and without Previous COVID-19 Infection: A Prospective Observational Study].	Mikrobiyol Bul
35088622	Acquired Hemophilia A following Pfizer-BioNTech SARS CoV-2 mRNA vaccine, successfully treated with prednisolone and rituximab.	J Oncol Pharm Pract
35087233	Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trial.	Nat Med
35085851	Intranasal COVID-19 vaccines: From bench to bed.	EBioMedicine
35082199	Spike protein of SARS-CoV-2 suppresses gonadotrophin secretion from bovine anterior pituitaries.	J Reprod Dev
35078661	A recombinant SARS-CoV-2 receptor-binding domain expressed in an engineered fungal strain of Thermothelomyces heterothallica induces a functional immune response in mice.	Vaccine
35078277	Designed SARS-CoV-2 receptor binding domain variants form stable monomers.	Biotechnol J
35074136	Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study.	Lancet
35073761	N7-Methylation of the Coronavirus RNA Cap Is Required for Maximal Virulence by Preventing Innate Immune Recognition.	mBio
35073758	Longitudinal Study after Sputnik V Vaccination Shows Durable SARS-CoV-2 Neutralizing Antibodies and Reduced Viral Variant Escape to Neutralization over Time.	mBio
35071273	Growth, Antigenicity, and Immunogenicity of SARS-CoV-2 Spike Variants Revealed by a Live rVSV-SARS-CoV-2 Virus.	Front Med (Lausanne)
35069994	Gastrointestinal and hepatic side effects of potential treatment for COVID-19 and vaccination in patients with chronic liver diseases.	World J Hepatol
35069504	ABO Blood Group Incompatibility Protects Against SARS-CoV-2 Transmission.	Front Microbiol
35066730	Potential impact of combined influenza and pneumococcal vaccines on the severity of respiratory illness in COVID-19 infection among type 2 diabetic patients.	Clin Exp Med
35062761	Plant-Based Vaccines: Antigen Design, Diversity, and Strategies for High Level Production.	Vaccines (Basel)
35062757	Comparative Immunogenicity of the Recombinant Receptor-Binding Domain of Protein S SARS-CoV-2 Obtained in Prokaryotic and Mammalian Expression Systems.	Vaccines (Basel)
35062728	Development of an Oral Salmonella-Based Vaccine Platform against SARS-CoV-2.	Vaccines (Basel)
35062663	Expression of SARS-CoV-2 Spike Protein Receptor Binding Domain on Recombinant B. subtilis on Spore Surface: A Potential COVID-19 Oral Vaccine Candidate.	Vaccines (Basel)
35062211	SARS-CoV-2 Spike Expression at the Surface of Infected Primary Human Airway Epithelial Cells.	Viruses
35058437	Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2.	Nat Commun
35051080	Respiratory Safety Evaluation in Mice and Inhibition of Adenoviral Amplification in Human Bronchial Endothelial Cells Using a Novel Type of Chlorine Dioxide Gas Reactor.	Toxics
35049437	ADR Profile of the Covishield Vaccine Among Healthcare Workers in a Tertiary Care Teaching Hospital in India.	Curr Drug Saf
35049412	Modeled impact of the COVID-19 pandemic and associated reduction in adult vaccinations on herpes zoster in the United States.	Hum Vaccin Immunother
35046385	The antigenicity of SARS-CoV-2 Delta variants aggregated 10 high-frequency mutations in RBD has not changed sufficiently to replace the current vaccine strain.	Signal Transduct Target Ther
35045362	Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I study.	EBioMedicine
35038906	JIB-04 Has Broad-Spectrum Antiviral Activity and Inhibits SARS-CoV-2 Replication and Coronavirus Pathogenesis.	mBio
35038454	ACE2 internalization induced by a SARS-CoV-2 recombinant protein is modulated by angiotensin II type 1 and bradykinin 2 receptors.	Life Sci
35037999	Screening and identification of B cell epitope of the nucleocapsid protein in SARS-CoV-2 using the monoclonal antibodies.	Appl Microbiol Biotechnol
35036026	SARS-CoV-2 Antibody Neutralization Assay Platforms Based on Epitopes Sources: Live Virus, Pseudovirus, and Recombinant S Glycoprotein RBD.	Immune Netw
35035955	Whole-blood cytokine secretion assay as a high-throughput alternative for assessing the cell-mediated immunity profile after two doses of an adjuvanted SARS-CoV-2 recombinant protein vaccine candidate.	Clin Transl Immunology
35034078	Influenza vaccines: where we are, where we are going.	Curr Opin Pediatr
35033881	A quantitative assay for detection of SARS-CoV-2 neutralizing antibodies.	J Clin Virol
35032184	Preliminary nonclinical safety and immunogenicity of an rVSV-DeltaG-SARS-CoV-2-S vaccine in mice, hamsters, rabbits and pigs.	Arch Toxicol
35028901	Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome?	Mol Neurobiol
35023830	ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF- and IFNgamma-driven immunopathology.	Elife
35023731	Analysis of Recombinant Adenovirus Vectors by Ion Trap Charge Detection Mass Spectrometry: Accurate Molecular Weight Measurements beyond 150 MDa.	Anal Chem
35022571	SARS-CoV-2 membrane protein causes the mitochondrial apoptosis and pulmonary edema via targeting BOK.	Cell Death Differ
35022088	Eligibility criteria for pediatric patients who may benefit from anti SARS-CoV-2 monoclonal antibody therapy administration: an Italian inter-society consensus statement.	Ital J Pediatr
35020840	Patients diagnosed with COVID-19 and treated with anakinra: a real-world study in the USA.	Clin Exp Immunol
35019674	Recombinant Myeloperoxidase as a New Class of Antimicrobial Agents.	Microbiol Spectr
35015170	SARS-CoV-2 Spike protein is not pro-inflammatory in human primary macrophages: endotoxin contamination and lack of protein glycosylation as possible confounders.	Cell Biol Toxicol
35011529	Synthesis and In Vitro Study of Antiviral Activity of Glycyrrhizin Nicotinate Derivatives against HIV-1 Pseudoviruses and SARS-CoV-2 Viruses.	Molecules
35003088	An Integrated Platform for Serological Detection and Vaccination of COVID-19.	Front Immunol
35003058	Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19.	Front Immunol
34995117	A lethal mouse model for evaluating vaccine-associated enhanced respiratory disease during SARS-CoV-2 infection.	Sci Adv
34994386	Identification of immunodominant epitopes on nucleocapsid and spike proteins of the SARS-CoV-2 in Iranian COVID-19 patients.	Pathog Dis
34993395	Bradycardia associated with Multisystem Inflammatory Syndrome in Children with COVID-19: a case series.	Eur Heart J Case Rep
34992275	MCMV-based vaccine vectors expressing full-length viral proteins provide long-term humoral immune protection upon a single-shot vaccination.	Cell Mol Immunol
34990107	Column Agglutination Assay Using Polystyrene Microbeads for Rapid Detection of Antibodies against SARS-CoV-2.	ACS Appl Mater Interfaces
34987509	An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection.	Front Immunol
34986394	Rationale and design of a study to assess the safety and efficacy of rNAPc2 in COVID-19: the Phase 2b ASPEN-COVID-19 trial.	Am Heart J
34983950	Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates.	Cell Mol Immunol
34980703	Evaluation of a Lateral Flow Immunoassay COVIDTECH((R)) SARS-CoV-2 IgM/IgG Antibody Rapid Test.	Jpn J Infect Dis
34976974	Functional Trimeric SARS-CoV-2 Envelope Protein Expressed in Stable CHO Cells.	Front Bioeng Biotechnol
34975092	Post coronavirus disease-2019 vaccination Guillain-Barre syndrome.	Indian J Public Health
34965611	Development of a Recombinant Nucleocapsid Protein-Based ELISA for Detection of IgM and IgG Antibodies to SARS-CoV-2.	Biotechnol Appl Biochem
34963881	A potential hypothesis for 2019-nCoV infection therapy through delivery of recombinant ACE2 by red blood cell-hitchhiking.	J Biol Res (Thessalon)
34962997	Recombinant Adjuvanted Zoster Vaccine and Reduced Risk of Coronavirus Disease 2019 Diagnosis and Hospitalization in Older Adults.	J Infect Dis
34961153	High-Yield Production of Receptor Binding Domain of SARS-CoV-2 Linked to Bacterial Flagellin in Plants Using Self-Replicating Viral Vector pEff.	Plants (Basel)
34960806	Differential Effect of SARS-CoV-2 Spike Glycoprotein 1 on Human Bronchial and Alveolar Lung Mucosa Models: Implications for Pathogenicity.	Viruses
34960772	Adenovirus Biology, Recombinant Adenovirus, and Adenovirus Usage in Gene Therapy.	Viruses
34960250	Innovations in the Insect Cell Expression System for Industrial Recombinant Vaccine Antigen Production.	Vaccines (Basel)
34960133	A Systematic Review on COVID-19 Vaccine Strategies, Their Effectiveness, and Issues.	Vaccines (Basel)
34960131	Receptor-Binding Domain Proteins of SARS-CoV-2 Variants Elicited Robust Antibody Responses Cross-Reacting with Wild-Type and Mutant Viruses in Mice.	Vaccines (Basel)
34958163	Potential COVID-19 therapeutic approaches targeting angiotensin-converting enzyme 2; An updated review.	Rev Med Virol
34953526	Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial.	Lancet
34952759	Induction of Th1 and Th2 in the protection against SARS-CoV-2 through mucosal delivery of an adenovirus vaccine expressing an engineered spike protein.	Vaccine
34950152	SARS-CoV-2 N Protein Induces Acute Lung Injury in Mice via NF-kB Activation.	Front Immunol
34950112	Production of SARS-CoV-2 N Protein-Specific Monoclonal Antibody and Its Application in an ELISA-Based Detection System and Targeting the Interaction Between the Spike C-Terminal Domain and N Protein.	Front Microbiol
34948858	Modulatory Effects of Physical Activity Levels on Immune Responses and General Clinical Functions in Adult Patients with Mild to Moderate SARS-CoV-2 Infections-A Protocol for an Observational Prospective Follow-Up Investigation: Fit-COVID-19 Study.	Int J Environ Res Public Health
34946123	Microorganisms as Shapers of Human Civilization, from Pandemics to Even Our Genomes: Villains or Friends? A Historical Approach.	Microorganisms
34946016	A Mycobacteriophage-Based Vaccine Platform: SARS-CoV-2 Antigen Expression and Display.	Microorganisms
34944456	The Nuts and Bolts of SARS-CoV-2 Spike Receptor-Binding Domain Heterologous Expression.	Biomolecules
34938305	Soluble Human Angiotensin- Converting Enzyme 2 as a Potential Therapeutic Tool for COVID-19 is Produced at High Levels In Nicotiana benthamiana Plant With Potent Anti-SARS-CoV-2 Activity.	Front Plant Sci
34938290	Preclinical Immune Response and Safety Evaluation of the Protein Subunit Vaccine Nanocovax for COVID-19.	Front Immunol
34934775	If Not Now, When? Nonserotype Pneumococcal Protein Vaccines.	Open Forum Infect Dis
34934510	Angiotensin-converting enzyme 2 as a potential therapeutic target for COVID-19: A review.	J Pharm Anal
34927585	Structure-guided glyco-engineering of ACE2 for improved potency as soluble SARS-CoV-2 decoy receptor.	Elife
34922455	IgG antibody titers against SARS-CoV-2 nucleocapsid protein correlate with the severity of COVID-19 patients.	BMC Microbiol
34921425	Evaluation of hydrogen peroxide efficacy against AZD1222 chimpanzee adenovirus strain in the recombinant COVID-19 vaccine for application in cleaning validation in a pharmaceutical manufacturing industry.	Lett Appl Microbiol
34919976	Development and validation of novel kit for quantification of SARS-CoV-2 antibodies on clinical samples.	J Virol Methods
34915414	In vitro interaction of potential antiviral TMPRSS2 inhibitors with human serum albumin and cytochrome P 450 isoenzymes.	Biomed Pharmacother
34915268	Generation and utility of a single-chain fragment variable monoclonal antibody platform against a baculovirus expressed recombinant receptor binding domain of SARS-CoV-2 spike protein.	Mol Immunol
34914812	A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2.	PLoS Pathog
34914685	Vaccination with SARS-CoV-2 variants of concern protects mice from challenge with wild-type virus.	PLoS Biol
34914049	CRISPR Engineering of Bacteriophage T4 to Design Vaccines Against SARS-CoV-2 and Emerging Pathogens.	Methods Mol Biol
34914048	Design of Replication-Competent VSV- and Ervebo-Vectored Vaccines Against SARS-CoV-2.	Methods Mol Biol
34911569	Advances in the design and development of SARS-CoV-2 vaccines.	Mil Med Res
34910859	Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico.	N Engl J Med
34908642	Smartphone-based active vaccine safety surveillance (SmartVax) at a Swiss adult vaccination clinic - a pilot study.	Swiss Med Wkly
34904253	Preparation of highly specific monoclonal antibodies against SARS-CoV-2 nucleocapsid protein and the preliminary development of antigen detection test strips.	J Med Virol
34903275	Parsonage-Turner syndrome following coronavirus disease 2019 immunization with ChAdOx1-S vaccine: a case report and review of the literature.	J Med Case Rep
34903153	Development of a Platform for Producing Recombinant Protein Components of Epitope Vaccines for the Prevention of COVID-19.	Biochemistry (Mosc)
34890296	Thioredoxin Prevents Loss of UCP2 in Hyperoxia via MKK4-p38 MAPK-PGC1alpha Signaling and Limits Oxygen Toxicity.	Am J Respir Cell Mol Biol
34889013	A Dual-Color Fluorescent Probe Allows Simultaneous Imaging of Main and Papain-like Proteases of SARS-CoV-2-Infected Cells for Accurate Detection and Rapid Inhibitor Screening.	Angew Chem Int Ed Engl
34883321	Repeated Cardioembolic Stroke after COVID-19 mRNA Vaccination: A Case Report.	J Stroke Cerebrovasc Dis
34878838	TREM-2 is a sensor and activator of T cell response in SARS-CoV-2 infection.	Sci Adv
34878034	SARS-CoV-2 recombinant proteins stimulate distinct cellular and humoral immune response profiles in samples from COVID-19 convalescent patients.	Clinics (Sao Paulo)
34876592	Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2.	Nat Commun
34876022	Applicability of several rooted phylogenetic network algorithms for representing the evolutionary history of SARS-CoV-2.	BMC Ecol Evol
34875601	One hundred years of BCG vaccine.	Medicina (B Aires)
34870133	A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in India.	EClinicalMedicine
34869209	Site-Specific Glycosylation Patterns of the SARS-CoV-2 Spike Protein Derived From Recombinant Protein and Viral WA1 and D614G Strains.	Front Chem
34869070	Detection of Antibodies Against the SARS-CoV-2 Spike Protein and Analysis of the Peripheral Blood Mononuclear Cell Transcriptomic Profile, 15 Years After Recovery From SARS.	Front Cell Infect Microbiol
34868780	Management of Acquired Factor VIII Inhibitors With NovoSeven and Obizur.	Cureus
34868570	Massive pulmonary embolism complicating mild Covid 19 pneumonia: Successful systemic thrombolysis using rt-PA in an elderly patient: A case report.	Ann Med Surg (Lond)
34864488	A two-dose optimum for recombinant S1 protein-based COVID-19 vaccination.	Virology
34859135	Production of Recombinant Replication-defective Lentiviruses Bearing the SARS-CoV or SARS-CoV-2 Attachment Spike Glycoprotein and Their Application in Receptor Tropism and Neutralisation Assays.	Bio Protoc
34858397	Metformin Suppresses Monocyte Immunometabolic Activation by SARS-CoV-2 Spike Protein Subunit 1.	Front Immunol
34857771	Unique features of a recombinant haemagglutinin influenza vaccine that influence vaccine performance.	NPJ Vaccines
34856855	Immune variants of SARS-CoV-2 could be a significant challenge for developing a pan genotype-specific vaccine.	Hum Vaccin Immunother
34853815	Increasing Efficacy of Enveloped Whole-Virus Vaccines by In situ Immune-Complexing with the Natural Anti-Gal Antibody.	Med Res Arch
34851667	Lyophilized, thermostable Spike or RBD immunogenic liposomes induce protective immunity against SARS-CoV-2 in mice.	Sci Adv
34845662	Cardiovascular Complications of SARS-CoV-2 Vaccines: An Overview.	Cardiol Ther
34844820	International Nonproprietary Names (INN) for novel vaccine substances: A matter of safety.	Vaccine
34843713	Murine monoclonal antibodies against RBD of the SARS-CoV-2 spike protein as useful analytical tools for subunit vaccine development and clinical trials.	J Immunol Methods
34842834	High Prevalence of SARS-CoV-2 in an Indigenous Community of the Colombian Amazon Region.	Trop Med Infect Dis
34842604	Fc-Independent Protection from SARS-CoV-2 Infection by Recombinant Human Monoclonal Antibodies.	Antibodies (Basel)
34841098	Development and characterization of a quantitative ELISA to detect anti-SARS-CoV-2 spike antibodies.	Heliyon
34838689	Lack of effects on female fertility or pre- and postnatal development of offspring in rats after exposure to AS03-adjuvanted recombinant plant-derived virus-like particle vaccine candidate for COVID-19.	Reprod Toxicol
34838321	The knotty biology of canine coronavirus: A worrying model of coronaviruses' danger.	Res Vet Sci
34837582	Plant-derived VLP: a worthy platform to produce vaccine against SARS-CoV-2.	Biotechnol Lett
34835340	Ultrasensitive Detection of SARS-CoV-2 Spike Proteins Using the Thio-NAD Cycling Reaction: A Preliminary Study before Clinical Trials.	Microorganisms
34835275	Complicated Long Term Vaccine Induced Thrombotic Immune Thrombocytopenia-A Case Report.	Vaccines (Basel)
34835049	Killing Two Birds with One Stone by Administration of Soluble ACE2: A Promising Strategy to Treat Both Cardiovascular Diseases and SARS-CoV-2 Infection.	Viruses
34835009	Monoclonal Human Antibodies That Recognise the Exposed N and C Terminal Regions of the Often-Overlooked SARS-CoV-2 ORF3a Transmembrane Protein.	Viruses
34832577	IgG Study of Blood Sera of Patients with COVID-19.	Pathogens
34827712	Porphyrin Molecules Decorated on Metal-Organic Frameworks for Multi-Functional Biomedical Applications.	Biomolecules
34827040	Acute graft rejection in a high-risk corneal transplant following COVID-19 vaccination: A case report.	Indian J Ophthalmol
34821928	COVID-19 Vaccine Hesitancy and Early Adverse Events Reported in a Cohort of 7,881 Italian Physicians.	Ann Ig
34817278	Usefulness of ELISA Using Total Antibody against Plant-Expressed Recombinant Nucleocapsid Protein of SARS-CoV-2.	Microbiol Spectr
34817197	The N-Terminal Region of Middle East Respiratory Syndrome Coronavirus Accessory Protein 8b Is Essential for Enhanced Virulence of an Attenuated Murine Coronavirus.	J Virol
34815544	SARS-CoV-2 receptor binding domain radio-probe: a non-invasive approach for angiotensin-converting enzyme 2 mapping in mice.	Acta Pharmacol Sin
34815511	Recombinant protein subunit vaccine booster following two-dose inactivated vaccines dramatically enhanced anti-RBD responses and neutralizing titers against SARS-CoV-2 and Variants of Concern.	Cell Res
34815389	ACE2-like carboxypeptidase B38-CAP protects from SARS-CoV-2-induced lung injury.	Nat Commun
34813596	Detection of cross-reactive immunoglobulin A against the severe acute respiratory syndrome-coronavirus-2 spike 1 subunit in saliva.	PLoS One
34809743	[Preparation and identification of rat polyclonal antibody against SARS-CoV-2 main protease (Mpro)].	Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi
34807265	The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease.	Clin Sci (Lond)
34806704	Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2.	J Vis Exp
34804054	SARS-CoV-2 Exacerbates COVID-19 Pathology Through Activation of the Complement and Kinin Systems.	Front Immunol
34798238	Development of highly stable and de-immunized versions of recombinant alpha interferon: Promising candidates for the treatment of chronic and emerging viral diseases.	Clin Immunol
34797474	Eltrombopag for refractory vaccine-induced immune thrombotic thrombocytopenia.	J Thromb Thrombolysis
34793872	Epidemiological survey and genetic diversity of bovine coronavirus in Northeast China.	Virus Res
34793485	Recombinant production of a functional SARS-CoV-2 spike receptor binding domain in the green algae Chlamydomonas reinhardtii.	PLoS One
34791556	Evaluation of the Anti-Viral Activity of Human Recombinant Interferon Lambda-1 against SARS-CoV-2.	Bull Exp Biol Med
34790623	Delayed Use of the Recombinant Human IL-1 Receptor Antagonist Anakinra in Five COVID-19 Patients with Pulmonary Fibrosis and Persistent Hypoxaemia: A Preliminary Report.	Eur J Case Rep Intern Med
34786180	On the Selectivity of Heparan Sulfate Recognition by SARS-CoV-2 Spike Glycoprotein.	ACS Med Chem Lett
34786164	In the era of rapid mRNA-based vaccines: Why is there no effective hepatitis C virus vaccine yet?	World J Hepatol
34780058	SARS-CoV-2 nucleocapsid protein interacts with immunoregulators and stress granules and phase separates to form liquid droplets.	FEBS Lett
34780057	Scalable, methanol-free manufacturing of the SARS-CoV-2 receptor-binding domain in engineered Komagataella phaffii.	Biotechnol Bioeng
34778744	Recombinant protein subunit SARS-CoV-2 vaccines formulated with CoVaccine HT adjuvant induce broad, Th1 biased, humoral and cellular immune responses in mice.	Vaccine X
34778742	Metagenomic evidence for the co-existence of SARS and H1N1 in patients from 2007-2012 flu seasons in France.	Biosaf Health
34775749	Site-Specific and Stable Conjugation of the SARS-CoV-2 Receptor-Binding Domain to Liposomes in the Absence of Any Other Adjuvants Elicits Potent Neutralizing Antibodies in BALB/c Mice.	Bioconjug Chem
34775592	Identifying SARS-CoV-2 'memory' NK cells from COVID-19 convalescent donors for adoptive cell therapy.	Immunology
34774590	Nanoparticular CpG-adjuvanted SARS-CoV-2 S1 protein elicits broadly neutralizing and Th1-biased immunoreactivity in mice.	Int J Biol Macromol
34774545	Human carboxylesterase 1A plays a predominant role in the hydrolytic activation of remdesivir in humans.	Chem Biol Interact
34774197	Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial.	Lancet
34773078	Bioengineered angiotensin-converting-enzyme-2: a potential therapeutic option against SARS-CoV-2 infection.	J Hum Hypertens
34766165	Nano-therapeutic strategies to target coronavirus.	View (Beijing)
34766160	Therapeutic antibodies under development for SARS-CoV-2.	View (Beijing)
34764961	Isolation and Characterization of Mouse Monoclonal Antibodies That Neutralize SARS-CoV-2 and Its Variants of Concern Alpha, Beta, Gamma and Delta by Binding Conformational Epitopes of Glycosylated RBD With High Potency.	Front Immunol
34762914	Development and evaluation of a low cost IgG ELISA test based in RBD protein for COVID-19.	J Immunol Methods
34759261	Enhanced protective immunity against SARS-CoV-2 elicited by a VSV vector expressing a chimeric spike protein.	Signal Transduct Target Ther
34757689	Plantar herpes zoster following heterologous recombinant adenovirus-based COVID-19 vaccine.	J Cosmet Dermatol
34756612	Evaluation of a downstream process for the recovery and concentration of a Cell-Culture-Derived rVSV-Spike COVID-19 vaccine candidate.	Vaccine
34752741	COVID-19 associated coagulopathy: Mechanisms and host-directed treatment.	Am J Med Sci
34750014	Development of recombinant COVID-19 vaccine based on CHO-produced, prefusion spike trimer and alum/CpG adjuvants.	Vaccine
34747742	Tocilizumab in COVID-19: enthusiasm vs. evidence.	Lung India
34746910	An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine "Sputnik Light" for prevention of coronavirus infection in healthy adults.	Lancet Reg Health Eur
34746028	The Impact of ACE2 Polymorphisms on COVID-19 Disease: Susceptibility, Severity, and Therapy.	Front Cell Infect Microbiol
34745440	Peptide Inhibitors of the Interaction of the SARS-CoV-2 Receptor-Binding Domain with the ACE2 Cell Receptor.	Biochem Mosc Suppl B Biomed Chem
34745093	Non-Randomized Trial of Dornase Alfa for Acute Respiratory Distress Syndrome Secondary to Covid-19.	Front Immunol
34742396	Inducible protein expression in piggyBac transposase mediated stable HEK293 cell pools.	Methods Enzymol
34739558	In-solution buffer-free digestion allows full-sequence coverage and complete characterization of post-translational modifications of the receptor-binding domain of SARS-CoV-2 in a single ESI-MS spectrum.	Anal Bioanal Chem
34739037	Evaluating the Neutralizing Ability of a CpG-Adjuvanted S-2P Subunit Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern.	Clin Infect Dis
34735901	Shortening Door-to-Needle Time by Multidisciplinary Collaboration and Workflow Optimization During the COVID-19 Pandemic.	J Stroke Cerebrovasc Dis
34734906	COVID-19 Associated Wake-Up Stroke Treated With DWI/FLAIR Mismatch Guided Intravenous Alteplase: A Case Report.	Neurologist
34732275	SARS-CoV-2 variants and effectiveness of vaccines: a review of current evidence.	Epidemiol Infect
34724920	Association between tocilizumab and emerging multidrug-resistant organisms in critically ill patients with COVID-19: A multicenter, retrospective cohort study.	BMC Infect Dis
34724174	Regdanvimab: First Approval.	Drugs
34723156	Polyclonal F(ab')2 fragments of equine antibodies raised against the spike protein neutralize SARS-CoV-2 variants with high potency.	iScience
34722830	Transient yet Robust Expression of Proteins in the Mouse Liver via Intravenous Injection of Lipid Nanoparticle-encapsulated Nucleoside-modified mRNA.	Bio Protoc
34719824	Structural basis for the interaction of SARS-CoV-2 virulence factor nsp1 with DNA polymerase alpha-primase.	Protein Sci
34717971	Glycosylation and Serological Reactivity of an Expression-enhanced SARS-CoV-2 Viral Spike Mimetic.	J Mol Biol
34714719	Reporting of recombinant adenovirus-based COVID-19 vaccine adverse events in online versions of three highly circulated US newspapers.	Hum Vaccin Immunother
34714580	Specific delivering of RNAi using Spike's aptamer-functionalized lipid nanoparticles for targeting SARS-CoV-2: A strong anti-Covid drug in a clinical case study.	Chem Biol Drug Des
34710269	Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19.	J Thromb Haemost
34706134	Egg yolk immunoglobulin (IgY) targeting SARS-CoV-2 S1 as potential virus entry blocker.	J Appl Microbiol
34705339	NMR-Based Analysis of Nanobodies to SARS-CoV-2 Nsp9 Reveals a Possible Antiviral Strategy Against COVID-19.	Adv Biol (Weinh)
34699776	An easy pipeline for one-step purification of SARS-CoV-2 nucleocapsid protein from insect cell suspension culture.	J Virol Methods
34696367	Development of a Recombinant RBD Subunit Vaccine for SARS-CoV-2.	Viruses
34696315	Associations between Allelic Variants of the Human IgH 3' Regulatory Region 1 and the Immune Response to BNT162b2 mRNA Vaccine.	Vaccines (Basel)
34696295	Self-Replicating RNA Viruses for Vaccine Development against Infectious Diseases and Cancer.	Vaccines (Basel)
34696220	COVID-19 Vaccination in Patients with Myasthenia Gravis: A Single-Center Case Series.	Vaccines (Basel)
34696209	The Rise of Vectored Vaccines: A Legacy of the COVID-19 Global Crisis.	Vaccines (Basel)
34694794	Electrochemical Capillary-Flow Immunoassay for Detecting Anti-SARS-CoV-2 Nucleocapsid Protein Antibodies at the Point of Care.	ACS Sens
34689960	Peptides-based therapeutics: Emerging potential therapeutic agents for COVID-19.	Therapie
34689655	A Pair of "ACEs".	J Dent Res
34688949	Measuring the impact of a single dose of ChAdOx1 nCoV-19 (recombinant) coronavirus vaccine on hospital stay, ICU requirement, and mortality outcome in a tertiary care centre.	Int J Infect Dis
34688919	Yeast-expressed recombinant SARS-CoV-2 receptor binding domain RBD203-N1 as a COVID-19 protein vaccine candidate.	Protein Expr Purif
34688775	Upregulation of type 1 conventional dendritic cells implicates antigen cross-presentation in multisystem inflammatory syndrome.	J Allergy Clin Immunol
34687769	Therapeutic antibodies - natural and pathological barriers and strategies to overcome them.	Pharmacol Ther
34685696	Vaccines against COVID-19: Priority to mRNA-Based Formulations.	Cells
34684671	Glycyrrhizic Acid Inhibits SARS-CoV-2 Infection by Blocking Spike Protein-Mediated Cell Attachment.	Molecules
34683878	The Revolving Door of Adenovirus Cell Entry: Not All Pathways Are Equal.	Pharmaceutics
34679506	Recombinant Protein Expression and Purification of N, S1, and RBD of SARS-CoV-2 from Mammalian Cells and Their Potential Applications.	Diagnostics (Basel)
34678315	Development of a highly specific and sensitive VHH-based sandwich immunoassay for the detection of the SARS-CoV-2 nucleoprotein.	J Biol Chem
34678096	Simultaneous Detection of SARS-CoV-2 IgG/IgM Antibodies, Using Gold Nanoparticles-Based Lateral Flow Immunoassay.	Monoclon Antib Immunodiagn Immunother
34671199	Receptor-binding domain of SARS-CoV-2 spike protein efficiently inhibits SARS-CoV-2 infection and attachment to mouse lung.	Int J Biol Sci
34670086	Suppression of O-Linked Glycosylation of the SARS-CoV-2 Spike by Quaternary Structural Restraints.	Anal Chem
34668746	Robust Evaluation of Ultraviolet-C Sensitivity for SARS-CoV-2 and Surrogate Coronaviruses.	Microbiol Spectr
34668428	ACE2: a key modulator of the renin-angiotensin system and pregnancy.	Am J Physiol Regul Integr Comp Physiol
34667599	Endothelial dysfunction and COVID-19 (Review).	Biomed Rep
34661088	The effect of N-glycosylation of SARS-CoV-2 spike protein on the virus interaction with the host cell ACE2 receptor.	iScience
34659650	Review: Development of SARS-CoV-2 immuno-enhanced COVID-19 vaccines with nano-platform.	Nano Res
34658688	Evaluation of Cell-Penetrating Peptides as Mucosal Immune Enhancers for Nasal Vaccination.	Int J Pept Res Ther
34655522	Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan.	Lancet Respir Med
34650951	Efficacy of COVID-19 Treatments: A Bayesian Network Meta-Analysis of Randomized Controlled Trials.	Front Public Health
34649620	Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants.	Genome Med
34648356	Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses.	Sci Immunol
34648139	The role of single-domain antibodies (or nanobodies) in SARS-CoV-2 neutralization.	Mol Biol Rep
34646292	Impact of Specific N-Glycan Modifications on the Use of Plant-Produced SARS-CoV-2 Antigens in Serological Assays.	Front Plant Sci
34642634	Renin Angiotensin Aldosterone System Antagonism in 2019 Novel Coronavirus Acute Lung Injury.	Open Forum Infect Dis
34638527	Cloning of a Passage-Free SARS-CoV-2 Genome and Mutagenesis Using Red Recombination.	Int J Mol Sci
34637549	Single domain shark VNAR antibodies neutralize SARS-CoV-2 infection in vitro.	FASEB J
34635581	A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells.	Proc Natl Acad Sci U S A
34634204	Glycan-Based Flow-Through Device for the Detection of SARS-COV-2.	ACS Sens
34632328	Intranasal vaccination with a Newcastle disease virus-vectored vaccine protects hamsters from SARS-CoV-2 infection and disease.	iScience
34631661	A Linkage-specific Sialic Acid Labeling Strategy Reveals Different Site-specific Glycosylation Patterns in SARS-CoV-2 Spike Protein Produced in CHO and HEK Cell Substrates.	Front Chem
34628049	A cell-free high throughput assay for assessment of SARS-CoV-2 neutralizing antibodies.	N Biotechnol
34619430	Symptomatic post-vaccination SARS-CoV-2 infections in healthcare workers- A multicenter cohort study.	Diabetes Metab Syndr
34612299	A peptide-based subunit candidate vaccine against SARS-CoV-2 delivered by biodegradable mesoporous silica nanoparticles induced high humoral and cellular immunity in mice.	Biomater Sci
34611521	ACE2-cytomimetic particles restrict SARS-Cov-2 spike protein binding to cellular targets.	Biotechnol Rep (Amst)
34611365	Expression and characterization of SARS-CoV-2 spike proteins.	Nat Protoc
34607456	A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape Mutants.	mBio
34603303	A Combination Adjuvant for the Induction of Potent Antiviral Immune Responses for a Recombinant SARS-CoV-2 Protein Vaccine.	Front Immunol
34598965	Doxycycline-induced acquired haemophilia A.	BMJ Case Rep
34598434	Approach to COVID-19 pandemic management in Madrid. Chronic of a year.	Rev Esp Quimioter
34597298	Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial.	PLoS Med
34594910	Development of a PDRA Method for Detection of the D614G Mutation in COVID-19 Virus - Worldwide, 2021.	China CDC Wkly
34594203	Darier's Disease Flare following COVID-19 Vaccine.	Case Rep Dermatol
34586015	Versatile and rapid microfluidics-assisted antibody discovery.	MAbs
34585949	Mutations in the Methyltransferase Motifs of L Protein Attenuate Newcastle Disease Virus by Regulating Viral Translation and Cell-to-Cell Spread.	Microbiol Spectr
34580409	Viral S protein histochemistry reveals few potential SARS-CoV-2 entry sites in human ocular tissues.	Sci Rep
34579215	Plant-Expressed Receptor Binding Domain of the SARS-CoV-2 Spike Protein Elicits Humoral Immunity in Mice.	Vaccines (Basel)
34578109	Methodological Development of a Multi-Readout Assay for the Assessment of Antiviral Drugs against SARS-CoV-2.	Pathogens
34576934	Inactivation Activities of Ozonated Water, Slightly Acidic Electrolyzed Water and Ethanol against SARS-CoV-2.	Molecules
34576862	In Vitro Rapid Antigen Test Performance with the SARS-CoV-2 Variants of Concern B.1.1.7 (Alpha), B.1.351 (Beta), P.1 (Gamma), and B.1.617.2 (Delta).	Microorganisms
34574555	Development and Evaluation of Quantitative Immunoglobulin G Enzyme-Linked Immunosorbent Assay for the Diagnosis of Coronavirus Disease 2019 Using Truncated Recombinant Nucleocapsid Protein as Assay Antigen.	Int J Environ Res Public Health
34570513	Discovery and Mechanism of SARS-CoV-2 Main Protease Inhibitors.	J Med Chem
34568087	COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions.	Front Cell Infect Microbiol
34566657	Therapeutic Potential of Annexins in Sepsis and COVID-19.	Front Pharmacol
34565332	Addressing the 'hypoxia paradox' in severe COVID-19: literature review and report of four cases treated with erythropoietin analogues.	Mol Med
34561300	Analysis of SARS-CoV-2 infection dynamic in vivo using reporter-expressing viruses.	Proc Natl Acad Sci U S A
34558627	Diversity of ACE2 and its interaction with SARS-CoV-2 receptor binding domain.	Biochem J
34551104	Safety and Immunogenicity of a Recombinant Adenovirus Type-5-Vectored Coronavirus Disease 2019 (COVID-19) Vaccine With a Homologous Prime-Boost Regimen in Healthy Participants Aged >/=6 Years: A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Trial.	Clin Infect Dis
34547822	A surrogate cell-based SARS-CoV-2 spike blocking assay.	Eur J Immunol
34546608	Leukocytoclastic vasculitis as a cutaneous manifestation of ChAdOx1 nCoV-19 corona virus vaccine (recombinant).	Dermatol Ther
34545040	An immunologist's perspective on anti-COVID-19 vaccines.	Curr Opin Allergy Clin Immunol
34544043	Case Report: Paucisymptomatic College-Age Population as a Reservoir for Potentially Neutralization-Resistant Severe Acute Respiratory Syndrome Coronavirus 2 Variants.	Am J Trop Med Hyg
34543643	Generation and characterisation of a semi-synthetic siderophore-immunogen conjugate and a derivative recombinant triacetylfusarinine C-specific monoclonal antibody with fungal diagnostic application.	Anal Biochem
34542663	A reverse vaccinology and immunoinformatics approach for designing a multiepitope vaccine against SARS-CoV-2.	Immunogenetics
34541573	Potent neutralizing RBD-specific antibody cocktail against SARS-CoV-2 and its mutant.	MedComm (2020)
34541571	A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: An open-label phase 1 clinical trial.	Lancet Reg Health Am
34541480	Effectiveness of the first component of Gam-COVID-Vac (Sputnik V) on reduction of SARS-CoV-2 confirmed infections, hospitalisations and mortality in patients aged 60-79: a retrospective cohort study in Argentina.	EClinicalMedicine
34541054	Optimised Method for the Production and Titration of Lentiviral Vectors Pseudotyped with the SARS-CoV-2 Spike.	Bio Protoc
34539141	Recombinant angiopoietin-like protein 4 attenuates intestinal barrier structure and function injury after ischemia/reperfusion.	World J Gastroenterol
34538956	Use of the rheumatic drug tocilizumab for treatment of SARS-CoV-2 patients.	Reumatologia
34537403	Next biotechnological plants for addressing global challenges: The contribution of transgenesis and new breeding techniques.	N Biotechnol
34535326	Diagnosis and treatment of hairy cell leukemia as the COVID-19 pandemic continues.	Blood Rev
34528522	Emergence of COVID-19 variants among ChAdOx1 nCoV-19 (recombinant) vaccine recipients.	Indian J Med Res
34523986	A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 Infection and Its Application in a Population-Based Survey by Mail.	Microbiol Spectr
34520491	Development of in-house, indirect ELISAs for the detection of SARS-CoV-2 spike protein-associated serology in COVID-19 patients in Panama.	PLoS One
34512635	Recombinant Mycobacterium paragordonae Expressing SARS-CoV-2 Receptor-Binding Domain as a Vaccine Candidate Against SARS-CoV-2 Infections.	Front Immunol
34511939	Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety.	Infect Drug Resist
34505032	A prospective observational safety study on ChAdOx1 nCoV-19 corona virus vaccine (recombinant) use in healthcare workers- first results from India.	EClinicalMedicine
34499954	Mucosal IgA response elicited by intranasal immunization of Lactobacillus plantarum expressing surface-displayed RBD protein of SARS-CoV-2.	Int J Biol Macromol
34499854	Generation and transmission of interlineage recombinants in the SARS-CoV-2 pandemic.	Cell
34499677	Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamsters.	PLoS One
34498761	A novel competition ELISA for the rapid quantification of SARS-CoV-2 neutralizing antibodies in convalescent plasma.	Transfusion
34495697	A Bifluorescent-Based Assay for the Identification of Neutralizing Antibodies against SARS-CoV-2 Variants of Concern In Vitro and In Vivo.	J Virol
34493903	SERS-based lateral flow immunoassay for sensitive and simultaneous detection of anti-SARS-CoV-2 IgM and IgG antibodies by using gap-enhanced Raman nanotags.	Sens Actuators B Chem
34493582	Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice.	Proc Natl Acad Sci U S A
34492082	Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection.	PLoS Pathog
34491572	Occurrence of COVID-19 in priority groups receiving ChAdOx1 nCoV-19 coronavirus vaccine (recombinant): A preliminary analysis from north India.	J Med Virol
34489146	A Comparison of SARS-COV-2 Neutralizing Antibody Therapies in High-Risk Patients with Mild to Moderate COVID-19 Disease at a Single Academic Hospital.	J Emerg Med
34488566	Aortic thrombosis in a neonate with COVID-19-related fetal inflammatory response syndrome requiring amputation of the leg: a case report.	Paediatr Int Child Health
34488453	Immunological Profiling of COVID-19 Patients with Pulmonary Sequelae.	mBio
34487951	Impact of early versus late administration of bamlanivimab on readmissions in patients with high-risk COVID-19.	Am J Emerg Med
34487767	The dominant strain of SARS-CoV-2 is a mosaicism.	Virus Res
34485950	Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination.	Cell Rep Med
34485255	Cell-Free Glycoengineering of the Recombinant SARS-CoV-2 Spike Glycoprotein.	Front Bioeng Biotechnol
34484202	Sargramostim (rhu GM-CSF) as Cancer Therapy (Systematic Review) and An Immunomodulator. A Drug Before Its Time?	Front Immunol
34483273	Bilateral Immune-Mediated Keratolysis After Immunization With SARS-CoV-2 Recombinant Viral Vector Vaccine.	Cornea
34481699	SARS-COV-2 recombinant Receptor-Binding-Domain (RBD) induces neutralizing antibodies against variant strains of SARS-CoV-2 and SARS-CoV-1.	Vaccine
34475772	COVID-19 in Patients with Atopic Dermatitis Treated with Dupilumab: Three Cases and a Literature Review.	Clin Cosmet Investig Dermatol
34462676	Vaccine Development Throughout History.	Cureus
34462471	A comparative recombination analysis of human coronaviruses and implications for the SARS-CoV-2 pandemic.	Sci Rep
34457370	A Vaccine Based on the Receptor-Binding Domain of the Spike Protein Expressed in Glycoengineered Pichia pastoris Targeting SARS-CoV-2 Stimulates Neutralizing and Protective Antibody Responses.	Engineering (Beijing)
34455696	A decoy strategy to activate the immune system.	IUBMB Life
34453338	In vitro data suggest that Indian delta variant B.1.617 of SARS-CoV-2 escapes neutralization by both receptor affinity and immune evasion.	Allergy
34452287	Elicitation of Broadly Neutralizing Antibodies against B.1.1.7, B.1.351, and B.1.617.1 SARS-CoV-2 Variants by Three Prototype Strain-Derived Recombinant Protein Vaccines.	Viruses
34452053	Recombinant Antigens Based on Non-Glycosylated Regions from RBD SARS-CoV-2 as Potential Vaccine Candidates against COVID-19.	Vaccines (Basel)
34451516	Potential for Developing Plant-Derived Candidate Vaccines and Biologics against Emerging Coronavirus Infections.	Pathogens
34451501	Recombinant SARS-CoV-2 Nucleocapsid Protein: Expression, Purification, and Its Biochemical Characterization and Utility in Serological Assay Development to Assess Immunological Responses to SARS-CoV-2 Infection.	Pathogens
34448800	Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season.	MMWR Recomm Rep
34448030	The opportunity cost of automated glycopeptide analysis: case study profiling the SARS-CoV-2 S glycoprotein.	Anal Bioanal Chem
34443990	Considerations for Home-Based Treatment of Fabry Disease in Poland during the COVID-19 Pandemic and Beyond.	Int J Environ Res Public Health
34440612	Affinity Tag Coating Enables Reliable Detection of Antigen-Specific B Cells in Immunospot Assays.	Cells
34439781	Full-Length Recombinant hSP-D Binds and Inhibits SARS-CoV-2.	Biomolecules
34431700	A Novel Potentially Recombinant Rodent Coronavirus with a Polybasic Cleavage Site in the Spike Protein.	J Virol
34428473	The impact of spike mutated variants of SARS-CoV2 [Alpha, Beta, Gamma, Delta, and Lambda] on the efficacy of subunit recombinant vaccines.	Braz J Infect Dis
34427932	Incomplete IgG avidity maturation after seasonal coronavirus infections.	J Med Virol
34427670	Critically Ill Coronavirus Disease 2019 Patients Exhibit Hyperactive Cytokine Responses Associated With Effector Exhausted Senescent T Cells in Acute Infection.	J Infect Dis
34425781	Development and clinical evaluation of a rapid antibody lateral flow assay for the diagnosis of SARS-CoV-2 infection.	BMC Infect Dis
34420786	Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection.	Vaccine
34420183	Evaluating Stability and Activity of SARS-CoV-2 PLpro for High-throughput Screening of Inhibitors.	Mol Biotechnol
34416777	[SARS-CoV-2 vaccines and reaction of the immune system. Can the epidemic spread of the virus be prevented by vaccination?]	Dtsch Med Wochenschr
34415051	Systemic thrombolysis in ischaemic stroke patients with COVID-19.	Acta Neurol Scand
34408130	Yeast-produced RBD-based recombinant protein vaccines elicit broadly neutralizing antibodies and durable protective immunity against SARS-CoV-2 infection.	Cell Discov
34406867	Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve In Vitro to Higher Infectivity through More Efficient Binding to Heparan Sulfate and Reduced S1/S2 Cleavage.	J Virol
34403292	Prospective clinical trial of hepatitis B vaccination for children with hematological malignancies: a study on the safety and immunogenicity efficacy.	Hum Vaccin Immunother
34403037	Generation and Characterization of a Nanobody Against SARS-CoV.	Virol Sin
34396395	BPIFB4 Circulating Levels and Its Prognostic Relevance in COVID-19.	J Gerontol A Biol Sci Med Sci
34396087	Recombinant human plasma gelsolin (rhu-pGSN) in a patient hospitalized with critical COVID-19 pneumonia.	Clin Infect Pract
34394876	COVID-19 Recombinant mRNA Vaccines and Serious Ocular Inflammatory Side Effects: Real or Coincidence?	J Ophthalmic Vis Res
34393616	3D-Printed COVID-19 immunosensors with electronic readout.	Chem Eng J
34386028	The C-Terminal Half of SARS-CoV-2 Nucleocapsid Protein, Industrially Produced in Plants, Is Valid as Antigen in COVID-19 Serological Tests.	Front Plant Sci
34385423	Potent prophylactic and therapeutic efficacy of recombinant human ACE2-Fc against SARS-CoV-2 infection in vivo.	Cell Discov
34383735	Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.	MMWR Morb Mortal Wkly Rep
34381282	An electrochemical immunosensor using SARS-CoV-2 spike protein-nickel hydroxide nanoparticles bio-conjugate modified SPCE for ultrasensitive detection of SARS-CoV-2 antibodies.	Microchem J
34381049	Downregulation of exhausted cytotoxic T cells in gene expression networks of multisystem inflammatory syndrome in children.	Nat Commun
34379705	Rapid generation of mouse model for emerging infectious disease with the case of severe COVID-19.	PLoS Pathog
34379509	A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in Hamsters.	J Virol
34379411	Refining the N-Termini of the SARS-CoV-2 Spike Protein and Its Discrete Receptor-Binding Domain.	J Proteome Res
34378982	Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein.	mSphere
34376712	Bioactive recombinant human oncostatin M for NMR-based screening in drug discovery.	Sci Rep
34375345	Longitudinal analysis to characterize classes and subclasses of antibody responses to recombinant receptor-binding protein (RBD) of SARS-CoV-2 in COVID-19 patients in Thailand.	PLoS One
34375189	The use of Pseudotyped Coronaviruses for the Screening of Entry Inhibitors: Green Tea Extract Inhibits the Entry of SARS-CoV-1, MERSCoV, and SARS-CoV-2 by Blocking Receptor-spike Interaction.	Curr Pharm Biotechnol
34372230	Construction of Fluorescent Immunosensor Quenchbody to Detect His-Tagged Recombinant Proteins Produced in Bioprocess.	Sensors (Basel)
34370799	Intranasal type I interferon treatment is beneficial only when administered before clinical signs onset in the SARS-CoV-2 hamster model.	PLoS Pathog
34368915	Multicentre Performance Evaluation of the Elecsys Anti-SARS-CoV-2 Immunoassay as an Aid in Determining Previous Exposure to SARS-CoV-2.	Infect Dis Ther
34368648	Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2.	iScience
34366403	Concerning the unexpected prothrombotic state following some coronavirus disease 2019 vaccines.	J Cardiovasc Med (Hagerstown)
34365904	Live attenuated coronavirus vaccines deficient in N7-Methyltransferase activity induce both humoral and cellular immune responses in mice.	Emerg Microbes Infect
34363713	Cutaneous reactions to inactivated SARS-CoV-2 vaccine and ChAdOx1-S (recombinant) vaccine against SARS-CoV-2: a case series from the Philippines.	J Eur Acad Dermatol Venereol
34362602	Developing-country vaccine manufacturers' technical capabilities can make a difference in global immunization.	Vaccine
34360706	Boosted Pro-Inflammatory Activity in Human PBMCs by Lipopolysaccharide and SARS-CoV-2 Spike Protein Is Regulated by alpha-1 Antitrypsin.	Int J Mol Sci
34358177	Combating Human Viral Diseases: Will Plant-Based Vaccines Be the Answer?	Vaccines (Basel)
34358149	Fusion Protein of Rotavirus VP6 and SARS-CoV-2 Receptor Binding Domain Induces T Cell Responses.	Vaccines (Basel)
34358119	Soluble Angiotensin Converting Enzyme 2 (ACE2) Is Upregulated and Soluble Endothelial Nitric Oxide Synthase (eNOS) Is Downregulated in COVID-19-induced Acute Respiratory Distress Syndrome (ARDS).	Pharmaceuticals (Basel)
34345597	Efficacy and safety of potential vaccine candidates against coronavirus disease 2019: A systematic review.	J Adv Pharm Technol Res
34344659	COVID-19-associated ischaemic stroke due to underlying carotid artery thrombosis in a healthy young woman.	BMJ Case Rep
34341769	CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2.	ACS Cent Sci
34341227	SARS-CoV-2 infection after COVID-19 immunization in healthcare workers: A retrospective, pilot study.	Indian J Med Res
34337036	Characterization of the Modulatory Effect of Hydroxychloroquine on ACE2 Activity: New Insights in relation to COVID-19.	Biomed Res Int
34334899	Pulmonary embolism in coronavirus disease 2019: the silent killer.	Med J Armed Forces India
34324997	Rescue of recombinant canine distemper virus that expresses S1 subunit of SARS-CoV-2 spike protein in vitro.	Microb Pathog
34324210	SARS-CoV-2 pseudovirus infectivity and expression of viral entry-related factors ACE2, TMPRSS2, Kim-1, and NRP-1 in human cells from the respiratory, urinary, digestive, reproductive, and immune systems.	J Med Virol
34315190	One hundred and ten years of Allergen Immunotherapy: A journey from empiric observation to evidence.	Allergy
34315173	Aberrant glycosylation of anti-SARS-CoV-2 spike IgG is a prothrombotic stimulus for platelets.	Blood
34310400	Immunogenicity and safety of a recombinant fusion protein vaccine (V-01) against coronavirus disease 2019 in healthy adults: a randomized, double-blind, placebo-controlled, phase II trial.	Chin Med J (Engl)
34307196	Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy.	Front Cell Infect Microbiol
34305855	Inhibition of SARS CoV Envelope Protein by Flavonoids and Classical Viroporin Inhibitors.	Front Microbiol
34305135	Editorial: Targets for Disease-Modifying Therapies in Alzheimer's Disease, Including Amyloid beta and Tau Protein.	Med Sci Monit
34303337	Nanovaccine: A Hope to Triumph the Battle Against Novel Coronavirus Disease 2019 (COVID-19)	Recent Pat Nanotechnol
34303138	A high-specificity flap probe-based isothermal nucleic acid amplification method based on recombinant FEN1-Bst DNA polymerase.	Biosens Bioelectron
34301275	Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics.	Virol J
34299155	Variable Induction of Pro-Inflammatory Cytokines by Commercial SARS CoV-2 Spike Protein Reagents: Potential Impacts of LPS on In Vitro Modeling and Pathogenic Mechanisms In Vivo.	Int J Mol Sci
34299089	Role of Extracellular Vimentin in Cancer-Cell Functionality and Its Influence on Cell Monolayer Permeability Changes Induced by SARS-CoV-2 Receptor Binding Domain.	Int J Mol Sci
34291477	Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNA-based or adenoviral vector-based SARS-CoV-2 vaccination.	Clin Exp Dermatol
34289779	Recombinant chimpanzee adenovirus AdC7 expressing dimeric tandem-repeat spike protein RBD protects mice against COVID-19.	Emerg Microbes Infect
34288726	Evaluation of Cell-Based and Surrogate SARS-CoV-2 Neutralization Assays.	J Clin Microbiol
34287229	Identification of Human SARS-CoV-2 Monoclonal Antibodies from Convalescent Patients Using EBV Immortalization.	Antibodies (Basel)
34285303	Kinetic characterisation and inhibitor sensitivity of Candida albicans and Candida auris recombinant AOX expressed in a self-assembled proteoliposome system.	Sci Rep
34285130	A recombinant spike protein subunit vaccine confers protective immunity against SARS-CoV-2 infection and transmission in hamsters.	Sci Transl Med
34284575	Comprehensive O-Glycosylation Analysis of the SARS-CoV-2 Spike Protein with Biomimetic Trp-Arg Materials.	Anal Chem
34283643	Immune Responses to Recombinant Adenoviruses As Gene Therapy Vectors and COVID-19 Vaccines: A Two-Edged Sword.	Hum Gene Ther
34282035	Enhancement of Cell-Based Vaccine Manufacturing through Process Intensification.	PDA J Pharm Sci Technol
34280963	A dossier on COVID-19 chronicle.	J Basic Clin Physiol Pharmacol
34280256	Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein.	Blood
34278956	Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine.	Emerg Microbes Infect
34278670	Corrigendum: Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine.	Angew Chem Int Ed Engl
34275974	Emergency use of COVID-19 vaccines recommended by the World Health Organization (WHO) as of June 2021.	Drug Discov Ther
34274941	A bivalent recombinant vaccine: a promising strategy against both SARS-CoV-2 variants and wild type of the virus.	Signal Transduct Target Ther
34274845	Evaluation of in vitro activity of copper gluconate against SARS-CoV-2 using confocal microscopy-based high content screening.	J Trace Elem Med Biol
34273271	A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations.	Cell Rep
34271432	Natto extract, a Japanese fermented soybean food, directly inhibits viral infections including SARS-CoV-2 in vitro.	Biochem Biophys Res Commun
34270996	HIV-1 genetic diversity and drug resistance mutations in the northern Brazilian region.	Braz J Infect Dis
34267185	Safety and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older: two single-center, randomised, double-blind, placebo-controlled, phase 1 and phase 2 trials.	Signal Transduct Target Ther
34265628	Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.	Virology
34264868	Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotide.	JCI Insight
34264519	Rapid and cost-effective process based on insect larvae for scale-up production of SARS-COV-2 spike protein for serological COVID-19 testing.	Biotechnol Bioeng
34264384	Tocilizumab in patients with COVID-19: which patient, time, and dose?	J Anesth
34253798	Inferring the ecological niche of bat viruses closely related to SARS-CoV-2 using phylogeographic analyses of Rhinolophus species.	Sci Rep
34250530	Cross-validation of ELISA and a portable surface plasmon resonance instrument for IgG antibody serology with SARS-CoV-2 positive individuals.	Analyst
34250222	Current vaccine technology with an emphasis on recombinant measles virus as a new perspective for vaccination against SARS-CoV-2.	EuroMediterr J Environ Integr
34248283	Developing an Optical Interferometric Detection Method based biosensor for detecting specific SARS-CoV-2 immunoglobulins in Serum and Saliva, and their corresponding ELISA correlation.	Sens Actuators B Chem
34245473	Determination of human COVID-19 total antibodies in serum using a time-resolved fluorescence immunoassay.	Biotechnol Appl Biochem
34245243	Comparison of the Immunogenicity of Cell Culture-Based and Recombinant Quadrivalent Influenza Vaccines to Conventional Egg-Based Quadrivalent Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized Open-Label Trial.	Clin Infect Dis
34237302	Recombinant SARS-CoV-2 envelope protein traffics to the trans-Golgi network following amphipol-mediated delivery into human cells.	J Biol Chem
34229729	Evaluation of the efficacy and safety of recombinant erythropoietin on the improvement of hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial.	Trials
34229274	A mass spectrometry-based targeted assay for detection of SARS-CoV-2 antigen from clinical specimens.	EBioMedicine
34228301	Interferons and Multiple Sclerosis: Lessons from 25 Years of Clinical and Real-World Experience with Intramuscular Interferon Beta-1a (Avonex).	CNS Drugs
34226895	A bivalent recombinant vaccine targeting the S1 protein induces neutralizing antibodies against both SARS-CoV-2 variants and wild-type of the virus.	MedComm (2020)
34226102	Laser-facilitated epicutaneous immunization of mice with SARS-CoV-2 spike protein induces antibodies inhibiting spike/ACE2 binding.	Vaccine
34222848	Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC-COV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation study.	EClinicalMedicine
34220844	The Antigenicity of Epidemic SARS-CoV-2 Variants in the United Kingdom.	Front Immunol
34219448	SARS-CoV-2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical Studies.	ACS Chem Biol
34213846	Insufficient type I IFN immunity underlies life-threatening COVID-19 pneumonia.	C R Biol
34213308	Site-Specific Steric Control of SARS-CoV-2 Spike Glycosylation.	Biochemistry
34211491	N-Glycosylation of the SARS-CoV-2 Receptor Binding Domain Is Important for Functional Expression in Plants.	Front Plant Sci
34209694	SARS-CoV-2 Production in a Scalable High Cell Density Bioreactor.	Vaccines (Basel)
34208050	Significant Inactivation of SARS-CoV-2 In Vitro by a Green Tea Catechin, a Catechin-Derivative, and Black Tea Galloylated Theaflavins.	Molecules
34204890	Beneficial Effects of Mineralocorticoid Receptor Pathway Blockade against Endothelial Inflammation Induced by SARS-CoV-2 Spike Protein.	Biomedicines
34202429	Intranasal Vaccination Strategy to Control the COVID-19 Pandemic from a Veterinary Medicine Perspective.	Animals (Basel)
34200372	ACE2-Independent Interaction of SARS-CoV-2 Spike Protein with Human Epithelial Cells Is Inhibited by Unfractionated Heparin.	Cells
34199224	Is SARS-CoV-2 Neutralized More Effectively by IgM and IgA than IgG Having the Same Fab Region?	Pathogens
34198324	Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonuclease.	Biochem J
34197281	Safety and immunogenicity of a recombinant interferon-armed RBD dimer vaccine (V-01) for COVID-19 in healthy adults: a randomized, double-blind, placebo-controlled, Phase I trial.	Emerg Microbes Infect
34194331	A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2.	Front Pharmacol
34192426	Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.	N Engl J Med
34191362	CyDisCo production of functional recombinant SARS-CoV-2 spike receptor binding domain.	Protein Sci
34191346	Plasma ACE2 species are differentially altered in COVID-19 patients.	FASEB J
34190748	Triple-target stimuli-responsive anti-COVID-19 face mask with physiological virus-inactivating agents.	Biomater Sci
34189359	Severe Epistaxis after Tissue Plasminogen Activator administration for Acute Ischemic Stroke in SARS-COV-2 Infection.	Brain Circ
34187304	Expression and functional identification of recombinant SARS-CoV-2 receptor binding domain (RBD) from E. coli system.	Prep Biochem Biotechnol
34185868	SARS-CoV-2 in eight municipalities of the Colombian tropics: high immunity, clinical and sociodemographic outcomes.	Trans R Soc Trop Med Hyg
34182038	An optimized and robust SARS-CoV-2 pseudovirus system for viral entry research.	J Virol Methods
34180347	COVID-19 vaccines: concerns beyond protective efficacy and safety.	Expert Rev Vaccines
34179862	A recombinant receptor-binding domain in trimeric form generates protective immunity against SARS-CoV-2 infection in nonhuman primates.	Innovation (Camb)
34179146	SARS-CoV-2 Spike Protein Induces Degradation of Junctional Proteins That Maintain Endothelial Barrier Integrity.	Front Cardiovasc Med
34177838	Expression of Human ACE2 N-terminal Domain, Part of the Receptor for SARS-CoV-2, in Fusion With Maltose-Binding Protein, E. coli Ribonuclease I and Human RNase A.	Front Microbiol
34177298	Review of Pharmacotherapy Trialed for Management of the Coronavirus Disease-19.	Eurasian J Med
34173107	Dynamics of Antibodies to Various Antigens of the SARS-CoV-2 Coronavirus in Patients with Confirmed COVID-19 Infection.	Bull Exp Biol Med
34171548	A SARS-CoV-2 Nucleocapsid Variant that Affects Antigen Test Performance.	J Clin Virol
34168368	Rapid generation of potent antibodies by autonomous hypermutation in yeast.	Nat Chem Biol
34163462	Regulated Intramembrane Proteolysis of ACE2: A Potential Mechanism Contributing to COVID-19 Pathogenesis?	Front Immunol
34162739	Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.	Proc Natl Acad Sci U S A
34162141	An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages.	Int Immunopharmacol
34161348	Performance of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies in South Africa.	PLoS One
34155551	Simultaneous enrichment and separation of neutral and sialyl glycopeptides of SARS-CoV-2 spike protein enabled by dual-functionalized Ti-IMAC material.	Anal Bioanal Chem
34154407	Allosteric Activation of SARS-CoV-2 RNA-Dependent RNA Polymerase by Remdesivir Triphosphate and Other Phosphorylated Nucleotides.	mBio
34150933	Production of the Receptor-binding Domain of the Viral Spike Proteins from 2003 and 2019 SARS CoVs and the Four Common Human Coronaviruses for Serologic Assays and Inhibitor Screening.	Bio Protoc
34150735	Engineering of Chinese Hamster Ovary Cells With NDPK-A to Enhance DNA Nuclear Delivery Combined With EBNA1 Plasmid Maintenance Gives Improved Exogenous Transient Reporter, mAb and SARS-CoV-2 Spike Protein Expression.	Front Bioeng Biotechnol
34150187	Temperature responsive smart polymer for enabling affinity enrichment of current coronavirus (SARS-CoV-2) to improve its diagnostic sensitivity.	Comput Struct Biotechnol J
34148926	Improved Detection Sensitivity of an Antigen Test for SARS-CoV-2 Nucleocapsid Proteins with Thio-NAD Cycling.	Biol Pharm Bull
34142531	[Peptide inhibitors of the interaction of the SARS-CoV-2 receptor-binding domain with the ACE2 cell receptor].	Biomed Khim
34139879	Tergitol-15-S-9 inactivates SARS-CoV-2 and boosts immunoassay signals.	Biotechniques
34139362	Proteome Profiling of Recombinant DNase Therapy in Reducing NETs and Aiding Recovery in COVID-19 Patients.	Mol Cell Proteomics
34133899	Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice.	J Virol
34133128	Epitope-Functionalized Gold Nanoparticles for Rapid and Selective Detection of SARS-CoV-2 IgG Antibodies.	ACS Nano
34130087	Facile and rapid detection of SARS-CoV-2 antibody based on a noncompetitive fluorescence polarization immunoassay in human serum samples.	Biosens Bioelectron
34125647	Seroprevalence of SARS-CoV-2 (COVID-19) exposure in pet cats and dogs in Minnesota, USA.	Virulence
34120824	Tocilizumab in COVID-19: The Cerrahpasa-PREDICT score.	J Infect Chemother
34112629	[COVID-19 - The vaccine miracle must include strictness and caution].	Virologie (Montrouge)
34111237	The Effect of Neutropenia and Filgrastim (G-CSF) on Cancer Patients With Coronavirus Disease 2019 (COVID-19) Infection.	Clin Infect Dis
34105997	Identification of Novel T-Cell Epitopes on Infectious Bronchitis Virus N Protein and Development of a Multi-epitope Vaccine.	J Virol
34102015	What gastroenterologists should know about SARS-CoV 2 vaccine: World Endoscopy Organization perspective.	United European Gastroenterol J
34099081	Improved diagnosis of SARS-CoV-2 by using nucleoprotein and spike protein fragment 2 in quantitative dual ELISA tests.	Epidemiol Infect
34099051	Crucial mutation in the exoribonuclease domain of nsp14 of PEDV leads to high genetic instability during viral replication.	Cell Biosci
34087220	Synthetic proteins for COVID-19 diagnostics.	Peptides
34083682	Generation of restriction endonucleases barcode map to trace SARS-CoV-2 origin and evolution.	Sci Rep
34075345	Molecular Aspects Concerning the Use of the SARS-CoV-2 Receptor Binding Domain as a Target for Preventive Vaccines.	ACS Cent Sci
34073484	Diagnostic Potential of a Luminex-Based Coronavirus Disease 2019 Suspension Immunoassay (COVID-19 SIA) for the Detection of Antibodies against SARS-CoV-2.	Viruses
34073456	Biomedical Text Link Prediction for Drug Discovery: A Case Study with COVID-19.	Pharmaceutics
34073159	Production of SARS-CoV-2 Virus-Like Particles in Insect Cells.	Vaccines (Basel)
34068677	Local Sustained GM-CSF Delivery by Genetically Engineered Encapsulated Cells Enhanced Both Cellular and Humoral SARS-CoV-2 Spike-Specific Immune Response in an Experimental Murine Spike DNA Vaccination Model.	Vaccines (Basel)
34066920	IgM and IgG Immunoreactivity of SARS-CoV-2 Recombinant M Protein.	Int J Mol Sci
34066016	Mice Immunized with the Vaccine Candidate HexaPro Spike Produce Neutralizing Antibodies against SARS-CoV-2.	Vaccines (Basel)
34063733	Environmental Risk Assessment of Recombinant Viral Vector Vaccines against SARS-Cov-2.	Vaccines (Basel)
34063562	Rotavirus as an Expression Platform of Domains of the SARS-CoV-2 Spike Protein.	Vaccines (Basel)
34063315	A Reliable Indirect ELISA Protocol for Detection of Human Antibodies Directed to SARS-CoV-2 NP Protein.	Diagnostics (Basel)
34061776	Mild COVID-19 despite autoantibodies against type I IFNs in autoimmune polyendocrine syndrome type 1.	J Clin Invest
34059058	Serial markers of coagulation and inflammation and the occurrence of clinical pulmonary thromboembolism in mechanically ventilated patients with SARS-CoV-2 infection; the prospective Maastricht intensive care COVID cohort.	Thromb J
34056088	Assessing Antigen Structural Integrity through Glycosylation Analysis of the SARS-CoV-2 Viral Spike.	ACS Cent Sci
34054808	Human Surfactant Protein D Binds Spike Protein and Acts as an Entry Inhibitor of SARS-CoV-2 Pseudotyped Viral Particles.	Front Immunol
34051226	Robust and low-cost ELISA based on IgG-Fc tagged recombinant proteins to screen for anti-SARS-CoV-2 antibodies.	J Immunol Methods
34048905	Expression and purification of recombinant SARS-CoV-2 nucleocapsid protein in inclusion bodies and its application in serological detection.	Protein Expr Purif
34048457	Avian antibodies (IgY) targeting spike glycoprotein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inhibit receptor binding and viral replication.	PLoS One
34047541	Facile Determination of COVID-19 Seroconversion via Nonradiative Energy Transfer.	ACS Sens
34045884	In vivo and in vitro Evaluation of Cytokine Expression Profiles During Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection.	J Inflamm Res
34045817	Off-label Use of Itolizumab in Patients with COVID-19 ARDS: Our Clinical Experience in a Dedicated COVID Center.	Indian J Crit Care Med
34043618	DNA vaccination induced protective immunity against SARS CoV-2 infection in hamsterss.	PLoS Negl Trop Dis
34041264	Large-Scale Recombinant Production of the SARS-CoV-2 Proteome for High-Throughput and Structural Biology Applications.	Front Mol Biosci
34037587	[Thrombosis and COVID-19 vaccine: much ado about nothing?]	G Ital Cardiol (Rome)
34035562	Development of a rapid and sensitive quantum dot nanobead-based double-antigen sandwich lateral flow immunoassay and its clinical performance for the detection of SARS-CoV-2 total antibodies.	Sens Actuators B Chem
34032294	Viral coinfections in COVID-19.	J Med Virol
34028654	Microalgae: therapeutic potentials and applications.	Mol Biol Rep
34020215	Efficacy and safety of lopinavir-ritonavir in COVID-19: A systematic review of randomized controlled trials.	J Infect Public Health
34016243	Development of a Unique Rapid Test to Detect Anti-bodies Directed Against an Extended RBD of SARS-CoV-2 Spike Protein.	Chimia (Aarau)
34014629	Covid-19 Vaccines	LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
34013321	Novel Canine Coronavirus Isolated from a Hospitalized Patient With Pneumonia in East Malaysia.	Clin Infect Dis
34011555	Treatment of high-risk bleeding with susoctocog alfa in a patient with acquired haemophilia A and a nosocomial severe acute respiratory syndrome coronavirus 2 infection.	Eur J Hosp Pharm
34006662	A Generic, Scalable, and Rapid Time-Resolved Forster Resonance Energy Transfer-Based Assay for Antigen Detection-SARS-CoV-2 as a Proof of Concept.	mBio
34003736	ZMPSTE24 Regulates SARS-CoV-2 Spike Protein-enhanced Expression of Endothelial PAI-1.	Am J Respir Cell Mol Biol
33993682	[In vitro activity of human recombinant alpha-2b interferon against SARS-CoV-2 virus].	Vopr Virusol
33993519	Recombinant CD137-Fc, its synthesis, and applications for improving the immune system functions, such as tumor immunotherapy and to reduce the inflammation due to the novel coronavirus.	J Cell Biochem
33986957	The Use of Dornase Alfa in the Management of COVID-19-Associated Adult Respiratory Distress Syndrome.	Crit Care Res Pract
33984393	Development of an immunochromatographic kit to detect severe acute respiratory syndrome coronavirus 2.	J Virol Methods
33983397	Rapid detection of inter-clade recombination in SARS-CoV-2 with Bolotie.	Genetics
33980321	Stem cell therapies and benefaction of somatic cell nuclear transfer cloning in COVID-19 era.	Stem Cell Res Ther
33979020	A simple, sensitive, and low-cost FACS assay for detecting antibodies against the native SARS-CoV-2 spike protein.	Immun Inflamm Dis
33974610	Monoclonal Antibodies vs COVID-19: Eduardo Ojito-Magaz MS General Director, Molecular Immunology Center.	MEDICC Rev
33974607	COVID-19 Requires Innovation, Regulation and Rigor: Amaylid Arteaga-Garcia MD MS Director, National Clinical Trials Coordinating Center (CENCEC).	MEDICC Rev
33973446	[Optimization of expression conditions and determination the proteolytic activity of codon-optimized SARS-CoV-2 main protease in Escherichia coli].	Sheng Wu Gong Cheng Xue Bao
33972631	Development and characterization of two equine formulations towards SARS-CoV-2 proteins for the potential treatment of COVID-19.	Sci Rep
33972374	Cellular and Humoral Immune Responses in Mice Immunized with Vaccinia Virus Expressing the SARS-CoV-2 Spike Protein.	J Immunol
33972256	Tolerability, Safety, Pharmacokinetics, and Immunogenicity of a Novel SARS-CoV-2 Neutralizing Antibody, Etesevimab, in Chinese Healthy Adults: a Randomized, Double-Blind, Placebo-Controlled, First-in-Human Phase 1 Study.	Antimicrob Agents Chemother
33971404	Circulating extracellular vesicles are endowed with enhanced procoagulant activity in SARS-CoV-2 infection.	EBioMedicine
33970846	The Effect of Recombinant Human Interferon Alpha Nasal Drops to Prevent COVID-19 Pneumonia for Medical Staff in an Epidemic Area.	Curr Top Med Chem
33967626	Recombinant Human Thymosin Beta-4 Protects against Mouse Coronavirus Infection.	Mediators Inflamm
33967342	In silico identification of RBD subdomain of spike protein from Pro(322)-Thr(581) for applications in vaccine development against SARS-CoV2.	J Mol Struct
33966930	SARS-CoV-2 vaccines: Lights and shadows.	Eur J Intern Med
33962629	Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte.	Cardiovasc Diabetol
33961621	Structural basis for SARS-CoV-2 neutralizing antibodies with novel binding epitopes.	PLoS Biol
33960659	COVID-19: vaccine's progress.	Microb Biotechnol
33959781	Process development and scale-up optimization of the SARS-CoV-2 receptor binding domain-based vaccine candidate, RBD219-N1C1.	Appl Microbiol Biotechnol
33959697	mRNA technology as one of the promising platforms for the SARS-CoV-2 vaccine development.	Vavilovskii Zhurnal Genet Selektsii
33959390	COVID-19 in Russia: Clinical and Immunological Features of the First-Wave Patients.	Acta Naturae
33955213	Single-Domain Antibodies for the Detection of SARS-CoV-2 Nucleocapsid Protein.	Anal Chem
33951374	Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant.	N Engl J Med
33950993	Off-label tocilizumab and adjuvant iron chelator effectiveness in a group of severe COVID-19 pneumonia patients: A single center experience.	Medicine (Baltimore)
33950776	Experimental studies using OMV in a new platform of SARS-CoV-2 vaccines.	Hum Vaccin Immunother
33950387	Reproducible and Easy Production of Mammalian Proteins by Transient Gene Expression in High Five Insect Cells.	Methods Mol Biol
33947753	Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection.	mBio
33946802	Antiviral Properties of the NSAID Drug Naproxen Targeting the Nucleoprotein of SARS-CoV-2 Coronavirus.	Molecules
33944697	Germline IGHV3-53-encoded RBD-targeting neutralizing antibodies are commonly present in the antibody repertoires of COVID-19 patients.	Emerg Microbes Infect
33937725	Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice.	iScience
33937326	Developmental Landscape of Potential Vaccine Candidates Based on Viral Vector for Prophylaxis of COVID-19.	Front Mol Biosci
33930819	Expression of SARS coronavirus 1 spike protein from a herpesviral vector induces innate immune signaling and neutralizing antibody responses.	Virology
33926459	A novel pseudovirus-based mouse model of SARS-CoV-2 infection to test COVID-19 interventions.	J Biomed Sci
33925446	A Nanoscaffolded Spike-RBD Vaccine Provides Protection against SARS-CoV-2 with Minimal Anti-Scaffold Response.	Vaccines (Basel)
33923573	Development of a Vaccine against SARS-CoV-2 Based on the Receptor-Binding Domain Displayed on Virus-Like Particles.	Vaccines (Basel)
33923338	From Multiplex Serology to Serolomics-A Novel Approach to the Antibody Response against the SARS-CoV-2 Proteome.	Viruses
33918914	Broad-Spectrum Antiviral Activity of 3D8, a Nucleic Acid-Hydrolyzing Single-Chain Variable Fragment (scFv), Targeting SARS-CoV-2 and Multiple Coronaviruses In Vitro.	Viruses
33914787	Fast and efficient purification of SARS-CoV-2 RNA dependent RNA polymerase complex expressed in Escherichia coli.	PLoS One
33912411	Reactivity of human antisera to codon optimized SARS-CoV2 viral proteins expressed in Escherichia coli.	Tzu Chi Med J
33908208	Roles of Type I and III Interferons in COVID-19.	Yonsei Med J
33907732	Nanotraps for the containment and clearance of SARS-CoV-2.	Matter
33907509	Review of Covid-19 vaccine clinical trials - A puzzle with missing pieces.	Int J Biol Sci
33906110	Production in Escherichia coli of recombinant COVID-19 spike protein fragments fused to CRM197.	Biochem Biophys Res Commun
33897974	Enzyme kinetic and binding studies identify determinants of specificity for the immunomodulatory enzyme ScpA, a C5a inactivating bacterial protease.	Comput Struct Biotechnol J
33897742	Efficient Transient Expression of Recombinant Proteins Using DNA Viral Vectors in Freshwater Microalgal Species.	Front Plant Sci
33893632	Increased VWF and Decreased ADAMTS-13 in COVID-19: Creating a Milieu for (Micro)Thrombosis.	Semin Thromb Hemost
33889450	Bioinformatic prediction of immunodominant regions in spike protein for early diagnosis of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).	PeerJ
33887436	Natural killer cells play an important role in virus infection control: Antiviral mechanism, subset expansion and clinical application.	Clin Immunol
33887210	Recombinant protein vaccines against SARS-CoV-2.	Lancet Infect Dis
33887209	Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1-2, dose-ranging study.	Lancet Infect Dis
33887208	Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial.	Lancet Infect Dis
33882225	Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.	N Engl J Med
33880315	Newly Diagnosed Acute Myeloid Leukemia in a Patient With Severe SARS-CoV-2 Infection.	Cureus
33880064	Optimizing Dose-Adjusted EPOCH Chemotherapy with Long-Acting Granulocyte Colony-Stimulating Factor During the COVID-19 Epidemic.	Cancer Manag Res
33879983	Development of in-house ELISAs for the detection of anti-SARSCoV2 RBD and N IgG and IgM antibodies in biological samples.	J King Saud Univ Sci
33871970	Structural and Functional Characterization of SARS-CoV-2 RBD Domains Produced in Mammalian Cells.	Anal Chem
33870242	SARS-CoV-2 colonization of maternal and fetal cells of the human placenta promotes alteration of local renin-angiotensin system.	Med (N Y)
33869946	Development of a Nucleocapsid Protein-Based ELISA for Detection of Human IgM and IgG Antibodies to SARS-CoV-2.	ACS Omega
33868324	SARS-CoV-2 Antigens Expressed in Plants Detect Antibody Responses in COVID-19 Patients.	Front Plant Sci
33865990	A novel application of delayed-type hipersensitivity reaction to measure cellular immune response in SARS-CoV-2 exposed individuals.	Clin Immunol
33862474	Novel inhibitors of the main protease enzyme of SARS-CoV-2 identified via molecular dynamics simulation-guided in vitro assay.	Bioorg Chem
33861802	Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity.	PLoS Pathog
33860869	Induction of Exaggerated Cytokine Production in Human Peripheral Blood Mononuclear Cells by a Recombinant SARS-CoV-2 Spike Glycoprotein S1 and Its Inhibition by Dexamethasone.	Inflammation
33859400	Generation of recombinant hyperimmune globulins from diverse B-cell repertoires.	Nat Biotechnol
33857754	Development of flexible electrochemical impedance spectroscopy-based biosensing platform for rapid screening of SARS-CoV-2 inhibitors.	Biosens Bioelectron
33853532	Estimating asymptomatic SARS-CoV-2 infections in a geographic area of low disease incidence.	BMC Infect Dis
33852968	Oral inhalation for delivery of proteins and peptides to the lungs.	Eur J Pharm Biopharm
33852951	An efficient system to generate truncated human angiotensin converting enzyme 2 (hACE2) capable of binding RBD and spike protein of SARS-CoV2.	Protein Expr Purif
33847226	SARSCoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice.	Hum Vaccin Immunother
33846704	Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study.	Lancet Microbe
33844797	[SARS CoV-2 Vaccine studies currently in phase III].	Rev Chilena Infectol
33844274	Characterization of HIV-1 virus-like particles and determination of Gag stoichiometry for different production platforms.	Biotechnol Bioeng
33843251	Call for More Effective Regulation of Clinical Trials with Advanced Therapy Medicinal Products Consisting of or Containing Genetically Modified Organisms in the European Union.	Hum Gene Ther
33841880	Preclinical development of a molecular clamp-stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2.	Clin Transl Immunology
33841439	Revisiting Pleiotropic Effects of Type I Interferons: Rationale for Its Prophylactic and Therapeutic Use Against SARS-CoV-2.	Front Immunol
33839165	Structure-based Design of a Specific, Homogeneous Luminescence Enzyme Reporter Assay for SARS-CoV-2.	J Mol Biol
33838744	Establishment of a reverse genetics system for SARS-CoV-2 using circular polymerase extension reaction.	Cell Rep
33838638	Free SARS-CoV-2 Spike Protein S1 Particles May Play a Role in the Pathogenesis of COVID-19 Infection.	Biochemistry (Mosc)
33838626	Recombinant SARS-CoV-2 S Protein Binds to Glycans of the Lactosamine Family in vitro.	Biochemistry (Mosc)
33837958	Bioreactor production of rVSV-based vectors in Vero cell suspension cultures.	Biotechnol Bioeng
33837212	Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates.	NPJ Vaccines
33837204	Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany.	Nat Commun
33835769	Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.	N Engl J Med
33834168	In Vitro-Administered Dexamethasone Suppresses T Cell Function With Reversal by Interleukin-7 in Coronavirus Disease 2019.	Crit Care Explor
33832783	The Next Set of COVID-19 Vaccines: Leveraging New Development Platforms to Increase Access for More People Around the World.	Clin Ther
33827460	IgG and IgM antibody formation to spike and nucleocapsid proteins in COVID-19 characterized by multiplex immunoblot assays.	BMC Infect Dis
33824382	Distinct SARS-CoV-2 antibody reactivity patterns in coronavirus convalescent plasma revealed by a coronavirus antigen microarray.	Sci Rep
33824130	Novel Coronavirus-2019 (2019-nCoV): Perspectives of emergence, prophylaxis and predicted treatment approaches.	Pak J Pharm Sci
33815307	Genomic Feature Analysis of Betacoronavirus Provides Insights Into SARS and COVID-19 Pandemics.	Front Microbiol
33810465	Neutralizing Monoclonal Anti-SARS-CoV-2 Antibodies Isolated from Immunized Rabbits Define Novel Vulnerable Spike-Protein Epitope.	Viruses
33810026	Potent Neutralization Antibodies Induced by a Recombinant Trimeric Spike Protein Vaccine Candidate Containing PIKA Adjuvant for COVID-19.	Vaccines (Basel)
33809269	A Descriptive-Multivariate Analysis of Community Knowledge, Confidence, and Trust in COVID-19 Clinical Trials among Healthcare Workers in Uganda.	Vaccines (Basel)
33804162	COVID-19: Insights into Potential Vaccines.	Microorganisms
33803850	Quantitative Spectrochip-Coupled Lateral Flow Immunoassay Demonstrates Clinical Potential for Overcoming Coronavirus Disease 2019 Pandemic Screening Challenges.	Micromachines (Basel)
33800932	The Combination of Bromelain and Acetylcysteine (BromAc) Synergistically Inactivates SARS-CoV-2.	Viruses
33794143	SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies.	Cell
33787218	Novel Compounds Targeting Neuropilin Receptor 1 with Potential To Interfere with SARS-CoV-2 Virus Entry.	ACS Chem Neurosci
33786833	SARS-CoV-2 (COVID-19) vaccination in dermatology patients on immunomodulatory and biologic agents: Recommendations from the Australasian Medical Dermatology Group.	Australas J Dermatol
33786172	Low type I interferon response in COVID-19 patients: Interferon response may be a potential treatment for COVID-19.	Biomed Rep
33784482	A Recombinant Fragment of Human Surfactant Protein D Binds Spike Protein and Inhibits Infectivity and Replication of SARS-CoV-2 in Clinical Samples.	Am J Respir Cell Mol Biol
33777030	Induction of Potent and Durable Neutralizing Antibodies Against SARS-CoV-2 Using a Receptor Binding Domain-Based Immunogen.	Front Immunol
33773111	Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials.	Lancet Infect Dis
33773105	Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein.	Cell
33772778	A single subcutaneous or intranasal immunization with adenovirus-based SARS-CoV-2 vaccine induces robust humoral and cellular immune responses in mice.	Eur J Immunol
33770348	The Role of Mucosal Immunity and Recombinant Probiotics in SARS-CoV2 Vaccine Development.	Probiotics Antimicrob Proteins
33759207	Monoclonal antibodies capable of binding SARS-CoV-2 spike protein receptor-binding motif specifically prevent GM-CSF induction.	J Leukoc Biol
33758527	Coronil, a Tri-Herbal Formulation, Attenuates Spike-Protein-Mediated SARS-CoV-2 Viral Entry into Human Alveolar Epithelial Cells and Pro-Inflammatory Cytokines Production by Inhibiting Spike Protein-ACE-2 Interaction.	J Inflamm Res
33756225	Landscape of SARS-CoV-2 spike protein-interacting cells in human tissues.	Int Immunopharmacol
33753964	Wild Sambucus nigra L. from north-east edge of the species range: A valuable germplasm with inhibitory capacity against SARS-CoV2 S-protein RBD and hACE2 binding in vitro.	Ind Crops Prod
33751609	There is no evidence of SARS-CoV-2 laboratory origin: Response to Segreto and Deigin (DOI: 10.1002/bies.202000240).	Bioessays
33748577	MXene-Graphene Field-Effect Transistor Sensing of Influenza Virus and SARS-CoV-2.	ACS Omega
33742097	Fluorescence-detection size-exclusion chromatography utilizing nanobody technology for expression screening of membrane proteins.	Commun Biol
33741993	Ad26.COV2.S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory disease.	NPJ Vaccines
33741992	Human endogenous retrovirus-enveloped baculoviral DNA vaccines against MERS-CoV and SARS-CoV2.	NPJ Vaccines
33740454	Novel approaches for vaccine development.	Cell
33737804	Withanone from Withania somnifera Attenuates SARS-CoV-2 RBD and Host ACE2 Interactions to Rescue Spike Protein Induced Pathologies in Humanized Zebrafish Model.	Drug Des Devel Ther
33732940	Discovery of Clioquinol and analogues as novel inhibitors of Severe Acute Respiratory Syndrome Coronavirus 2 infection, ACE2 and ACE2 - Spike protein interaction in vitro.	Heliyon
33732292	Immunoregulatory therapy strategies that target cytokine storms in patients with COVID-19 (Review).	Exp Ther Med
33731916	Recombinant vaccine containing an RBD-Fc fusion induced protection against SARS-CoV-2 in nonhuman primates and mice.	Cell Mol Immunol
33731300	Genetic modification to design a stable yeast-expressed recombinant SARS-CoV-2 receptor binding domain as a COVID-19 vaccine candidate.	Biochim Biophys Acta Gen Subj
33731271	Intranasal administration of a recombinant RBD vaccine induced protective immunity against SARS-CoV-2 in mouse.	Vaccine
33725211	Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses.	J Clin Immunol
33722288	SARS-CoV-2 vaccine ChAdOx1 nCoV-19 infection of human cell lines reveals low levels of viral backbone gene transcription alongside very high levels of SARS-CoV-2 S glycoprotein gene transcription.	Genome Med
33718731	Optical Detection of CoV-SARS-2 Viral Proteins to Sub-Picomolar Concentrations.	ACS Omega
33711560	SARS_CoV2 RBD gene transcription cannot be driven by CMV promoter.	Virology
33711012	Natural selection in the evolution of SARS-CoV-2 in bats created a generalist virus and highly capable human pathogen.	PLoS Biol
33709675	Therapeutic strategies in patients with coagulopathy and disseminated intravascular coagulation: awareness of the phase-dependent characteristics.	Minerva Med
33709491	Synthetic Homogeneous Glycoforms of the SARS-CoV-2 Spike Receptor-Binding Domain Reveals Different Binding Profiles of Monoclonal Antibodies.	Angew Chem Int Ed Engl
33707427	SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface.	Nat Commun
33691606	Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates.	Emerg Microbes Infect
33688035	One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection.	Proc Natl Acad Sci U S A
33688034	A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike.	Proc Natl Acad Sci U S A
33685461	Endotheliopathy in septic conditions: mechanistic insight into intravascular coagulation.	Crit Care
33683136	A SARS-CoV-2 Peptide Spectral Library Enables Rapid, Sensitive Identification of Virus Peptides in Complex Biological Samples.	J Proteome Res
33683065	[Interferon gamma in the treatment of patients with moderate COVID-19].	Vopr Virusol
33676899	Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity.	EBioMedicine
33676782	Vaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerations for a risk/benefit assessment.	Vaccine
33673067	Titers of Neutralizing Antibodies against SARS-CoV-2 Are Independent of Symptoms of Non-Severe COVID-19 in Young Adults.	Viruses
33664494	Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies.	Nat Med
33662796	Recombinant ADAMTS13 reduces abnormally up-regulated von Willebrand factor in plasma from patients with severe COVID-19.	Thromb Res
33658497	Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaques.	Nat Commun
33655803	Host Modulation and Treatment of Periodontal Disease.	J Dent Res
33655614	Targeting the Main Protease of SARS-CoV-2: From the Establishment of High Throughput Screening to the Design of Tailored Inhibitors.	Angew Chem Int Ed Engl
33653892	Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model.	mBio
33640142	Biosecurity risks associated with vaccine platform technologies.	Vaccine
33639626	Mechanisms of COVID-19 Entry into the Cell: Potential Therapeutic Approaches Based on Virus Entry Inhibition in COVID-19 Patients with Underlying Diseases.	Iran J Allergy Asthma Immunol
33635931	Inhibition of anti-viral stress granule formation by coronavirus endoribonuclease nsp15 ensures efficient virus replication.	PLoS Pathog
33635533	Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update.	High Blood Press Cardiovasc Prev
33630751	A Low-Cost SARS-CoV-2 rRBD ELISA to Detect Serostatus in Ecuadorian Population with COVID-19.	Am J Trop Med Hyg
33629859	Aptamer Conjugated Gold Nanostar-Based Distance-Dependent Nanoparticle Surface Energy Transfer Spectroscopy for Ultrasensitive Detection and Inactivation of Corona Virus.	J Phys Chem Lett
33628749	A review on the advancements in the development of vaccines to combat coronavirus disease 2019.	Clin Exp Vaccine Res
33627390	Effect of an Adenovirus-Vectored Universal Influenza Virus Vaccine on Pulmonary Pathophysiology in a Mouse Model.	J Virol
33624533	An overview of vaccine development for COVID-19.	Ther Deliv
33620016	Effect of a genetically engineered interferon-alpha versus traditional interferon-alpha in the treatment of moderate-to-severe COVID-19: a randomised clinical trial.	Ann Med
33619344	In silico detection of SARS-CoV-2 specific B-cell epitopes and validation in ELISA for serological diagnosis of COVID-19.	Sci Rep
33619170	Vaccines for older adults.	BMJ
33618668	Identification and functional analysis of the SARS-COV-2 nucleocapsid protein.	BMC Microbiol
33610448	Immunotherapy for COVID-19: Evolving treatment of viral infection and associated adverse immunological reactions.	Transfus Apher Sci
33608968	Large scale production and characterization of SARS-CoV-2 whole antigen for serological test development.	J Clin Lab Anal
33607284	Variants in ACE2; potential influences on virus infection and COVID-19 severity.	Infect Genet Evol
33603836	Recombinant interleukin-2 stimulates lymphocyte recovery in patients with severe COVID-19.	Exp Ther Med
33602937	Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections.	Nat Commun
33600384	Decline in Receipt of Vaccines by Medicare Beneficiaries During the COVID-19 Pandemic - United States, 2020.	MMWR Morb Mortal Wkly Rep
33598439	Reverse Transcription Recombinase-Aided Amplification Assay With Lateral Flow Dipstick Assay for Rapid Detection of 2019 Novel Coronavirus.	Front Cell Infect Microbiol
33596485	Available COVID-19 serial seroconversion panel for validation of SARS-CoV-2 antibody assays.	Diagn Microbiol Infect Dis
33594346	Acute pulmonary embolism and systemic thrombolysis in the era of COVID-19 global pandemic 2020: a case series of seven patients admitted to a regional hospital in the French epidemic cluster.	Eur Heart J Case Rep
33592744	Single-step, wash-free digital immunoassay for rapid quantitative analysis of serological antibody against SARS-CoV-2 by photonic resonator absorption microscopy.	Talanta
33590886	Comment on Hadadi et al., Does recombinant human erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects? J. Med. Virol. 2020; 92:915-918.	J Med Virol
33584747	Development of Plant-Produced Recombinant ACE2-Fc Fusion Protein as a Potential Therapeutic Agent Against SARS-CoV-2.	Front Plant Sci
33584719	Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model.	Front Immunol
33584306	HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons.	Front Pharmacol
33582454	Expression, purification and immunological characterization of recombinant nucleocapsid protein fragment from SARS-CoV-2.	Virology
33582147	Parameters of immunoglobulin extraction from dried blood spot cards and immunoassays for detection of antibody response to pathogens including the novel SARS-CoV-2.	J Immunol Methods
33578295	Age-dependent effects of the recombinant spike protein/SARS-CoV-2 on the M-CSF- and IL-34-differentiated macrophages in vitro.	Biochem Biophys Res Commun
33577760	Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity.	Immunity
33577086	American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver Disease.	Hepatology
33572725	Effect of An 84-bp Deletion of the Receptor-Binding Domain on the ACE2 Binding Affinity of the SARS-CoV-2 Spike Protein: An In Silico Analysis.	Genes (Basel)
33570381	Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19.	ACS Infect Dis
33567448	mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants.	Nature
33563543	Interferons and other cytokines, genetics and beyond in COVID-19 and autoimmunity.	Cytokine Growth Factor Rev
33558863	Expression and purification of tag-free SARS-CoV-2 RNA-dependent RNA polymerase in Escherichia coli.	STAR Protoc
33558635	Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobody.	Sci Rep
33557911	Carboxypeptidase B blocks ex vivo activation of the anaphylatoxin-neutrophil extracellular trap axis in neutrophils from COVID-19 patients.	Crit Care
33556147	Multimerization- and glycosylation-dependent receptor binding of SARS-CoV-2 spike proteins.	PLoS Pathog
33555988	A novel DNA and protein combination COVID-19 vaccine formulation provides full protection against SARS-CoV-2 in rhesus macaques.	Emerg Microbes Infect
33548227	How glycobiology can help us treat and beat the COVID-19 pandemic.	J Biol Chem
33545094	Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia.	Lancet
33542724	SP-A and SP-D: Dual Functioning Immune Molecules With Antiviral and Immunomodulatory Properties.	Front Immunol
33540410	Decline and Recurrence of Stroke Consultations during the COVID-19 Pandemic Lockdown Parallels Population Activity Levels.	Cerebrovasc Dis
33539188	Secretion of von Willebrand Factor and Suppression of ADAMTS-13 Activity by Markedly High Concentration of Ferritin.	Clin Appl Thromb Hemost
33534552	Toolkit for Quickly Generating and Characterizing Molecular Probes Specific for SARS-CoV-2 Nucleocapsid as a Primer for Future Coronavirus Pandemic Preparedness.	ACS Synth Biol
33532418	Does COVID-19 antibody serology testing correlate with disease severity? An analytical descriptive retrospective study.	J Family Med Prim Care
33529763	High level stable expression of recombinant HIV gp120 in glutamine synthetase gene deficient HEK293T cells.	Protein Expr Purif
33529230	High-level expression of the monomeric SARS-CoV-2 S protein RBD 320-537 in stably transfected CHO cells by the EEF1A1-based plasmid vector.	PLoS One
33529223	Development and performance evaluation of a rapid in-house ELISA for retrospective serosurveillance of SARS-CoV-2.	PLoS One
33526960	Presence of antibodies against SARS-CoV-2 spike protein in bovine whey IgG enriched fraction.	Int Dairy J
33526776	Piglet immunization with a spike subunit vaccine enhances disease by porcine epidemic diarrhea virus.	NPJ Vaccines
33524996	Allergische Reaktionen auf COVID-19-Impfungen - Was HNO-Arzte wissen sollten - Teil 1: Allgemeine Aspekte von Allergien auf Impfstoffe, immunologische Grundlagen von Allergien auf Impfstoffe, Immunmechanismen von allergischen und pseudoallergischen Reaktionen; Teil 2: Charakteristiken der mRNA-Impfstoffe BNT162b2 und mRNA-1273 zur Prophylaxe von COVID-19, weitere Impfstoff-Kandidaten und assoziierte Immunphanomene; Teil 3: Praktische Aspekte der Prophylaxe, Diagnostik und Therapie von Allergien auf COVID-19-Impfstoffe.	Laryngorhinootologie
33524396	Potent mouse monoclonal antibodies that block SARS-CoV-2 infection.	J Biol Chem
33521006	ACE2 Expression in Kidney and Testis May Cause Kidney and Testis Infection in COVID-19 Patients.	Front Med (Lausanne)
33516600	Recombinant SARS-CoV-2 RBD with a built in T helper epitope induces strong neutralization antibody response.	Vaccine
33515911	The Nucleocapsid protein triggers the main humoral immune response in COVID-19 patients.	Biochem Biophys Res Commun
33514944	Engineering SARS-CoV-2 using a reverse genetic system.	Nat Protoc
33499326	Optimising Vaccine Dose in Inoculation against SARS-CoV-2, a Multi-Factor Optimisation Modelling Study to Maximise Vaccine Safety and Efficacy.	Vaccines (Basel)
33499096	Strategies for Vaccination: Conventional Vaccine Approaches Versus New-Generation Strategies in Combination with Adjuvants.	Pharmaceutics
33496577	Magnetic Bead-Based Immunoassay Allows Rapid, Inexpensive, and Quantitative Detection of Human SARS-CoV-2 Antibodies.	ACS Sens
33493916	Natural biflavonoids as potential therapeutic agents against microbial diseases.	Sci Total Environ
33493450	Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial.	Lancet Respir Med
33491994	Increased resistance to fibrinolysis activation in patients with coronavirus disease 2019: a case series.	Blood Coagul Fibrinolysis
33488611	Genetic Dissection of the Regulatory Mechanisms of Ace2 in the Infected Mouse Lung.	Front Immunol
33486513	Beta interferons as immunotherapy in multiple sclerosis: a new outlook on a classic drug during the COVID-19 pandemic.	QJM
33484708	Chloroquine may induce endothelial injury through lysosomal dysfunction and oxidative stress.	Toxicol Appl Pharmacol
33483707	Systematic evaluation of IgG responses to SARS-CoV-2 spike protein-derived peptides for monitoring COVID-19 patients.	Cell Mol Immunol
33481336	Generation of enzymatically competent SARS-CoV-2 decoy receptor ACE2-Fc in glycoengineered Nicotiana benthamiana.	Biotechnol J
33477379	Chimeric Porcine Deltacoronaviruses with Sparrow Coronavirus Spike Protein or the Receptor-Binding Domain Infect Pigs but Lose Virulence and Intestinal Tropism.	Viruses
33472860	Coronavirus replication-transcription complex: Vital and selective NMPylation of a conserved site in nsp9 by the NiRAN-RdRp subunit.	Proc Natl Acad Sci U S A
33469510	A domain-based vaccine construct against SARS-CoV-2, the causative agent of COVID-19 pandemic: development of self-amplifying mRNA and peptide vaccines.	Bioimpacts
33464672	Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine*.	Angew Chem Int Ed Engl
33458462	Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic Analysis.	ACS Omega
33454213	The Counter Regulatory Axis of the Lung Renin-Angiotensin System in Severe COVID-19: Pathophysiology and Clinical Implications.	Heart Lung Circ
33453299	Nucleoprotein-based ELISA for detection of SARS-COV-2 IgG antibodies: Could an old assay be suitable for serodiagnosis of the new coronavirus?	J Virol Methods
33452689	EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines.	Allergy
33445936	Principles and new perspectives in the vaccination against SARS-CoV-2 virus.	Cas Lek Cesk
33441437	Cutting Edge: Mouse SARS-CoV-2 Epitope Reveals Infection and Vaccine-Elicited CD8 T Cell Responses.	J Immunol
33440088	Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine.	N Engl J Med
33436573	Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity.	Nat Commun
33435994	Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein.	Virol J
33432067	No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor.	Sci Rep
33431557	Generation and Characterization of recombinant SARS-CoV-2 expressing reporter genes.	J Virol
33430748	In Silico Prediction and Designing of Potential siRNAs to be used as Antivirals Against SARS-CoV-2.	Curr Pharm Des
33429915	Rapid SARS-CoV-2 Detection Using Electrochemical Immunosensor.	Sensors (Basel)
33426604	ACE-2-interacting Domain of SARS-CoV-2 (AIDS) Peptide Suppresses Inflammation to Reduce Fever and Protect Lungs and Heart in Mice: Implications for COVID-19 Therapy.	J Neuroimmune Pharmacol
33424908	Pilot Production of SARS-CoV-2 Related Proteins in Plants: A Proof of Concept for Rapid Repurposing of Indoor Farms Into Biomanufacturing Facilities.	Front Plant Sci
33422287	Impaired fibrinolysis in critically ill COVID-19 patients.	Br J Anaesth
33421475	Recombinant protein vaccines, a proven approach against coronavirus pandemics.	Adv Drug Deliv Rev
33420426	AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells.	Cell Res
33418320	BCG immunomodulation: From the 'hygiene hypothesis' to COVID-19.	Immunobiology
33414643	Calcio-Herbal Medicine Divya-Swasari-Vati Ameliorates SARS-CoV-2 Spike Protein-Induced Pathological Features and Inflammation in Humanized Zebrafish Model by Moderating IL-6 and TNF-alpha Cytokines.	J Inflamm Res
33414457	Interleukin-38 ameliorates poly(I:C) induced lung inflammation: therapeutic implications in respiratory viral infections.	Cell Death Dis
33412393	Evaluation of a new simultaneous anti-SARS-CoV-2 IgA, IgM and IgG screening automated assay based on native inactivated virus.	Int Immunopharmacol
33409271	Design, Expression, Purification, and Characterization of a YFP-Tagged 2019-nCoV Spike Receptor-Binding Domain Construct.	Front Bioeng Biotechnol
33401333	Coronavirus disease 2019 and the revival of passive immunization: Antibody therapy for inhibiting severe acute respiratory syndrome coronavirus 2 and preventing host cell infection: IUPHAR review: 31.	Br J Pharmacol
33400157	Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID-19 pneumonia and moderate hyperinflammation. A retrospective cohort study.	Intern Emerg Med
33397449	Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19).	Trials
33397387	Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions.	Virol J
33396184	The Two-Way Switch Role of ACE2 in the Treatment of Novel Coronavirus Pneumonia and Underlying Comorbidities.	Molecules
33386773	SARS-CoV-2 nucleocapsid protein intranasal inoculation induces local and systemic T cell responses in mice.	J Med Virol
33377103	A protocol for displaying viral envelope glycoproteins on the surface of vesicular stomatitis viruses.	STAR Protoc
33373718	Conus venom fractions inhibit the adhesion of Plasmodium falciparum erythrocyte membrane protein 1 domains to the host vascular receptors.	J Proteomics
33370363	Seroprevalence of SARS-CoV-2 IgG specific antibodies among healthcare workers in the Northern Metropolitan Area of Barcelona, Spain, after the first pandemic wave.	PLoS One
33359615	Application of real-time PCR to significantly reduce the time to obtain recombinant MVA virus.	J Virol Methods
33352786	Environmental Risk Assessment for rVSVDeltaG-ZEBOV-GP, a Genetically Modified Live Vaccine for Ebola Virus Disease.	Vaccines (Basel)
33352323	Recombinant tissue plasminogen activator treatment for COVID-19 associated ARDS and acute cor pulmonale.	Int J Infect Dis
33348746	Monitoring Viral Entry in Real-Time Using a Luciferase Recombinant Vesicular Stomatitis Virus Producing SARS-CoV-2, EBOV, LASV, CHIKV, and VSV Glycoproteins.	Viruses
33347529	Assessment and comparison of recombinant proteins from different sources for the detection of SARS-CoV-2 infection by using protein microarray.	Acta Biochim Biophys Sin (Shanghai)
33343609	A Roadmap for the Molecular Farming of Viral Glycoprotein Vaccines: Engineering Glycosylation and Glycosylation-Directed Folding.	Front Plant Sci
33341604	Neutralizing antibodies targeting SARS-CoV-2 spike protein.	Stem Cell Res
33340765	In vitro display evolution of IL-6R-binding unnatural peptides ribosomally initiated and cyclized with m-(chloromethyl)benzoic acid.	Biochem Biophys Res Commun
33333742	Identification of Host Cellular Protein Substrates of SARS-COV-2 Main Protease.	Int J Mol Sci
33331654	Evaluation of serum IgM and IgG antibodies in COVID-19 patients by enzyme linked immunosorbent assay.	J Med Virol
33331401	Natural versus Recombinant Viral Antigens in SARS-CoV-2 Serology: Challenges in Optimizing Laboratory Diagnosis of COVID-19.	Clinics (Sao Paulo)
33330840	Development of a High-Throughput Homogeneous AlphaLISA Drug Screening Assay for the Detection of SARS-CoV-2 Nucleocapsid.	ACS Pharmacol Transl Sci
33330645	The Genetic Dissection of Ace2 Expression Variation in the Heart of Murine Genetic Reference Population.	Front Cardiovasc Med
33330119	Foundation and Clinical Evaluation of a New Method for Detecting SARS-CoV-2 Antigen by Fluorescent Microsphere Immunochromatography.	Front Cell Infect Microbiol
33329603	Type I Interferon (IFN)-Regulated Activation of Canonical and Non-Canonical Signaling Pathways.	Front Immunol
33329352	Modification of Acute Stroke Pathway in Korea After the Coronavirus Disease 2019 Outbreak.	Front Neurol
33328475	A single dose of recombinant VSV-G-spike vaccine provides protection against SARS-CoV-2 challenge.	Nat Commun
33324387	Evaluation of Humoral Immunity to SARS-CoV-2: Diagnostic Value of a New Multiplex Addressable Laser Bead Immunoassay.	Front Microbiol
33316002	Combination of C21 and ARBs with rhACE2 as a therapeutic protocol: A new promising approach for treating ARDS in patients with coronavirus infection.	Med J Islam Repub Iran
33311634	Structural and functional comparison of SARS-CoV-2-spike receptor binding domain produced in Pichia pastoris and mammalian cells.	Sci Rep
33311439	Cationic nanocarriers as potent adjuvants for recombinant S-RBD vaccine of SARS-CoV-2.	Signal Transduct Target Ther
33310922	Age-dependent possible role of contact-activated blood coagulation factor XII as a potential contributor to the "bradykinin storm" in COVID-19 patients	Orv Hetil
33310781	Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses.	mBio
33303188	Immunomodulation for the management of severe SARS-CoV2 infections. State of the art and review of the literature.	Biochem Biophys Res Commun
33302991	Anakinra treatment in critically ill COVID-19 patients: a prospective cohort study.	Crit Care
33301853	Rapid, high-yield production of full-length SARS-CoV-2 spike ectodomain by transient gene expression in CHO cells.	J Biotechnol
33298149	A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study.	Trials
33296685	SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation.	Immunity
33292350	An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients.	Immun Ageing
33275613	A comparison of non-magnetic and magnetic beads for measuring IgG antibodies against Plasmodium vivax antigens in a multiplexed bead-based assay using Luminex technology (Bio-Plex 200 or MAGPIX).	PLoS One
33265982	Modeling the Molecular Impact of SARS-CoV-2 Infection on the Renin-Angiotensin System.	Viruses
33264067	Frontrunners in the race to develop a SARS-CoV-2 vaccine.	Can J Microbiol
33260775	Anti-SARS-CoV-2 Antibody Responses in Convalescent Plasma Donors Are Increased in Hospitalized Patients; Subanalyses of a Phase 2 Clinical Study.	Microorganisms
33259596	Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines.	Blood
33257686	Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platform.	Nat Commun
33250897	Rapid Response Subunit Vaccine Design in the Absence of Structural Information.	Front Immunol
33249290	A dramatic rise in serum ACE2 activity in a critically ill COVID-19 patient.	Int J Infect Dis
33240967	Bovine Interferon Lambda Is a Potent Antiviral Against SARS-CoV-2 Infection in vitro.	Front Vet Sci
33232769	SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells.	Vascul Pharmacol
33232211	Recombinant vaccines for COVID-19.	Hum Vaccin Immunother
33227340	Evaluating SARS-CoV-2 spike and nucleocapsid proteins as targets for antibody detection in severe and mild COVID-19 cases using a Luminex bead-based assay.	J Virol Methods
33221508	Nanozyme chemiluminescence paper test for rapid and sensitive detection of SARS-CoV-2 antigen.	Biosens Bioelectron
33218025	A Novel Purification Procedure for Active Recombinant Human DPP4 and the Inability of DPP4 to Bind SARS-CoV-2.	Molecules
33218001	Application of Viral Vectors for Vaccine Development with a Special Emphasis on COVID-19.	Viruses
33212162	Warp-Speed Covid-19 Vaccine Development: Beneficiaries of Maturation in Biopharmaceutical Technologies and Public-Private Partnerships.	J Pharm Sci
33208459	Systematic Examination of Antigen-Specific Recall T Cell Responses to SARS-CoV-2 versus Influenza Virus Reveals a Distinct Inflammatory Profile.	J Immunol
33203681	Global analysis of more than 50,000 SARS-CoV-2 genomes reveals epistasis between eight viral genes.	Proc Natl Acad Sci U S A
33195337	Brazilian Consortium for the Study on Renal Diseases Associated With COVID-19: A Multicentric Effort to Understand SARS-CoV-2-Related Nephropathy.	Front Med (Lausanne)
33194329	Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2, the etiologic agent of COVID-19 pandemic: an in silico approach.	PeerJ
33193454	CoVaccine HT Adjuvant Potentiates Robust Immune Responses to Recombinant SARS-CoV-2 Spike S1 Immunization.	Front Immunol
33190387	Sudden cardiogenic shock mimicking fulminant myocarditis in a surviving teenager affected by severe acute respiratory syndrome coronavirus 2 infection.	ESC Heart Fail
33189887	Major reduction of NKT cells in patients with severe COVID-19 pneumonia.	Clin Immunol
33188624	Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score Analysis.	J Clin Immunol
33187644	Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity.	Biochem Biophys Res Commun
33184753	Development and evaluation of a serological test for diagnosis of COVID-19 with selected recombinant spike proteins.	Eur J Clin Microbiol Infect Dis
33179911	Quercetin and Its Metabolites Inhibit Recombinant Human Angiotensin-Converting Enzyme 2 (ACE2) Activity.	J Agric Food Chem
33179852	Human soluble ACE2 improves the effect of remdesivir in SARS-CoV-2 infection.	EMBO Mol Med
33178094	An Example of a Stroke Unit Reshaping in the Context of a Regional Hub and Spoke System in the COVID-19 Era.	Front Neurol
33173718	Bioinspired DNase-I-Coated Melanin-Like Nanospheres for Modulation of Infection-Associated NETosis Dysregulation.	Adv Sci (Weinh)
33172191	New Technologies for Influenza Vaccines.	Microorganisms
33166547	A fluorescence-based high throughput-screening assay for the SARS-CoV RNA synthesis complex.	J Virol Methods
33164796	Identification of a dominant CD8(+) CTL epitope in the SARS-associated coronavirus 2 spike protein.	Vaccine
33163249	The Progression of SARS Coronavirus 2 (SARS-CoV2): Mutation in the Receptor Binding Domain of Spike Gene.	Immune Netw
33162299	Interleukin-6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID-19.	Eur J Intern Med
33161843	Flow-Mediated Susceptibility and Molecular Response of Cerebral Endothelia to SARS-CoV-2 Infection.	Stroke
33161277	COVID-19 update: The race to therapeutic development.	Drug Resist Updat
33148151	Insights from Pharmaceutical Biotechnology into Phenolic Biopharmaceuticals against COVID-19.	Curr Pharm Biotechnol
33144565	Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID-19.	Signal Transduct Target Ther
33135725	ACE2, the kidney and the emergence of COVID-19 two decades after ACE2 discovery.	Clin Sci (Lond)
33131609	Human recombinant soluble ACE2 in severe COVID-19.	Lancet Respir Med
33130319	Long-acting nanoparticulate DNase-1 for effective suppression of SARS-CoV-2-mediated neutrophil activities and cytokine storm.	Biomaterials
33128388	Production of trimeric SARS-CoV-2 spike protein by CHO cells for serological COVID-19 testing.	Biotechnol Bioeng
33126179	Dual lateral flow optical/chemiluminescence immunosensors for the rapid detection of salivary and serum IgA in patients with COVID-19 disease.	Biosens Bioelectron
33123207	Screening for Anti-Influenza Actives of Prefractionated Traditional Chinese Medicines.	Evid Based Complement Alternat Med
33121319	SARS-CoV-2 vaccine candidates in rapid development.	Hum Vaccin Immunother
33114742	Antibody Binding to SARS-CoV-2 S Glycoprotein Correlates with but Does Not Predict Neutralization.	Viruses
33112236	Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.	Elife
33111431	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	Proteomics
33111375	SARS-CoV-2 RBD Neutralizing Antibody Induction is Enhanced by Particulate Vaccination.	Adv Mater
33108655	Development and Expression of Subunit Vaccines Against Viruses in Plants.	Methods Mol Biol
33099241	A novel rapid detection for SARS-CoV-2 spike 1 antigens using human angiotensin converting enzyme 2 (ACE2).	Biosens Bioelectron
33098139	Tocilizumab use in patients with moderate to severe COVID-19: A retrospective cohort study.	J Clin Pharm Ther
33097094	Identification of AAV serotypes for lung gene therapy in human embryonic stem cell-derived lung organoids.	Stem Cell Res Ther
33089452	Human Hematopoietic Stem, Progenitor, and Immune Cells Respond Ex Vivo to SARS-CoV-2 Spike Protein.	Stem Cell Rev Rep
33087516	Humidity and Deposition Solution Play a Critical Role in Virus Inactivation by Heat Treatment of N95 Respirators.	mSphere
33080267	Designed variants of ACE2-Fc that decouple anti-SARS-CoV-2 activities from unwanted cardiovascular effects.	Int J Biol Macromol
33077685	Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins.	Mol Cell Proteomics
33073222	Rapid Response to Cytokine Storm Inhibition Using Anakinra in a Patient With COVID-19 Myocarditis.	CJC Open
33064991	Timeline: Vaccines.	Cell
33064620	The role of the thymus in COVID-19 disease severity: implications for antibody treatment and immunization.	Hum Vaccin Immunother
33064451	Comprehensive Analysis of the Glycan Complement of SARS-CoV-2 Spike Proteins Using Signature Ions-Triggered Electron-Transfer/Higher-Energy Collisional Dissociation (EThcD) Mass Spectrometry.	Anal Chem
33062952	An Enzymatic TMPRSS2 Assay for Assessment of Clinical Candidates and Discovery of Inhibitors as Potential Treatment of COVID-19.	ACS Pharmacol Transl Sci
33060840	Unique immunological profile in patients with COVID-19.	Cell Mol Immunol
33052685	Discovery of COVID-19 Inhibitors Targeting the SARS-CoV-2 Nsp13 Helicase.	J Phys Chem Lett
33048448	Generation of Recombinant SARS-CoV-2 Using a Bacterial Artificial Chromosome.	Curr Protoc Microbiol
33046644	Swine acute diarrhea syndrome coronavirus replication in primary human cells reveals potential susceptibility to infection.	Proc Natl Acad Sci U S A
33043052	Observational study of the use of recombinant tissue-type plasminogen activator in COVID-19 shows a decrease in physiological dead space.	ERJ Open Res
33039209	Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement.	Vaccine
33033717	Prepare for the Future: Dissecting the Spike to Seek Broadly Neutralizing Antibodies and Universal Vaccine for Pandemic Coronaviruses.	Front Mol Biosci
33032845	The impact of export regulations on recombinant viral vaccine development for emerging infectious diseases.	Vaccine
33032170	SARS-CoV-2 cell entry receptor ACE2 mediated endothelial dysfunction leads to vascular thrombosis in COVID-19 patients.	Med Hypotheses
33031955	TOCIVID-19 - A multicenter study on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia. Study protocol.	Contemp Clin Trials
33026741	Interferon Beta-1b and Lopinavir-Ritonavir for Middle East Respiratory Syndrome.	N Engl J Med
33024086	Is smaller better? Vaccine targeting recombinant receptor-binding domain might hold the key for mass production of effective prophylactics to fight the COVID-19 pandemic.	Signal Transduct Target Ther
33022015	Biochemical screening for SARS-CoV-2 main protease inhibitors.	PLoS One
33019628	Persistence of Anti-SARS-CoV-2 Antibodies in Non-Hospitalized COVID-19 Convalescent Health Care Workers.	J Clin Med
33017910	Defensin 5 for prevention of SARS-CoV-2 invasion and Covid-19 disease.	Med Hypotheses
33010978	Enhanced elicitation of potent neutralizing antibodies by the SARS-CoV-2 spike receptor binding domain Fc fusion protein in mice.	Vaccine
33007504	Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro.	Redox Biol
32998438	Development and Optimization of In-house ELISA for Detection of Human IgG Antibody to SARS-CoV-2 Full Length Spike Protein.	Pathogens
32997812	Accuracy of serological testing for SARS-CoV-2 antibodies: First results of a large mixed-method evaluation study.	Allergy
32995758	ReScan, a Multiplex Diagnostic Pipeline, Pans Human Sera for SARS-CoV-2 Antigens.	Cell Rep Med
32993479	Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically ventilated COVID-19 patients: a case series.	Mol Med
32991819	Lung Expression of Human Angiotensin-Converting Enzyme 2 Sensitizes the Mouse to SARS-CoV-2 Infection.	Am J Respir Cell Mol Biol
32991231	Neutralizing antibody response elicited by SARS-CoV-2 receptor-binding domain.	Hum Vaccin Immunother
32990161	Establishment of replication-competent vesicular stomatitis virus-based recombinant viruses suitable for SARS-CoV-2 entry and neutralization assays.	Emerg Microbes Infect
32989935	COVID-19 Patients Upregulate Toll-like Receptor 4-mediated Inflammatory Signaling That Mimics Bacterial Sepsis.	J Korean Med Sci
32985202	SARS-CoV-2: Zoonotic origin of pandemic coronavirus.	Acta Virol
32984400	Understanding Selenium and Glutathione as Antiviral Factors in COVID-19: Does the Viral M(pro) Protease Target Host Selenoproteins and Glutathione Synthesis?	Front Nutr
32983065	Development of HiBiT-Tagged Recombinant Infectious Bronchitis Coronavirus for Efficient in vitro and in vivo Viral Quantification.	Front Microbiol
32979942	Molecular Architecture of the SARS-CoV-2 Virus.	Cell
32978313	Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.	mBio
32975254	Detection of the SARS-CoV-2 humanized antibody with paper-based ELISA.	Analyst
32974328	Low-Cost, Large-Scale Production of the Anti-viral Lectin Griffithsin.	Front Bioeng Biotechnol
32966064	Development of a Parallel Reaction Monitoring Mass Spectrometry Assay for the Detection of SARS-CoV-2 Spike Glycoprotein and Nucleoprotein.	Anal Chem
32965677	N-terminally truncated nucleocapsid protein of SARS-CoV-2 as a better serological marker than whole nucleocapsid protein in evaluating the immunogenicity of inactivated SARS-CoV-2.	J Med Virol
32961082	Perspectives on development of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).	Hum Vaccin Immunother
32959400	Clinical characteristics and predictors of the duration of SARS-CoV-2 viral shedding in 140 healthcare workers.	J Intern Med
32940187	Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.	Rev Recent Clin Trials
32938769	The Enzymatic Activity of the nsp14 Exoribonuclease Is Critical for Replication of MERS-CoV and SARS-CoV-2.	J Virol
32935333	T-cell responses and therapies against SARS-CoV-2 infection.	Immunology
32924964	An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario.	J Basic Clin Physiol Pharmacol
32922804	Preliminary report of in vitro and in vivo effectiveness of dornase alfa on SARS-CoV-2 infection.	New Microbes New Infect
32922409	Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System.	Front Immunol
32921216	COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up.	Expert Rev Anti Infect Ther
32913364	A comprehensive, longitudinal analysis of humoral responses specific to four recombinant antigens of SARS-CoV-2 in severe and non-severe COVID-19 patients.	PLoS Pathog
32910179	Effect of Recombinant Human Granulocyte Colony-Stimulating Factor for Patients With Coronavirus Disease 2019 (COVID-19) and Lymphopenia: A Randomized Clinical Trial.	JAMA Intern Med
32910155	Immune Stimulation With Recombinant Human Granulocyte Colony-Stimulating Factor for Coronavirus Disease 2019 (COVID-19)-Beware of Blind Spots.	JAMA Intern Med
32907757	Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengineering the coronavirus glycan-shield to present alpha-gal epitopes.	Vaccine
32899754	The Potential of Algal Biotechnology to Produce Antiviral Compounds and Biopharmaceuticals.	Molecules
32897177	SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates.	Emerg Microbes Infect
32896291	Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia.	Lancet
32890908	Two serological approaches for detection of antibodies to SARS-CoV-2 in different scenarios: a screening tool and a point-of-care test.	Diagn Microbiol Infect Dis
32887634	SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19.	J Hematol Oncol
32877576	Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine.	N Engl J Med
32870351	Future perspective: high-throughput construction of new ultrasensitive cytokine and virion liquid chips for high-throughput screening (HTS) of anti-inflammatory drugs or clinical diagnosis and treatment of inflammatory diseases.	Anal Bioanal Chem
32864605	Development and effectiveness of pseudotyped SARS-CoV-2 system as determined by neutralizing efficiency and entry inhibition test in vitro.	Biosaf Health
32864572	Treatment Options Available for COVID-19 and an Analysis on Possible Role of Combination of rhACE2, Angiotensin (1-7) and Angiotensin (1-9) as Effective Therapeutic Measure.	SN Compr Clin Med
32860432	Tocilizumab use in COVID-19-associated pneumonia.	J Med Virol
32858060	Evaluation of SARS-CoV-2 prototype serologic test in hospitalized patients.	Clin Biochem
32854108	A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures.	Nature
32850978	Combination Therapy Using Inhalable GapmeR and Recombinant ACE2 for COVID-19.	Front Mol Biosci
32850977	Molecular Pathogenesis, Immunopathogenesis and Novel Therapeutic Strategy Against COVID-19.	Front Mol Biosci
32847856	SARS-CoV-2 and Three Related Coronaviruses Utilize Multiple ACE2 Orthologs and Are Potently Blocked by an Improved ACE2-Ig.	J Virol
32846910	A Scalable Topical Vectored Vaccine Candidate against SARS-CoV-2.	Vaccines (Basel)
32845122	Quantum Dot-Conjugated SARS-CoV-2 Spike Pseudo-Virions Enable Tracking of Angiotensin Converting Enzyme 2 Binding and Endocytosis.	ACS Nano
32841605	Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor.	Cell Host Microbe
32837985	Development of cell-based pseudovirus entry assay to identify potential viral entry inhibitors and neutralizing antibodies against SARS-CoV-2.	Genes Dis
32837460	A review on Promising vaccine development progress for COVID-19 disease.	Vacunas
32835775	Identification B and T-Cell epitopes and functional exposed amino acids of S protein as a potential vaccine candidate against SARS-CoV-2/COVID-19.	Microb Pathog
32835245	Anakinra for severe forms of COVID-19: a cohort study.	Lancet Rheumatol
32831940	Anti-interleukin-6 monoclonal antibody for cytokine storm in COVID-19.	Ann Thorac Med
32829467	Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome.	J Clin Immunol
32826924	An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques.	Nat Commun
32822911	A combinational approach to restore cytokine balance and to inhibit virus growth may promote patient recovery in severe COVID-19 cases.	Cytokine
32820746	Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2020-21 Influenza Season.	MMWR Recomm Rep
32817270	In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges.	Science
32808459	Is Growth Hormone Insufficiency the Missing Link Between Obesity, Male Gender, Age, and COVID-19 Severity?	Obesity (Silver Spring)
32804015	A novel biparatopic hybrid antibody-ACE2 fusion that blocks SARS-CoV-2 infection: implications for therapy.	MAbs
32801840	A Review on Currently Available Potential Therapeutic Options for COVID-19.	Int J Gen Med
32796155	Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity.	JCI Insight
32769760	The Controversy of Renin-Angiotensin-System Blocker Facilitation Versus Countering COVID-19 Infection.	J Cardiovasc Pharmacol
32763313	Remdesivir triphosphate can efficiently inhibit the RNA-dependent RNA polymerase from various flaviviruses.	Antiviral Res
32758889	Rethinking interleukin-6 blockade for treatment of COVID-19.	Med Hypotheses
32753517	Cytokine storm release syndrome and the prospects for immunotherapy with COVID-19, part 3: The role of GM-CSF.	Cleve Clin J Med
32745670	New disease old vaccine: Is recombinant BCG vaccine an answer for COVID-19?	Cell Immunol
32744052	IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).	J Biol Regul Homeost Agents
32738193	A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition.	Cell Host Microbe
32735992	Design of an engineered ACE2 as a novel therapeutics against COVID-19.	J Theor Biol
32732280	Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy.	Science
32730512	[Renin Angiotensin Axis, Angiotensin Converting Enzyme 2 and Coronavirus].	Rev Chil Pediatr
32726802	A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity.	Nature
32724171	Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic.	Nat Microbiol
32722191	Head-to-Head Accuracy Comparison of Three Commercial COVID-19 IgM/IgG Serology Rapid Tests.	J Clin Med
32721804	Recombinant protein targeting and opsonizing spike glycoprotein for enhancing SARS-CoV-2 phagocytosis.	Med Hypotheses
32720890	Multiple novel non-canonically transcribed sub-genomic mRNAs produced by avian coronavirus infectious bronchitis virus.	J Gen Virol
32707942	Evaluation of Current Therapies for COVID-19 Treatment.	Microorganisms
32707445	Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections.	EBioMedicine
32703906	Structure-based design of prefusion-stabilized SARS-CoV-2 spikes.	Science
32703420	Efficient production of recombinant SARS-CoV-2 spike protein using the baculovirus-silkworm system.	Biochem Biophys Res Commun
32702935	An infant with coronavirus disease 2019 in China: A case report.	Medicine (Baltimore)
32702299	Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial.	Lancet
32700671	Monoclonal antibodies for the S2 subunit of spike of SARS-CoV-1 cross-react with the newly-emerged SARS-CoV-2.	Euro Surveill
32698494	Self-Amplifying RNA Viruses as RNA Vaccines.	Int J Mol Sci
32696811	Long-term positive severe acute respiratory syndrome coronavirus 2 ribonucleic acid and therapeutic effect of antivirals in patients with coronavirus disease: Case reports.	Rev Soc Bras Med Trop
32696234	Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies.	Eur J Clin Pharmacol
32691875	SARS-CoV-2 S1 is superior to the RBD as a COVID-19 subunit vaccine antigen.	J Med Virol
32691863	Diagnostic accuracy of Augurix COVID-19 IgG serology rapid test.	Eur J Clin Invest
32687172	Identification of SARS-CoV-2 in a Proficiency Testing Program.	Am J Clin Pathol
32681308	Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak.	Eur J Clin Microbiol Infect Dis
32680924	Oncology-Inspired Treatment Options for COVID-19.	J Nucl Med
32679691	Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes.	Vaccines (Basel)
32679298	Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test.	J Clin Virol
32677909	A COVID-19 patient with multiple negative results for PCR assays outside Wuhan, China: a case report.	BMC Infect Dis
32660240	Development of a Sensitive Immunochromatographic Method Using Lanthanide Fluorescent Microsphere for Rapid Serodiagnosis of COVID-19.	ACS Sens
32659292	Immunoglobulin fragment F(ab')2 against RBD potently neutralizes SARS-CoV-2 in vitro.	Antiviral Res
32651113	Recombinant SARS-CoV-2 spike S1-Fc fusion protein induced high levels of neutralizing responses in nonhuman primates.	Vaccine
32643997	Effect of recombinant human granulocyte colony-stimulating factor on lymphocyte subsets in patients with COVID-19.	Infect Dis (Lond)
32643436	Pharmacological and non-pharmacological efforts at prevention, mitigation, and treatment for COVID-19.	J Drug Target
32634813	COVID-19 and Stroke: Casual or Causal Role?	Cerebrovasc Dis
32632085	Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia.	Nat Commun
32626626	Role of the Backbenchers of the Renin-Angiotensin System ACE2 and AT2 Receptors in COVID-19: Lessons From SARS.	Cureus
32613971	Construction and immunogenic studies of a mFc fusion receptor binding domain (RBD) of spike protein as a subunit vaccine against SARS-CoV-2 infection.	Chem Commun (Camb)
32605363	SARS-CoV-2 Coronavirus Nucleocapsid Antigen-Detecting Half-Strip Lateral Flow Assay Toward the Development of Point of Care Tests Using Commercially Available Reagents.	Anal Chem
32604797	Data and Text Mining Help Identify Key Proteins Involved in the Molecular Mechanisms Shared by SARS-CoV-2 and HIV-1.	Molecules
32603801	Validation of a commercially available SARS-CoV-2 serological immunoassay.	Clin Microbiol Infect
32591466	COVID-19 Vaccines: "Warp Speed" Needs Mind Melds, Not Warped Minds.	J Virol
32581256	Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication.	Acta Pharmacol Sin
32579100	Insights into SARS-CoV-2, the Coronavirus Underlying COVID-19: Recent Genomic Data and the Development of Reverse Genetics Systems.	J Gen Virol
32571182	Molecular Targets in the Chemotherapy of Coronavirus Infection.	Biochemistry (Mosc)
32564046	Coronavirus SARS-Cov-2 and arterial hypertension - facts and myths.	Pol Merkur Lekarski
32560746	Efficacy and safety of aerosolized intra-tracheal dornase alfa administration in patients with SARS-CoV-2-induced acute respiratory distress syndrome (ARDS): a structured summary of a study protocol for a randomised controlled trial.	Trials
32557541	A Comprehensive Review of Tocilizumab in COVID-19 Acute Respiratory Distress Syndrome.	J Clin Pharmacol
32550040	Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019.	Chronic Dis Transl Med
32546188	The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection.	Crit Care
32546125	Erythropoietin as candidate for supportive treatment of severe COVID-19.	Mol Med
32546029	Case report: use of lenzilumab and tocilizumab for the treatment of coronavirus disease 2019.	Immunotherapy
32542396	Decoy ACE2-expressing extracellular vesicles that competitively bind SARS-CoV-2 as a possible COVID-19 therapy.	Clin Sci (Lond)
32537687	Impact of COVID-19 on thyroid cancer surgery and adjunct therapy.	Updates Surg
32535705	Is Hypertension a Real Risk Factor for Poor Prognosis in the COVID-19 Pandemic?	Curr Hypertens Rep
32532085	Broad-Spectrum Host-Based Antivirals Targeting the Interferon and Lipogenesis Pathways as Potential Treatment Options for the Pandemic Coronavirus Disease 2019 (COVID-19).	Viruses
32527802	The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients.	Sci Immunol
32527136	Large pulmonary cavity in COVID-19 cured patient case report.	Ann Palliat Med
32518941	Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: Implications for vaccination and antibody therapeutics.	Glycobiology
32508026	A new and rapid approach for detecting COVID-19 based on S1 protein fragments.	Clin Transl Med
32505777	Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays.	J Clin Virol
32504802	Optimizing high-yield production of SARS-CoV-2 soluble spike trimers for serology assays.	Protein Expr Purif
32503816	Oral Methioninase for Covid-19 Methionine-restriction Therapy.	In Vivo
32501454	Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study.	Lancet Rheumatol
32497796	Combination of thrombolytic and immunosuppressive therapy for coronavirus disease 2019: A case report.	Int J Infect Dis
32485620	Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies.	J Clin Virol
32485251	A recombinant Lactobacillus plantarum strain expressing the spike protein of SARS-CoV-2.	Int J Biol Macromol
32483586	Clinical Validation of a SARS-CoV-2 Real-Time Reverse Transcription PCR Assay Targeting the Nucleocapsid Gene.	J Appl Lab Med
32478959	Topical recombinant human acidic fibroblast growth factor: An effective therapeutic agent for facemask wearing-induced pressure sores.	Dermatol Ther
32476472	COVID-19: ACE2centric Infective Disease?	Hypertension
32469114	An update on ACE2 amplification and its therapeutic potential.	Acta Physiol (Oxf)
32464097	Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19.	Cell Host Microbe
32461321	Porcine Epidemic Diarrhea Virus Deficient in RNA Cap Guanine-N-7 Methylation Is Attenuated and Induces Higher Type I and III Interferon Responses.	J Virol
32456286	Antiviral Effects of Hydroxychloroquine and Type I Interferon on In Vitro Fatal Feline Coronavirus Infection.	Viruses
32450106	Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial.	Lancet
32443163	Interferons in the Therapy of Severe Coronavirus Infections: A Critical Analysis and Recollection of a Forgotten Therapeutic Regimen with Interferon Beta.	Drug Res (Stuttg)
32438383	Inhaled modified angiotensin converting enzyme 2 (ACE2) as a decoy to mitigate SARS-CoV-2 infection.	N Z Med J
32435607	Potential Role of ACE2 in Coronavirus Disease 2019 (COVID-19) Prevention and Management.	J Transl Int Med
32428864	Angiotensin converting enzyme-2 as therapeutic target in COVID-19.	Diabetes Metab Syndr
32422932	Detection of Recombinant Rousettus Bat Coronavirus GCCDC1 in Lesser Dawn Bats (Eonycteris spelaea) in Singapore.	Viruses
32410206	Clinical characteristics and drug therapies in patients with the common-type coronavirus disease 2019 in Hunan, China.	Int J Clin Pharm
32397182	Influenza Virus Like Particles (VLPs): Opportunities for H7N9 Vaccine Development.	Viruses
32394467	A global treatments for coronaviruses including COVID-19.	J Cell Physiol
32392562	JAK Inhibition as a New Treatment Strategy for Patients with COVID-19.	Int Arch Allergy Immunol
32389618	An infant with a mild SARS-CoV-2 infection detected only by anal swabs: a case report.	Braz J Infect Dis
32377399	COVID-19 vaccines: breaking record times to first-in-human trials.	NPJ Vaccines
32376359	Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2.	Microb Pathog
32366740	COVID-19 and Avoiding Ibuprofen. How Good Is the Evidence?	Am J Ther
32366695	Site-specific glycan analysis of the SARS-CoV-2 spike.	Science
32365944	SARS Unique Domain (SUD) of Severe Acute Respiratory Syndrome Coronavirus Induces NLRP3 Inflammasome-Dependent CXCL10-Mediated Pulmonary Inflammation.	Int J Mol Sci
32362193	Quadruple therapy for asymptomatic COVID-19 infection patients.	Expert Rev Anti Infect Ther
32360182	Antiviral activities of type I interferons to SARS-CoV-2 infection.	Antiviral Res
32356252	COVID-19: Therapeutics and Their Toxicities.	J Med Toxicol
32354636	Blockade of SARS-CoV-2 infection by recombinant soluble ACE2.	Kidney Int
32352535	COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options.	Cardiovasc Res
32344853	Searching for SARS-COV-2 on Particulate Matter: A Possible Early Indicator of COVID-19 Epidemic Recurrence.	Int J Environ Res Public Health
32336612	The pivotal link between ACE2 deficiency and SARS-CoV-2 infection.	Eur J Intern Med
32333836	Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2.	Cell
32333398	A hypothesis for pathobiology and treatment of COVID-19: The centrality of ACE1/ACE2 imbalance.	Br J Pharmacol
32332765	Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig.	Nat Commun
32331255	Origin, Potential Therapeutic Targets and Treatment for Coronavirus Disease (COVID-19).	Pathogens
32323974	Rapid and Sensitive Detection of anti-SARS-CoV-2 IgG, Using Lanthanide-Doped Nanoparticles-Based Lateral Flow Immunoassay.	Anal Chem
32315281	Possible Bat Origin of Severe Acute Respiratory Syndrome Coronavirus 2.	Emerg Infect Dis
32311431	Etiology and genetic evolution of canine coronavirus circulating in five provinces of China, during 2018-2019.	Microb Pathog
32306047	Antibody Detection and Dynamic Characteristics in Patients With Coronavirus Disease 2019.	Clin Infect Dis
32298218	Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19.	Hum Vaccin Immunother
32270515	Does recombinant human erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects?	J Med Virol
32267081	Continuous Intravenous Anakinra Infusion to Calm the Cytokine Storm in Macrophage Activation Syndrome.	ACR Open Rheumatol
32267072	Intravenous Anakinra for Macrophage Activation Syndrome May Hold Lessons for Treatment of Cytokine Storm in the Setting of Coronavirus Disease 2019.	ACR Open Rheumatol
32265331	Single-Dose, Intranasal Immunization with Recombinant Parainfluenza Virus 5 Expressing Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike Protein Protects Mice from Fatal MERS-CoV Infection.	mBio
32264791	Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2.	Circ Res
32250244	Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients.	Elife
32249203	Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development.	EBioMedicine
32234130	[Progress and challenge of vaccine development against 2019-novel coronavirus (2019-nCoV)].	Zhonghua Yu Fang Yi Xue Za Zhi
32229605	Evaluation of Nucleocapsid and Spike Protein-Based Enzyme-Linked Immunosorbent Assays for Detecting Antibodies against SARS-CoV-2.	J Clin Microbiol
32219057	The SARS-CoV-2 Vaccine Pipeline: an Overview.	Curr Trop Med Rep
32216114	Structural and biochemical characterization of SADS-CoV papain-like protease 2.	Protein Sci
32198501	Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19).	Clin Infect Dis
32188728	Structure-Guided Mutagenesis Alters Deubiquitinating Activity and Attenuates Pathogenesis of a Murine Coronavirus.	J Virol
32117569	Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China.	F1000Res
32057575	Recombinant infectious bronchitis coronavirus H120 with the spike protein S1 gene of the nephropathogenic IBYZ strain remains attenuated but induces protective immunity.	Vaccine
32045235	alpha-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment.	J Med Chem
31967321	Cross-species transmission of the newly identified coronavirus 2019-nCoV.	J Med Virol
31905842	Investigation of the Role of the Spike Protein in Reversing the Virulence of the Highly Virulent Taiwan Porcine Epidemic Diarrhea Virus Pintung 52 Strains and Its Attenuated Counterpart.	Viruses
